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ABSTRACT
Bartonella henselae is a zoonotic agent in which the domestic cat serves as the 
natural reservoir, and humans acquire potentially serious infections associated with this 
microorganism. The purpose o f this research is to contribute to the understanding of the 
pathogenesis of B. henselae in the domestic cat using a molecular approach.
Using sequence differences in a portion of thel6S rRNA gene between B. henselae 
genotype I, and B. henselae genotype II, a nested polymerase chain reaction (nPCR) 
was designed and used to investigate various phases of feline bartonellosis. The nPCR 
detected 3.2 organisms per milliliter of blood which is below the detection limits of 
standard bacterial culture. Bartonella henselae LSU 16 genotype II, Bartonella 
henselae Baby genotype II, Bartonella henselae 87-66 genotype I, and Bartonella 
henselae Houston-1 genotype I were used in this study to infect cats. The PCR assay 
detected Bartonella DNA in 40 blood samples that were culture negative. The 
bacteremia as determined by PCR lasted for a period of 1 to 9 weeks longer than 
determined by culture methods in 10 of the 16 cats. An episode of relapsing bacteremia 
occurred in two cats during the infection. Of the twenty-three cats examined,
Bartonella DNA was detected in various tissues from 10 of the 23 cats. The spleen of 
nine o f the 10 cats was positive for Bartonella DNA. The other tissues in which 
Bartonella DNA was detected included bone marrow, lymph node, kidney, lung, liver, 
brain, and heart valve. Histopathological lesions associated with nonspecific antigenic 
stimulation were seen in the cats but organisms could not be visualized in tissue. RNA 
expression analysis using the RT-PCR assay with primers specific for the 16S rRNA 
and the citrate synthase gene (gitA) of Bartonella detected no Bartonella RNA
xiv
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expression in the tissue o f infected cats. Bartonella genotypes remained the same 
throughout the period of the acute bacteremia and in the recurring bacteremia in two 
cats as determined by the PCR assay. The persistent Bartonella DNA detected in tissue 
was B. henselae genotype II. B. henselae genotype I was not detected in any o f the 
infected cats.
X V
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CHAPTER ONE 
REVIEW OF LITERATURE 
Description and History of the Genus 
Bartonella
Taxonomy. The genus Bartonella is named for A. L. Barton who described 
Bartonella bacilliformis in 1909 as an intraerythrocytic bacterium. Bartonella 
bacilliformis was at one time the only species in the genus Bartonella. The genus 
Bartonella and Grahamella were the only two genera in the family Bartonellaceae that 
were in the Order Rickettsiales. With DNA-DNA hybridization techniques, the 
taxonomy and classification of the family Bartonellaceae was changed and the current 
Bartonella species, other than B. bacilliformis, changed names and taxonomy several 
times before being finally placed into the current order o f Bartonellaceae. The 1984 
edition of Bergey’s Manual of Systematic Bacteriology divided the order Rickettsiales 
into three families namely, Rickettsiaceae, Bartonellaceae, and Anaplasmataceae 
(Weiss 1984). Bartonella bacilliformis was the only member o f the genus Bartonella, 
and Grahamella was the other genus in the family Bartonellaceae. The Rickettsiaceae 
family initially included three genera, Rickettsia, Coxiella, and Rochalimaea. The first 
and current Bartonella species (other than B. bacilliformis), B. quintana, was first 
named Rickettsia quintana in 1917 as proposed by Schmincke, and is the causative 
agent of trench fever (Maurin 1996). Rickettsia quintana was then transferred to the 
genus Rochalimaea by Krieg in 1961 (Maruin 1996). The next Rochalimaea named 
was R. vinsonii isolated from voles (Microtus pennsylvanicus) in Canada (Weiss et al. 
1978). The third Rochalimaea species, R. henselae had been visualized in tissue 
sections of lesions with Warthin-Starry staining but had not been successfully cultured
l
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or identified (Angritt et al.1988; Leboit et al. 1988). Using the polymerase chain 
reaction(PCR) and oligonucleotide primers complementary to 16S ribosomal RNA 
genes of eubacteria, Reiman amplified the 16S ribosomal gene fragment o f 
Rochalimaea henselae directly from tissue samples o f patients with bacillary 
angiomatosis (Reiman et al. 1990). Slater et al. (1990) and Welch et al. (1992) then 
isolated the organism on solid medium supplemented with horse or human blood from 
the blood of patients infected with the human immunodeficiency vims (HIV), transplant 
recipients, immunocompetent patients with bacteremia and a patient with peliosis 
hepatis (Slater et al. 1990; Welch et al. 1992). Based on DNA-DNA hybridization data 
and comparison o f existing 16S rRNA gene sequences, Rochalimaea and Coxiella were 
removed from the Rickettsiaceae family, and the genus Rochalimaea were renamed 
Bartonella (Brenner et al. 1993). The genus Rochalimaea was transferred from the 
family Rickettsiaceae to the family Bartonellaceae and united with the genus 
Bartonella. The family Bartonellaceae was removed from the order Rickettsiales 
(Brenner et al. 1993). The current genus Bartonella was created. Bartonella species 
were removed from the order Rickettsiales, and the genus Bartonella and Grahamella 
were combined. Closely related genera based on the sequence homology o f the 16S 
rRNA gene are the Brucella and the Agrobacterium (Regnery et al.1992; Anderson and 
Neuman 1997). The genus Bartonella is in the family Bartonellaceae and belongs to 
the alpha-2-subdivision of the class Proteobacteria. There are presently 14 recognized 
species of Bartonella. Included in the group is B. henselae, B. bacilliformis, B. 
quintana, B. elizabethae (all human pathogens), B. vinsonii, (B. vinsonii subspecies
2
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berkhoffi), B. grahamii, B. taylorii, B. doshiae, B. talpae, B. peromysci, B. clarridgeae, 
B. koehlerae, B. alsatica, B. tribocorum.
Description of the genus. Bartonella species are small (0.6 by 1.0 um) gram 
negative rods that are often slightly curved. Bartonella species in general are 
biochemically inert (Bergy’s Manual, Ninth edition). They are oxidase, catalase, and 
urease negative, aerobic, and highly fastidious. They do not produce acid from 
carbohydrates. B. bacilliformis possesses polar flagella whereas B. henselae and B. 
quintana display twitching motility due to the presence of pili (Welch and Slater, 1999). 
The genome sizes have been estimated to be 1.5 x 106 bp for B. quintana and 2 xI06bp 
for B. vinsonii (Meyers et al. 1980) and the guanine plus cytosine content o f the 
genomes for Bartonella species is estimated at 39 to 40% (Weiss et al. 1978; Tyeryar et 
al. 1973; Welch et al. 1992). Plasmids have not been described (Kreuger et al. 1995). A 
bacteriophage particle has been identified in both B. bacilliformis (Umemori et al. 1992) 
and B. henselae (Anderson et al.1994). Gene sequences of B. henselae published are 
those encoding the citrate synthase, 16S rRNA (Daly et al. 1993; Regnery et al. 1993), 
5S rRNA, 23S rRNA genes, intergenic regions between rRNA genes (Minnick 1994), a 
60-kDa antigen in B. henselae (Anderson et al.1993) and a unique 17-kDA gene 
(Anderson et al. 1995).
Bartonella species and hum an disease. The disease syndrome attributed to B. 
bacilliformis is bartonellosis or Carrion’s disease. Carrion’s disease is geographically 
confined to the South American Andes region. Its regional occurrence is the result of 
the limited distribution o f the sand fly (Lutzomyia verrucarum), the vector. Carrion’s 
disease is a biphasic disease consisting of an acute hemolytic anemia (Oroya fever) and
3
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a chronic form (verruga peruana) that presents with vascular proliferative skin lesions. 
Evidence from the artifacts o f pre-Columbian culture suggests that the verruga peruana 
form o f Carrion's disease was present in Ecuador at least 1,000 years before the arrival 
of Europeans (Anderson and Neuman 1997).
Bartonella quintana, the causative agent of trench fever was first identified among 
battlefield troops in World War I (Review by Anderson and Neuman 1997). It was 
estimated that over 1 million troops were affected. The disease was characterized by a 
5-day relapsing fever, with severe and persistent pain in the shins, and although rarely 
fatal, it resulted in prolonged disability. The disease also affected troops in World War
II. Trench fever was a debilitating febrile illness characterized by fever, rash, bone pain 
and splenomegaly. The disease is often associated with poor sanitation and personal 
hygiene, and is communicable by means of the body louse (Pediculus humanus). 
Infection is thought to be transmitted from lice to humans via the arthropod excreta, 
which enters the body through broken skin (Maurin and Raoult 1996). Since World 
War II infections associated with B. quintana were rare until the description of 
infections in human immunodeficiency virus (HIV)-infected patients. The reason for 
the reemergence of B. quintana infections after many years o f apparent absence is 
unclear (Reiman 1998).
In addition to causing diseases with which Bartonella has been historically 
connected, members o f the genus Bartonella have been isolated from a range of 
emerging diseases with a wide array of clinical syndromes. B. henselae is associated 
with diseases with granulomatous features such as cat scratch disease, and vascular 
proliferative disease, such as bacillary angiomatosis, peliosis, and epidemics of
4
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bacteremic illness. B. quintana is associated with bacteremic illness, endocarditis, and 
bacillary angiomatosis and peliosis, but not cat scratch disease. B. quintana infection is 
epidemiologically associated with homelessness, low income, and exposure to lice 
(Koehler et al. 1997). B. quintana infections are seen in HIV-infected patients, chronic 
alcoholics, and homeless individuals (Drancourt et al. 1993; Koehler et al.1992; Spach 
et al. 1993).
B. henselae is associated with bacteremic illness, endocarditis, bacillary 
angiomatosis, peliosis, and cat scratch disease. B. henselae infections are 
epidemiologically linked to cat and flea exposure (Koehler et al. 1997). The most 
common Bartonella infection in humans is cat scratch disease (CSD). In the United 
States the number of CSD cases is estimated to be approximately 25,000 annually 
(Welch and Slater 1999). Typical CSD occurs in about 89% of the cases and is usually 
a self-limiting disease with fever and lymphadenopathy, usually preceded by an 
erythematous papule at the inoculation site (Welch and Slater 1999). Most cases of 
CSD are resolved within 2-6 months (Margilith et al.1992). About one-third of the 
patients have a fever, and about one-sixth develop lymph node suppuration (Welch and 
Slater 1999). Inflammatory reactions include granulomata and stellate necrosis seen on 
histopathological examination of the nodes (Welch and Slater 1999). Atypical CSD 
occurs in about 11% of the cases. Complications resulting from atypical CSD include 
encephalitis, retinitis, hepatic and splenic abscesses, pneumonia osteomyelitis, lytic 
bone lesions, conjunctivitis, and central nervous system involvement (Anderson 1997).
Other Bartonella species involved in human disease include B. elizabethae, which 
was isolated from a single patient with endocarditis (Daly et al. 1993), and B.
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clarridgeiae, which has been isolated from a patient with cat scratch disease (Kordick et 
al. 1997a). Bartonella vinsonii subsp. berkhoffii was reported in a case o f endocarditis 
in a human that was blood culture-negative and afebrile (Roux et al. 2000). In that case, 
Bartonella DNA was detected by PCR from valvular material removed during aortic 
valve replacement. The bacterium was never cultured.
Bartonella species not related to human disease. Bartonella vinosonii, B. 
grahamii, B. taylorii, B. doshiae, B. talpae, B. koehlerae, and B. peromysci have all 
been identified in a wide range of mammalian species, including felines and rodents 
(Birtles et al. 1995; Heller et al. 1997; Chomel et al. 1995; Droz et al. 1999) but are all 
presently considered nonpathogenic to humans. B. vinsonii has been isolated from vole 
and canines and designated B. vinsonii subsp. vinsonii and B. vinsonii subsp. berkhoffii, 
respectively (Kordick and Breitschwerdt 1998). B. vinsonii subsp. vinsonii was first 
isolated in 1946 from the spleen of a vole and was not described again until 1995 when 
B. vinsonii subsp. berkhoffi was isolated from a dog with vascular endocarditis 
(Breitschwerdt and Kordick 1995). In North Carolina and Virginia 3.6% of 1,920 dogs 
were seropositive for B. vinsonii subsp. berkhoffii (Pappalardo et al. 1997). A study by 
Chang et al. (1998) demonstrated the prevalence o f antibodies (7% to 51%) to B. 
vinsonii subsp. berkhoffii in coyotes (Canis latrans) from parts of northern California. 
The seroprevlaence o f Bartonella in coyotes in California was from the coastal counties 
and thought to be vector transmitted from wildlife to domestic dogs (Chang et al. 1998).
Bartonella henselae 
Background and history. Bartonella henselae, a member of the family 
Bartonellaceae has emerged as an important microorganism in the last 5 years.
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Bartonella henselae is a zoonotic agent causing a wide array o f human disease 
syndromes with the domestic cat as a major reservoir for the organism. In humans, B. 
henselae is associated with cat scratch disease, bacillary angiomatosis, and bacillary 
peliosis. The search for the infectious agent responsible for these new emerging 
diseases and the connection to the domestic cat evolved slowly and involved clinical 
medicine, traditional microbiology, and genetic approaches. The various manifestations 
of CSD have been recognized for over 100 years but “la maladies des griffes du chat” 
was not identified as a syndrome until 1950 (Debre et al, 1950). The search for the 
etiologic agent o f CSD has been long with the first described clinical cases in 1931 by 
Debre and Semelaigne and published in 1950 (Shinall 1990). Organisms that have been 
reported as the potential etiologic agent o f the disease included a herpes-like virus 
(Kalter et al. 1969), a hemagglutinating virus (Turner et al. 1959), Chlamydia (Emmons 
et al. 1976), and an acid-fast bacillus (Boyd 1961). Despite the unknown etiology, a 
clinical diagnosis o f CSD was based on the presence of three criteria: 1) history of 
animal contact with the presence of a scratch or an inoculation lesion of the skin, eye or 
mucous membrane; 2) a positive CSD skin test (CSD antigen); 3) regional 
lymphadenopathy with negative laboratory results for other causes of 
lymphadenopathy; and 4) characteristic histopathologic changes consistent with CSD in 
a biopsied lymph node (Margileth 1988).
In 1988, the Armed Forces Institute o f Pathology named Ajipia felis  as the agent of 
CSD (Regnery and Tappero 1995). Wear et al. (1983), reported finding bacteria in 
lymph nodes of cat scratch disease patients meeting the criteria by using the Warthin- 
Starry silver stain. Then in 1988, English et al. (1988) reported the isolation, of a
7
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bacterial agent from a lymph node of a CSD patient’s. The isolate, Afipia felis, was 
named after the Armed Forces Institute of Pathology (Afipia), the source o f the original 
isolate, and felis referring to the presumed vertebrate vector o f CSD (Wear et al.1983; 
English et al. 1988; Regnery and Tappero 1995). Upon further investigation, other 
laboratories could not recover isolates of A. felis from CSD patients, and a serological 
link between A. felis and cats could not be demonstrated (Bergmans et al. 1995;
Regnery and Tappero 1995).
The next part of the story and the true etiologic agent o f  CSD emerged when patients 
infected with human immunodeficiency virus (HIV) developed cutaneous and 
subcutaneous vascular lesions containing baciilary organisms seen on Warthin-Stany 
silver stain described as indistinguishable from baciilary organisms seen in CSD 
patients (Stoler et al. 1983, Koehler et al. 1993; Tappero et al. 1993). Zangwill et 
al.(1993), reported that patients with baciilary angiomatosis had a household kitten 
under the age of 1 year and reported traumatic contact with a cat. Reiman (1990) 
identified DNA from baciilary angiomatosis skin lesions that was not necessarily 
identical to but was related to Rochalimaea quintana. Independently but about the same 
time in Houston, Texas, Rochalimaea-Yike organisms were isolated from the blood of 
HIV-infected patients with relapsing fever of unknown origin. In Oklahoma, Welch et 
al. (1992) isolated a similar organism and coined the new species designation R. 
henselae in recognition o f the contribution of Diane Hensel, who initially isolated 
several o f the organisms in Oklahoma (Regnery et al. 1992a). Regnery et al. (1992b) 
then developed an indirect fluorescence antibody (IFA) using the Houston-1 isolate o f 
R. henselae and found high antibody titers to R. henselae in patients identified with
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HIV-infected baciilary angiomatosis and later in CSD patients (Tappero et al. 1992; 
Regnery et al. 1992). This was the first laboratory evidence that R. henselae was 
associated with CSD. R. henselae was isolated directly from the lymph nodes of two 
CSD patients and identified in 1993 by Dolan et al. Using archival sources 93% of the 
skin-test positive CSD patients tested positive by IFA to Rochalimaea antigen (Szelc et 
al. 1992). Also, pasteurized exudate collected from suppurative CSD lymph nodes used 
in the skin test as antigen was shown by PCR to contain Rochalimaea nucleic acid 
sequences and R. henselae sequences in particular (Perkins et al. 1992; Anderson et al. 
1993).
A role for the cat in the life cycle o f R. henselae was proposed following the 
discovery o f R. henselae as the etiologic agent o f CSD. Involvement o f the cat in the 
life cycle of B. henselae was demonstrated by Bartonella-specific IFA antibodies in 39 
of 48 cats living in households reporting human CSD in a study by Zangwill, 1993. 
After detecting anti -Bartonella henselae antibodies in a cat by IFA, Regnery et al. 
(1992a) isolated B. henselae from the blood of a single cat not linked to human illness. 
R. henselae was isolated from the blood o f cats whose owners were diagnosed with 
baciilary angiomatosis established the cat as a reservoir for R. henselae infection 
(Koehler et al. 1994) Cat ownership was then considered a risk factor for diagnosis of 
CSD and baciilary angiomatosis. In the last decade the reservoir, the possible vectors, 
the diseases, the epidemiology, the genetic characteristics, and many other aspects of B. 
henselae have been studied. Despite all these years, many aspects o f  feline 
bartonellosis are still unclear.
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B. henselae, the causative agent o f cat scratch disease (CSD), has been linked by 
epidemiologic and serologic studies to cats (Zangwill, et al.1993; Childs et al.1994; 
Chomel et al.1995; Demers et al.1995; Koehler et al. 1994). Contact with cats, 
especially kittens, has been shown to be a significant risk factor (Zangwill et al. 1993). 
In the vast majority of CSD cases, patients have been bitten or scratched by a cat. In a 
small percentage o f CSD patients, no history of animal contact was reported (Caithers et 
al.1969).
The role of the flea (Ctenocephalides felis) as a vector for transmission has been 
explored. B. henselae has been amplified by PCR from the flea gut after 24 hours and 
nine days after feeding on cat blood seeded with B. henselae (Higgins et al. 1996).
Using an IFA assay Higgins et al. (1996) were able to observe B. henselae in dissected 
guts o f fleas after3 hours and at 9 days after infectious feeding. Qualitatively the 
number of fluorescing bacteria were more plentiful in flea guts at 9 days. Experimental 
transmission of B. henselae between cats by way of a cat flea vector has been 
demonstrated (Chomel et al. 1996). The route o f the exposure from cat to cat was not 
clear until an experimental infection of domestic cats with B. henselae by inoculation of 
flea feces alone (Foil et al. 1998). Direct transmission of B. henselae from cat fleas to 
humans has not been demonstrated. Reports of tick bites before infection with B. 
henselae have been reported (Lucey et al.1992).
Cat scratch disease accounts for approximately 24,000 cases annually in the United 
States, with an estimated 2,000 hospital admissions (Jackson et al. 1993). The estimated 
health-care cost of CSD in 1992 in the U.S. is $12 million per year (Jackson et al.
1993). The peak incidence o f cases of CSD is in persons between ages 2 and 14
10
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(Caithers 1985; Zangwill et al. 1993). The incidence is reported to be higher in males 
(60%) and in whites (Klein et al. 1994) and is seasonal with most cases recognized in 
the second half of the year (Carithers 1985). Individual reports from numerous 
countries suggest a worldwide distribution of CSD (Flexman et al.1995; Ueno et al. 
1995; Waldvogel et al.1995).
Bartonella henselae and Cats 
Prevalence. Prevalence studies performed in both cats and human patients to 
determine seroprevalence of B. henselae use the indirect fluorescent-antibody test 
(IFA), the enzyme-linked immunoabsorbent assay (ELISA), and the western blot 
analysis. Several prevalence studies done in cats have shown the sensitivity (86.2 % 
ELISA versus 88% IFA) and specificity (95.9% ELISA versus 94% IFA) when 
measuring IgG between the IFA and ELISA to be similar (Guptill et al. 1997; Regnery 
et al. 1996). Other studies, done by Bergmans et al, (1997) on human patients have 
pointed out the pitfalls and fallacies o f serological tests and showed preparation of 
Bartonella-specific antigen influenced the outcome of the test, and measurement of IgM 
(71%) was shown to have a greater sensitivity than that o f IgG (40.9%) serology. In 
other studies B. quintana and B. clarridgeiae have been shown to serologically cross- 
react with B. henselae antigens thus influencing seroprevalence o f B. henselae in cats 
(Childs et al. 1995; Kordick et al. 1997a; Freeland et al. 1999). Nevertheless, the 
prevalence o f B. henselae in cats as determined by serologic evidence using Bartonella- 
specific antigens and by the presence of bacteremia in cats has been reported and varies 
according to the type o f cat population (pet or stray), age o f the animal, gender, region 
of the country as influenced by weather patterns and flea infestation of cats. Chomel et
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al. (1995) found impounded and former stray cats were 2.86 times more likely to be 
bacteremic than pet cats and young cats (<1 year old) were 1.64 times more likely than 
adult cats to be bacteremic, and bacteremic cats were more likely than nonbacteremic 
cats to be infested with fleas. In a study by Zangwill et al. (1993) in Connecticut, 46% 
of the pet cats not associated with human disease and 81% o f cats living in households 
reporting human CSD were seropositive. Childs et al. (1995) found 44.4% (n=9) of 
feral cats, 11.8% of stray cats (n=195), and 12.5% of cats (n=24) in veterinary hospitals 
were seropositive in Baltimore, Maryland and that cats are more likely to acquire and 
transmit B. henselae in the first year of their life. Childs et al. (1995) found that 28% of 
the cats in a group o f 1,370 cats from an animal shelter in Maryland had antibodies to B. 
henselae. Jamerson et al, (1995) found a higher seroprevalence in southeastern United 
States, Hawaii, coastal California, the Pacific Northwest and the south central plains 
54.6%, 47.4%, 40.0%, 34.3%, and 36.7%, respectively. Alaska, the Rocky Mountain- 
Great Plains region, and the Midwest had low average prevalence of 5.0%, 3.7%, and 
6.7%, respectively. The overall seroprevelance throughout these regions was 27.9% 
(n=628) (Jameson et al. 1995). The seroprevalence of B. henselae in cats in this study 
appeared to be influenced by climate. Foley et al. (1998) surveyed a group o f 11 
catteries from diverse geographical locations in North America and found a 
seroprevalence o f 35.8%.
Bartonella henselae has a worldwide distribution. The seroprevalence varies widely 
among different countries and geographic regions within countries. Seroprevalence of 
B. henselae ranges from 3.7% to 65.4% in the United States, and from 6 to 22% in 
Japan (Yoshida et al. 1996; Breitschwerdt and Kordick 1995; Childs, et al. 1994;
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Chomel et al.1995; Jamerson et al.1995). In Autstralia the seroprevalence is 33%, in 
Egypt 12%, and in Portugal 7% (Ueno et al. 1995; von Alleerberger et al. 1995). In a 
study in the Netherlands by Bergman et al. (1997), using the enzyme-linked 
immunoassay 50% (n=l 13) o f  sheltered cats were seropositive, 56% (n=50) o f pet cats 
were seropositive, and 22% o f sheltered cats were bacteremic; none of the specific- 
pathogen free cats were seropositive. In an Indonesian cat population Marston et al. 
(1999) found 54% (n=70) were positive by IFA and 43% (n=14) of feral cats were 
culture positive for B. henselae. The prevalence o f B. henselae in Germany determined 
by blood culture from household cats was 13% (n=l00) (Sander et al. 1997). In this 
study young, female cats (24 months of age or younger) were more likely to be found 
positive for B. henselae.
Strain variability. B. henselae is a zoonotic agent and has adapted to survive and 
replicate in the human host (incidental host) and the feline host (natural host) (Reiman
1998). Both the diversity o f strains within cat reservoirs and that cause various human 
clinical syndromes has not been compared extensively. B. henselae genotype 
differences have been described using various genotypic methods. B. henselae causes a 
diverse spectrum of diseases in humans that range from self-limiting to severe. Because 
of the diverse pathology and different host adaptation, strain variability would be 
expected with B. henselae. The difference in the clinical presentation of B. henselae in 
humans and cats suggest that different strains may exist. It is expected that there will be 
greater strain diversity in the natural host (cat) than within the incidental human host 
(Reiman 1998). The majority o f available clinically relevant B. henselae strains have
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been isolated in the United States (Dolan et al.1993; Koehler et al. 1992; Lucey et al. 
1992).
The first isolate of B. henselae was named B. henselae Houston-1 and was isolated 
from an HIV-infected patient in Houston and identified as the prototype strain (Regnery 
et al. 1992). The next human strain was isolated from the blood o f febrile patients with 
AIDS in Oklahoma and designated B. henselae ATCC 49793 (Slater et al. 1990). These 
two strains were identified by genotypic methods including ribosomal RNA gene 
analysis and were similar. Arvand et al. (1997) isolated the first B. henselae from 
Europe. This group isolated B. henselae from the baciilary angiomatosis lesions of an 
HIV-infected patient in Germany and named it B. henselae Berlin-1. Using pulsed-field 
gel electrophoresis of endonuclease-restricted chromosomal DNA, the Berlin-1 isolated 
was compare to the B. henselae strains isolated from patients in the United States 
(Arvand et al. 1997). The two strains were indiscernible suggesting that these strains 
might represent one clone. The Berlin-1 strain was similar to the ATCC 49793 
(Oklahoma strain) but did have one differing band, indicating a close relationship 
between the strains. A feline blood isolate named Berlin-2 was also compared in the 
Germany study and displayed a digestion profile with at least eight different bands 
which would be a distinct clone (Arvand et al. 1997). Using the 16S rRNA gene 
sequence analysis, Bergmans et al. (1994) found a difference of 3 bp located at 
positions 172 to 175 of the 16S rRNA gene of B. henselae from CSD patients. The B. 
henselae isolates were then divided into 2 groups, genotype I and genotype II according 
to 16S rRNA gene sequence. B. henselae genotype I has a TAG sequence and B. 
henselae genotype II has a ATT sequence between the 172 and 175 region of the 16S
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rRNA gene (Bergman et al. 1994). Genotype I was identical to the sequence describe 
by Regnery et al. (1992) as Houston-1 and genotype II was identical to the so called 
“BA-TF sequence found by Reiman et al. (1990) in patients with baciilary 
angiomatosis. Using two type-specific PCRs that could discriminate between B. 
henselae variants, Bergman et al.(1996) investigated the B. henselae strains in samples 
from cat-scratch disease patients in The Netherlands. Bergmans et al. (1996) found 32 
of 41 Bartonella DNA-positive samples from Dutch patients with CSD contained B 
henselae genotype I , seven samples contained B. henselae genotype II and 2 samples 
were found to be negative in both type-specific PCRs. Similarly, Sander et al. (1999) 
found 23 of 39 of the PCR-positive patients in Switzerland were infected with B. 
henselae genotype I, and 9 o f 39 were infected with B. henselae genotype II. Heller et 
al. (1999) found genotype I in 59% of Dutch patients and genotype II in 23% o f these 
patients with cat scratch disease.
Further work was done to investigate the genotypes isolated from cats. Several 
studies suggest that B. henselae genotype II is more common among cats than B. 
henselae genotype I (Bergmans et al. 1997; Heller et al. 1997). Heller et al. (1997) 
characterized B. henselae isolates from cats in France and found 34% o f the isolates 
were B. henselae genotype I and 36% of the isolates were B. henselae genotype II. 
Bergmans et al. (1997) found typed strains of B. henselae isolates from cats in the 
Netherlands using Bartonella-specific PCR and hybridization assay and by 16S-23S 
spacer PCR-restriction fragment length polymorphism (RFLP). Three B. henselae types 
were found according to the RFLP patterns and were labeled A, B, and G (Bergmans et 
al.1997). RFLP pattern A corresponds to 16S rRNA genotype I, while RFLP pattern B
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corresponds to genotype II. RFLP pattern G did not correspond to either 16S rRNA 
genotype I or genotype II. RFLP pattern B (genotype II) was found more common 
within the cats that typed as A or G. The various strains of B. henselae have been 
shown to influence the immunological response of the host. Drancourt et al. (1996), 
have documented CSD patients who were seronegative on a standard IFA diagnostic 
test for B. henselae Houston-1 antigen but were seropositive for a Marseille strain of B. 
henselae (Drancourt et al. 1996). Other studies have shown that up to 60% of CSD 
patients may test negative in conventional B. henselae seroassays (Dupon et al.1996; 
Yoshida et al. 1996). Yamamoto et al. (1998) has shown the lack o f cross protection 
between B. henselae genotype I and genotype II. Freeland et al. (1999) demonstrated at 
least three antigenic differences between genotype I strain (Houston-1) and a genotype 
II strain LSU 16.
Pathogenesis. The pathogenesis of B. henselae in cats is not clearly understood. 
The pathogenesis o f an infectious disease is influenced by many factors involving the 
host and the infectious agent. The immunological response of the host, the age, feline 
genetic differences, additional infections, the dose, the route o f entry into the host, 
virulence factors o f  the microorganism, and the strain of the microorganism, are some 
of the factors that influence the pathogenesis of an infectious agent. Clinical signs in 
experimentally infected animals range from no overt clinical signs to fever, mild 
anorexia, lymphadenopathy, central nervous signs including abnormal behavior and 
vacant staring, signs of focal motor seizures, nystagmus, and rigidity (Kordick et 
al.1999; O’Reilly et al. 1999a). Numerous experimental B. henselae infections have 
been induced in cats and a wide range o f clinical responses seen (Green et al. 1996;
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Kordick et al.1995; Regnery et al. 1996; Guptill et al. 1997; O ’Reilly et al. 1999a). 
Regnery et al. (1996) established a bacteremia and a Bartonella-specific IgG antibody 
response in 31 cats inoculated with B. henselae Houston-1 strain and did not observe 
clinical disease in any o f the animals. In a study by O ’Reilly et al. (1999a), acute 
clinical disease with bacteremia, antibody response, and adverse clinical signs were 
established in cats using a pathogenic strain of B. henselae called LSU 16. Bacteremia 
can be established in most cats within 1 to 2 weeks after inoculation (Regnery et al. 
1996; Guptill et al. 1997; O’Reilly et al. 1999a). The magnitude and duration o f the 
bacteremia is varied. The magnitude o f bacteremia in experimental infection is reported 
to be significant and sometimes exceeds 106CFU/ml o f blood (O’Reilly et al. 1999a). 
Bacteremia can persist for weeks to months, and in some cats, a relapsing bacteremia 
occurs in both experimental and naturally occurring Bartonella infections (Regnery et 
al. 1996; Guptill et al. 1997; Kordick et al. 1999a). Intervals of culture-negative cats 
can be random and vary in duration. Kordick et al. (1999) reported intervals o f 1 to 4 
months o f culture negative results before recurrent bacteremia could be detected.
Pathogenesis of B. henselae at the cellular and molecular levels is poorly 
characterized. Bartonella are most closely related to Brucella based on the 
phylogenetic relationships o f the 16S rRNA gene sequence analysis. Bartonella, like 
Brucella are considered intracellular pathogens and can cause chronic bacteremia 
probably because of the ability to survive in macrophages and because o f the relative 
low virulence of these organisms. Several studies have shown attachment and entry of 
Bartonella into several types of cells. Batterman et al. (1995) has shown attachment to 
and entry of B. henselae into human epithelial cells. Bundle-forming pili have been
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demonstrated by electron microscopy in B. henselae and are thought to be an important 
virulence factor. A strong correlation between degree o f attachment to epithelial cells 
and degree of piliation has been shown (Batterman et al. 1995). Batterman et al. (1995) 
demonstrated a relationship between piliation and phase variation. The two phases of 
the colonies noted were dry colonies embedded in the agar and mucoid colonies. B. 
henselae 87-66 (ATCC 49793) produced dry colonies which deeply embedded in the 
agar where as B. henselae ATCC 49793 colonies were mucoid and did not pit the agar. 
The heterogeneity in colony types suggests a phase variation and is seen in multiple 
passages on laboratory media. Batterman et al. (1995) demonstrated that the rough 
adherent colony type B. henselae 87-66 expressed pili and that most of the smooth 
colony type of B. henselae ATCC 49793 had few pili (Batterman et al.1995). Zbinden 
et al (1995) demonstrated intracellular location within the Vero cells mainly around the 
nuclei. Presently however, mechanisms of entry have not been discovered. Clarridge
(1996) demonstrated a cohesive factor in B. henselae associated with organisms existing 
in a tightly packed array. Clarridge suggested that the cohesive growth factor o f B. 
henselae might help in resistance to antibiotic penetration and contribute to the 
recurrence of infection (Clarridge 1996).
Species of Bartonella have been shown to have a positive tropism for endothelial 
cells and red blood cells. Entry o f B. henselae into the human endothelial cells has been 
demonstrated by Dehio et al. (1997). In vitro studies have shown B. henselae to 
colonize the vascular tissue with vascular uptake o f large bacterial aggregates by 
engulfment (Dehio et al. 1997). The organism first accumulates and aggregates on the 
endothelial surface and then enters and forms a structure called an invasome, which
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contains large and completely internalized bacterial aggregates (Dehio et al. 1997). 
Histological analysis demonstrates the presence o f bacterial clumps in close association 
within proliferating endothelial cells (Dehio et al. 1997). In other human studies it has 
been shown that B. henselae attaches and enters pericytes, macrophages and neutrophils 
(Anderson et al. 1997; Maurin and Raoult 1996).
Evaluation o f bacteremic cats during natural and experimental infections suggests 
the presence of intracellular, epicellular, and extracellular bacteria in the blood, with 
erythrocytes invasion being limited to a small percentage o f the bacterial population 
(Mehock et al. 1998). Intracellular location within the cat has been limited to the feline 
erythrocytes (Kordick and Breitschwerdt 1995). In these studies erythrocytes of 
persistently bacteremic cats, were studied, and identified 2.9% o f the erythrocytes in cat 
A were infected whereas 6.2% of the erythrocytes in cat B were infected with B. 
henselae. Epicellular or extracellular organisms were not found in the blood of either 
cat A or B in this study. Kordick and Breitschwerdt (1995) speculated that engulfrnent 
o f the bacteria by the erythrocyte membrane was a bacterium-induced or that forced 
endocytosis was involved in the engulfrnent. In vitro studies have suggested a 
intracellular location o f B. henselae in the feline erythrocytes (Mehock et al. 1998). 
Mehock et al. (1998) demonstrated invasion rates o f the feline erythrocytes to be from 2 
to 20% of the inoculum. Using laser scanning confocal microscopy to discriminate 
between intracellular and epicellular B. henselae cells, less than 1% o f the erythrocytes 
were determined to be infected. The role that invasion of feline red blood cells plays in 
the pathogenesis o f B. henselae has been speculated to have at least four potential 
benefits: 1) immune evasion, 2) hemin acquisition, 3) survival in the cat flea, and
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4) spread to other anatomical sites such as the liver or spleen (Mehock et al. 1998).
Identification of antigenic proteins and subunits of specific virulence factors of B. 
henselae has been limited. Burgess (1998) found that a 43 k-Da outer membrane 
protein was a major adhesin for human umbilical vein endothelial cells. A 17-kDa 
outer membrane protein from B. henselae was shown reactive with human sera from 
CSD patients (Anderson et al. 1995; Sweger et al. 2000). Freeland et al. (1999) showed 
the 11.3, 13.3, and 16.9/18.0 k-Da antigens, to be immunodominant in 83% (n=482) of 
seropositive cats naturally infected with B. henselae.
In vivo studies have demonstrated low endotoxin potency and diminished induction 
of neutrophilic oxidative metabolism, degranulation, and cheomtaxis by B. henselae 
when compared to E. coli and S. typhi (Fumarola et al. 1994).
Mode of transmission, vector. Several Bartonella species have been shown to 
require an ectoparasite for transmission. B. bacilliformis is transmitted by the 
Phlebotomus sand fly, (Schultz et al. 1968), and B. quintana, the etiological for trench 
fever is transmitted by the human body louse, Pediculus humanus (Strong et al. 1918). 
The association o f B. henselae with the cat flea, Ctenocephalides felis, has been shown 
in several studies (Foil et al. 1998; Higgins et al. 1996; Chomel et al. 1996). In an 
epidemiological study by Zangwill et al. (1993), the risk factors associated with the 
development o f cat scratch disease were established. Ownership of a kitten was the 
most significant risk factor noted. The finding of one kitten with fleas helped establish 
the role o f the flea as a biologic or mechanical vector in the transmission o f B. henselae 
in cats. Studies have detected B. henselae DNA by PCR from fleas of infected cats 
(Koehler et al.1994; Bergmans et al.1997). Higgins et al. (1996) demonstrated that B.
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henselae was viable after 9 days in flea feces o f fleas feed on infected cats. Tompkins
(1997) suggested that infection with B. henselae could occur by means o f flea feces 
inoculated into a cutaneous site. Chomel et al. (1996) demonstrated that the cat flea 
transmits B. henselae from infected cats to noninfected cats by removing fleas from one 
group to the other. In the study by Foil et al. (1998), experimental infection of cats with 
B. henselae was established by inoculation of flea feces that had been collected from 
infected cats.
Clinical manifestations. B. henselae infections in humans result in a wide array of 
diseases. Because clinical infection in cats can be asymptomatic, natural infections may 
have gone unnoticed for many years. Early reports suggested that cases o f regional and 
generalized feline lymphadenopathies of unknown cause were associated with 
Bartonella infections in cats (Kirkpatrick et al. 1989). Argyrophilic bacteria were seen 
in the lymph nodes o f cats with persistent idiopathic lymphadenopathy (Kirkpathrick et 
al. 1989). Epidemiological studies indicate that a large number of cats have been 
exposed to B. henselae or are infected with the organism (Childs et al. 1995; Chomel et 
al. 1995; Jameson et al. 1995; Koehler et al. 1994). Naturally infected cats appear to 
tolerate chronic infections without obvious clinical abnormalities. Cats can remain 
asymptomatic and bacteremic for many months (Koehler et al. 1994; Kordick et al.
1995). Several experimental infections have attempted to establish the clinical signs in 
cats. Clinical presentations in experimentally infected cats have varied from no clinical 
signs (Regnery et al. 1996; Abbott et al. 1997) to mild clinical signs with fever and 
histopathologic lesions (Guptill et al.1997) to acute clinical disease with fever, anorexia, 
and neurological signs (Kordick et al. 1997b; O ’Reilly et al. 1999a). Lappin and Black
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(1999) have reported a case of anterior uvetis in a cat in which antibodies to Bartonella 
species could be detected in serum and aqueous humor. Bacteremia in cats is a clinical 
presentation that is consistent with infection with B. henselae. Bacteremia can be of 
significant magnitude with counts ranging from 999 to 33,300 CFU/ml (Greene et al.
1996). Bacteremia can last for weeks to years and then relapse (Kordick et al. 1999).
In studies by Greene et al. (1996), recrudescent bacteremia in infected cats with lower 
magnitude (6 to 3,300 CFU/ml) was seen. In the acute phase o f the infection in cats, 
bacteremia was associated with febrile signs, whereas in recurrent episodes of 
bacteremia, fever not a usual clinical sign (Kordick et al. 1999).
Persistent infections. Persistent infections are known to occur in association with 
many bacteria, viruses, and protozoa. Examples o f microorganisms involved in 
persistent infections include Salmonella typhi which can persist in the gall bladder and 
urinary tract and is intermittently shed in urine and feces; Mycobacterium tuberculosis; 
Herpes simplex; Varicella-Zoster; Plasmodium vivax; and Toxoplasma gondii. In 
general, one way of explaining persistent infections is to regard them as a failure o f the 
host’s antimicrobial forces to eliminate the invading microorganism from tissue. 
Persistent infections cannot by definition be acutely lethal and in fact, they tend to cause 
only mild tissue damage or disease to the host. In certain acute infections, the patient 
appears to recover, but there is a later relapse. Persistent infections are not usually 
significant causes of acute illness but can be of particular importance because 1) They 
enable the infectious agent to persist in the community. 2) They can be activated in 
immunosuppressed patients. 3) Some are associated with immunopathological disease 
i.e. feline leukemia virus, hepatitis B virus, malaria. 4) Some are associated with
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neoplasms. 5) Some are immunosuppressive and permit disease caused by other 
normally harmless persistent microorganisms. The persistent organism can then 
continue to cause pathological changes or to be shed from the body. Bartonellosis in 
humans causes a persistent bacteremic illness in patients infected with B. henselae and 
B. quintana (Lucey et al. 1992; Welch, and Slater 1999). Fever with bacteremia is a 
common clinical presentation of Bartonella infection. Relapsing fever with bacteremia 
can occur in both immunocompromised and immunocompetent patients (Lucey et al. 
1992). Prolonged and recurring episodes of bacteremia are associated with Bartonella 
infections in cats. Kordick and Breitschwerdt (1997) demonstrated relapsing 
bacteremia in experimentally infected cats in a study where the cats were observed for 
213 days. Eleven of these cats were inoculated via blood transfusion and developed 
relapsing bacteremia. The reasons for relapsing bacteremia are unclear. Possible 
reasons for relapsing bacteremia in cats may result from repetitive evasion o f the 
immune system through antigenic variation by the organism via alteration of surface 
antigens, escape from the phagocytic cell, location in an immunologically privileged 
site, or sequestration in the host with intermittent release into the general circulation. 
The bacteremia in these cats persisted in the presence of variable antibody titers, 
suggesting that B. henselae antibodies are not effective in clearing infection. Kordick et 
al. (1999), followed a group of cats chronically infected with B. henselae for 454 days. 
In this study, cats were intermittently bacteremic without obvious clinical signs except 
for one cat with symptoms related to the central nervous system that resolved 
spontaneously and did not recur (Kordick et al. 1999). Intervals of 1 to 4 months
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occurred in which cats were culture negative. Recurrent episodes of bacteremia were 
not accompanied with fever and lasted for 454 days in two cats. (Kordick et al. 1999) 
Immunological response. The spectrum of disease seen in humans associated with 
Bartonella species is wide. The ability of Bartonella to elicit such different pathologic 
responses is associated with the immune status o f the host. B. henselae infection may 
produce either the granulomatous lymphadenitis that is characteristic o f cat scratch 
disease in immunocompetent patients or vascular proliferation in patients with defects 
in cellular immunity. The most severe manifestations of B. henselae infections occur in 
individuals with a depressed cellular immune response. B. henselae in humans is an 
intracellular pathogen and multiples within phagocytic cells and is considered a likely 
candidate for a Th-1 IFN-y type o f response (Anderson and Neuman 1997). The 
persistence of a Th-1 response to an intracellular pathogen is likely to result in an 
inflammatory tissue response as seen in infections due to Bartonella.
Results from studies of B. henselae infections in the murine model (BALB/c) 
demonstrated granulomatous inflammation in the liver with lesions consisting of 
lymphocytes, monocytes, and epithelioid cells (Regnath et al. 1998). Mononuclear cells 
were predominately CD4+ lymphocytes or CD1 lb+ monocytes. CD8+ lymphocytes 
were found in low numbers. Karem et al. (1999), found B. henselae-specific IgA in 
fecal samples of infected BALB/c mice 28 days after infection. In addition, a positive 
delayed-type hypersensitivity and IFN response in mice following in vitro stimulation 
of splenocytes indicated B. henselae-specific cellular responses.
Humoral immunity against B. henselae was studied in vitro by Rodriguez-Barradas 
et al. (1995). In this study, Bartonella was killed by complement-mediated cytolysis,
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and the presence o f specific antibodies did not increase the serum bactericidal activity 
or complement activation. Nonimmune sera killed more than 99.5% o f the inoculum 
within 2 hours, suggesting that specific antibodies did not contribute to the bactericidal 
activity of serum. Complement activation proceeded by both classical and alternative 
pathways. Activation of the alternative pathway is explained by the lipopolysaccharides 
of gram negative bacteria that activates C3. The classical pathway assays suggested in 
this study that B. henselae activated this pathway independent o f  the presence of 
specific antibodies. In this study phagocytosis and production o f  oxygen radicals, 
evaluated by flow cytometry, were significantly enhanced in the presence o f bacteria 
previously opsonized with immune sera.
The indirect fluorescent-antibody assay (IFA) is widely accepted as a diagnostic 
assay for B. henselae infection. The limitation of the IFA is the inability to differentiate 
species-specific serologic reactivity from cross-reactivity with other antigens of the 
same genus i.e. B. quintana. Western blot has been used to dissect the humoral immune 
response to B. henselae antigen in patients infected with B. henselae. McGill et al.
(1998) used serum specimens from 69 humans diagnosed with Bartonella infection 
(CSD) to investigate subclass level of IgG and other immunoglobulin (Ig) isotypes 
using western blot assay. The ranges o f B. henselae-reactive proteins recognized were 
17,48, 69, 97, and 116 k-Da and multiple bands at 200 Da. Reactivity to proteins did 
not occur in all specimens. In this study, a strong IgG response was detected to total 
antigen with the response limited to subclass IgGi. A lack of IgG3 and high levels of 
IgGi activity against B. henselae in CSD infection suggest increased opsonization 
activity during CSD rather than complement fixation. Ig isotype differences were
25
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
investigated in this same group of infected patients, and IgA was detected in 15 of the 
69 patients whereas IgM and IgE antibodies were essentially absent in these patients.
Anderson et al. (1995) identified a strong antibody response in patients with CSD to 
a 17 kDa antigen he expressed as a fusion protein. This type o f antigen would have 
value as a diagnostic reagent for rapid serologic diagnosis o f Bartonella infections.
A cellular-mediated delayed-type hypersensitivity has been shown to occur in 95 to 
98% of humans with CSD when the Hanger-Rose skin test is used for traditional CSD 
diagnostics (Szelc-Kelly et al. 1995). Other implications of cellular immune induction 
was seen in immunocompromised humans when they develop severe disease involving 
internal organs such as liver, spleen and central nervous system.
The immunological response o f cats to B. henselae is unclear. The different 
contributions o f antibody and cellular immunity are difficult to determine. The only 
cell in the cat that Bartonella has been associated with is the erythrocyte. An 
intracellular location of Bartonella other than in the erythrocyte has not been 
demonstrated in the cat. Other difficulties involved in the present interpretation of the 
immunological response seen in cats are the differences in the route o f inoculation and 
the source o f the inoculum. Intravenous, intradermal, intramuscular, and oral routes of 
inoculation have been performed in experimental infections of B. henselae in cats 
(Abbott et al. 1997; Guptill et al. 1997; Kordick and Breitschwerdt 1997). Sources of 
inoculum used in these studies include infected blood and urine and pure cultures of B. 
henselae (Abbott et al. 1997; Guptill et al. 1997; Kordick and Breitschwerdt 1997; 
Regnery et al. 1996). Other difficulties in the interpretation o f the immunological 
response seen in cats is the various strains of B. henselae used to experimentally infect
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cats, and the number o f passages o f the culture before the inoculum was prepared. B. 
henselae Houston-1, the prototype strain and a genotype I originally isolated from a 
human patient, has been used in many studies but genotype I strains are less commonly 
isolated from cats than are the B. henselae genotype II strains (Bergmans et al.1997; 
Heller et al. 1997). The seroprevalence o f B. henselae in cats varies throughout regions 
o f the United States and in Europe. Seroprevalence ranges from 3.7% to 65.4% in the 
United States (Jamerson et al. 1994; Childs et al. 1994; Chomel, 1996). An 
understanding of the role o f humoral antibodies and the cellular responses in cats is 
incomplete. High levels o f circulating antibodies to B. henselae can be detected in cats 
with bacteremia. Bacteremic cats have been shown to have higher B. henselae antibody 
titers than nonbacteremic cats (Chomel et al. 1995). Using an enzyme-linked 
immunosorbent assay (ELISA) for detection of B. henselae specific antibodies,
Freeland et al. (1999) demonstrated B. henselae specific IgM and IgG responses in 
experimentally infected cats with a pattern of a peak IgM level followed by a rise in IgG 
antibodies. Western blot analysis has been performed in infected cats to identify the 
immunodominant antigens. Freeland et al. (1999) identified 24 Bartonella-specific 
antigens recognized by cats during infection, and antigens o f the 11.3-13.3 kDa and 
16.9/18.0 kDa range were common and useful for an antibody screening test. Using the 
pathogenic strain B. henselae LSU 16, O’Reilly et al. (1999) demonstrated by ELISA 
measurable levels o f  IgM at 3 week post exposure and high levels o f IgG by 4 weeks 
postinfection. O f interest in this study was the IgM response that began to wane by 
week 6 but remained elevated in the infected cats throughout the study, suggesting 
continued antigenic stimulation. In the study by Greene et al. (1996), cats infected with
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B. henselae Houston-1 displayed serological response (IgG) that peaked between 3 to 
12 weeks after inoculation. The range of the antibodies demonstrated with IFA (B. 
henselae Houston-1 antigen) was 128 to 512 with one titer at 4096 in an adolescent cat. 
After 11-14 weeks, the antibody titer in five o f the cats was at or below 64. On 
rechallenge, the antibody titers increased more rapidly and at a higher level than those 
after the primary exposure.
The role of antibody responses to B. henselae infection in cats has been 
demonstrated in several studies. Guptill et al. (1999) compared the immune response of 
neonatal Specific Pathogen Free (SPF) cats experimentally infected to adult cats (SPF) 
with a normal mature immune system. Neonates (3-5 days o f age) were inoculated with 
B. henselae intradermally or orally and were bacteremic through 12-16 weeks similar to 
what occurred in adult cats. Cats inoculated intradermally produced IgG Bartonella- 
specific antibodies but orally inoculated neonatal cats did not. Cats with or without IgG 
became abacteremic at the same time suggesting that antibodies are not necessary to 
clear bacteremia. Parr et al. (1999) demonstrated the role of antibody in limiting 
clinical disease but not in the prevention of bacteremia and infection with B. henselae. 
Parr et al. (1999) demonstrated the effects of passive antibody by decreasing clinical 
disease and delayed onset o f bacteremia in experimentally infected cats. The effects of 
maternal antibodies were demonstrated in kittens from infected queens with maternal 
antibody. Kittens infected at 6 weeks of age became bacteremic but had decreased 
clinical disease, whereas kittens from noninfected queens show signs o f clinical disease.
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Guptill et al. (1998), demonstrated maternal anti-5, henselae antibodies in fetuses 
and kittens o f infected mothers at 2 weeks post-partum but were not detected at 10 
weeks post-partum.
Homologous protection has been shown in several studies with experimentally 
infected cats. Regnery et al. (1996) demonstrated homologous protection with B. 
henselae by lack o f heterologous protection by B. quint ana. In this study, cats infected 
with B. henselae failed to develop bacteremia on challenge exposure with B. henselae 
but did support B. henselae infection if previously infected with B. quintana. Greene et 
al. 1996), also demonstrated homologous protection with B. henselae after secondary 
challenge. Cats in this study also had higher and more rapid increase in serum antibody 
titers than after primary inoculation. Yamamoto et al. (1998), demonstrated lack of 
heterologous protection by various species and types of Bartonella in SPF cats. In this 
study, there was lack of cross protection between B. henselae and B. clarridgeiae and 
between B. henselae genotype I and II and the wildlife isolate, ‘Humboldt’.
Therapy and treatm ent. Bartonella isolates from humans are susceptible to
numerous antimicrobial agents including erythromycin, chloramphenicol, rifampin,
gentamicin, trimethoprim-sulfamethoxazole, doxycycline, and ciprofloxacin (Maurin
and Rauolt 1993; Musso et al. 1995). In vitro resistance to penicillin and ampicillin,
tetracycline or vancomycin has been noted (Welch and Slater 1999). There is, however,
a poor correlation between in vitro susceptibility and in vivo responsiveness to
antibiotics. Minimal inhibitory concentration (MIC) results obtained do not appear to
correlate with in vivo antimicrobial efficacy (Maurin et al. 1993). In human infections
numerous individual case reports indicate both successful or unsuccessful treatment of
%
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B. henselae infection (Margileth et al. 1991; Holley et al. 1991). Response of patients 
to antibiotics such as trimethoprim-sulfamethoxazole and fluoroquinolones are 
inconsistent (Welch and Slater, 1999). Human data suggest that higher doses and 
longer periods of administration o f antibiotics than normal are indicated for treatment of 
Bartonella infections. Patients with extensive hepatic involvement and regional 
lymphadenopathy responded to intravenous gentamicin within 48 hours with no 
recurrence o f symptoms (Bogue et al. 1989). Treatment o f healthy patients with typical 
CSD is supportive because the disease is self-limited. Azithromycin use accelerated the 
resolution of the lymphadenopathy o f typical CSD (Bass et al, 1998; Welch and Slater
1999). In patients with severe multisystemic disease, trimethoprim-sulfamethoxazole, 
ciprofloxacin or azithromycin is recommended (Margileth et al. 1998). In 
immunodeficient patients, therapy with erythromycin, clarithromycin, azithromycin, 
doxycycline, or tetracycline have been found to be effective (Koehler et al. 1997). 
Treatment in these patients was for 6-8 weeks with retreatment of 4-6 months in 
infections that relapse. Ciprofloxacin has been used successfully to eradicate 
Bartonella infection in humans (Margileth et al.1992; Holley 1991). The success of 
ciprofloxacin in treatment of Bartonella infections is attributed to the high drug 
concentration achieved in leukocytes, macrophages, and other tissues and organs 
frequently colonized by Bartonella organisms, including the spleen, liver, lymph nodes, 
heart, and bone (Kordick et al. 1997b).
Antibiotic therapy for control of B. henselae in infected cats has been investigated 
under controlled experimental condition in several studies. Amoxicillin, enrofloxacin, 
erythromycin, and tetracycline have been evaluated for efficacy of B. henselae
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infections in cats. Studies by Regnery et al. (1996) demonstrated reduction in 
bacteremia in experimentally infected cats with tetracycline and erythromycin after 34- 
55 days of treatment. Enrofloxacin-treated cats and amoxicillin-treated cats became 
abacteremic by day 98 and 127 after infection, respectively (Regnery et al. 1996). 
Greene et al. (1996), treated cats for 1 week with doxycycline and suppressed the 
bacteremia but infection was not cleared. These studies are misleading however 
because o f the method of detection o f bacteremia and the relapsing nature o f Bartonella 
infections. In the studies by Regnery et al. (1996) and Greene et al. (1996) efficacy of 
treatment was determined by bacteremia as detected by culture, which is not the most 
sensitive assay for defining bacteremia. Because relapsing bacteremia can occur in cats 
for long periods, a thorough understanding of the efficacy of antibiotics would involve 
following infected cats for long periods. Kordick et al. (1997b), treated cats infected 
with Bartonella species using enrofloxacin and doxycycline. In vivo efficacy of both 
antibiotics was examined in 18 experimentally infected cats and 25 naturally infected 
cats. Treatment success was achieved in 9 of 14 cats receiving enrofloxacin and 2 of 8 
cats receiving doxycycline. Treatment was ineffective in some of the infected cats 
despite plasma drug concentrations maintained above the MICs of enrofloxacin and 
doxycycline during each sampling period. Treatment success was based on elimination 
of bacteremia detected by culture or PCR. Doxycycline was chosen to treat Bartonella 
infected cats because o f its solubility in lipids and ability to cross cell membranes, 
whereas enrofloxacin is known to passively diffuse into bacteria and mammalian cells 
(Pocidalo 1989). Because cats can be chronically infected with Bartonella, treatment 
success may vary depending on the status of infection i.e. acute versus chronic
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infection. Antimicrobial efficacy may be more successful if given to the acutely 
infected cats, whereas success in the chronically infected cat may require longer periods 
of administration and or higher doses.
Laboratory Diagnosis of Bartonella Species 
Available test. Diagnostic tests available for the detection and diagnosis of B. 
henselae in cats include serologic testing, bacterial culture, histopathology with 
specialized silver staining, and nucleic acid detection using the polymerase chain 
reaction (PCR). In the acute phase of the disease, cats are usually bacteremic and the 
organism can be cultured from blood. Clinically, however, cats that are bacteremic 
often show no clinical signs of disease (Regnery et al.1992).
B. henselae can be isolated quite easily from a bacteremic cat using common blood 
containing media such as chocolate agar and blood agar. Cultures are incubated at 35- 
37°C in an atmosphere o f 5% CO2 . Isolation time varies from 7-35 days. A number of 
different solid media have been used, including trypticase soy agar with 5% sheep 
blood, chocolate agar, and heart infusion agar with 5% rabbit blood for the isolation of 
B. henselae. B. henselae has characteristic colony morphology on initial isolation. 
Colony morphology and growth characteristics can be used by those experienced with 
handling Bartonella species to recognize the pathogenic species (Clarridge et al.1995). 
Colonies are often invaginated, cauliflower-like and imbedded in the agar. It is thought 
that this autoadherence is due to the presence of genotype IV pili on the surface of the 
organism (Batterman et al. 1995). Subculturing of the organism results in more rapid 
colony growth, with visible colonies appearing after 2 to 3 days of incubation and a loss 
of the autoadherent phenotype (Anderson and Neuman 1997).
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Isolation and Culture. For many years microorganisms could be visualized in 
patients with CSD and bacillary angiomatosis but could not be grown in the laboratory. 
The initial detection of B. henselae and its laboratory propagation occurred in 1990 
(Slater et al. 1990). Using oligonucleotide primers complementary to the 16S ribosomal 
RNA genes of eubacteria, a polymerase chain reaction was used to amplify 16S 
ribosomal gene fragments directly from tissue samples of bacillary angiomatosis 
(Reiman et al. 1990). The PCR fragments were sequenced and identified as an 
uncharacterized microorganism closely related to Rochalimaea quintana (Reiman 
1990). The first isolation occurred when a curved gram-negative bacillus was isolated 
from several immunosuppressed patients with persistent fever and bacteremia (Slater et 
al. 1990). These primary cultures of blood were processed by centrifugation after 
blood-cell lysis, and colonies were isolated after 15 days on chocolate agar and sheep 
blood agar (Slater et al. 1990). It is now recognized that B. henselae can be cultured on 
enriched bacteriologic culture medium containing heme and in the presence o f 5% CO2. 
Success of isolation o f Bartonella species is variable depending on the time course of 
the infection and the choice o f specimen. In general, isolation of B. henselae from 
blood of patients with CSD who have no evidence o f systemic disease was unsuccessful 
(Anderson and Neuman 1997). On the contrary, patients who are immunocompromised 
with evidence of systemic disease usually are culture positive for Bartonella (Anderson 
and Neuman 1997). The optimal temperature for growth is 35 to 37°C for B. henselae,
B. elizabethae, and B. quintana. B. henselae has characteristic colony morphology on 
initial isolation. Colonies are often imbedded in the agar, and of a cauliflower-like 
appearance. The organism is often autoadherent and difficult to pick from the surface
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of the agar (Batterman et al. 1995). Upon subculturing o f the organism, the 
autoadherent phenotype is lost (Anderson and Neuman 1997). Colony morphology and 
growth characteristics are unique to Bartonella species and can be easily recognize by 
anyone trained to do so.
Several types of liquid media have been described that support primary isolation of 
B. henselae. A defined RPMI 1640 based medium supplemented with pyruvate, hemin, 
and amino acids was used to isolate B. henselae from blood and tissue specimens of 
infected patients and a domestic cat (Wong et al. 1995). A blood-free medium with 
blood-based components has been shown to support the growth o f  B. henselae 
(Schwartzman et al. 1993). This medium consists of brucella agar with 6 to 8% Fildes 
solution (BBL), which is a sterile digest o f sheep blood, and 250 pg o f hemin, a 
derivative of heme, which is the iron containing group of hemoglobin. Several 
commercial systems have also been used to identify Bartonella from blood (i.e. Septi- 
Chek biphasic system, BACTEC 460, and the BACTEC NR 660 system) (Larson,
1994). BacT/Alert (Organon Teknika, Durham, NC) using tryptic soy broth with 0.03% 
sodium polyanetholesulfonate (SPS) in CO2 has been used to isolate Bartonella from 
the blood of 5 patients who were immunosuppressed (Tiemo et al. 1995).
Direct plating of blood collected in EDTA and lysis centrifugation, using Isolator 
Wampole, (Cranbury, NJ) have been used successfully to isolate B. henselae, B. 
quintana, and B. clarridgeiae. Freezing of blood was shown to increase the sensitivity 
o f detection of B. henselae by increasing the number of CFU/ml recovered (Brenner et 
al. 1997). It is thought that the freezing lyses erythrocytes and leukocytes and may 
serve to liberate intracellular organisms or those organisms that may be on the surface
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or cell membrane (Brenner et al. 1997). Blood collected in tubes containing EDTA, 
frozen at -65°C and then plated have been shown to increase the number of CFU/ml 
compared to blood collected in the Isolator tubes (Brenner et al. 1997). Primary 
isolation o f Bartonella from tissue has also been accomplished by grinding tissue and 
plating on chocolate agar (Dolan et al. 1993).
Cell culture systems have also been used to isolate Bartonella from both blood and 
tissue. Endothelial cell lines have been used to cultivate B. henselae and B. quintana 
from skin lesions of patients with bacillary angiomatosis (Koehler et al. 1992). Co­
cultivation o f B. henselae with Vero cells provide substrate to which the Bartonella do 
not autoagglutinate and the cells provide an environment for growth (Dalton et al.
1995). B. henselae is grown in Vero cells for preparation o f antigen to use in the 
indirect fluorescent antibody assay (Regnery et al. 1992).
Identification. Bartonella species can be identified to the genus level by 
phenotypic characteristics such as growth requirements, gram stain, and colony 
morphology. Identification of Bartonella to species level is somewhat more difficult 
because in general Bartonella species are biochemically inert. Carbohydrate utilization 
cannot be determined by conventional tests but requires methods that may include 
genetic analysis. DNA-DNA hybridization and PCR amplification o f various genes 
followed by sequencing or restriction endonuclease analysis of amplicons have been 
successful in identification of Bartonella species.
Serological assays. Serological testing is used frequently for the diagnosis o f B. 
henselae in cats because these methods are practical and economical methods that can 
be performed by most laboratories. Serologic tests do have limitations and may not be a
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clear diagnostic indicator in some cases. Low antibody levels are detected many times 
and are not sufficient evidence to determine active or prior infection. Another 
limitation of some serological tests, is the sensitivity and specificity o f the test 
depending on the antigens used in the assay, the time of specimen collection, the format 
of the assay, and the indicators used to detect the antibody.
The serological response of the cat to B. henselae is not understood partially because 
Bartonella antigens recognized by the cat’s immune system have not been fully 
identified. Lack o f understanding of the immunodominant antigens is a controlling 
factor for the serological assay used for serodiagnosis o f Bartonella in cats. 
Serodiagnostic tools such as indirect immunofluroescent assay (IFA); enzyme-linked 
immunoassay (EIA) and the western blot analysis are all used to determine antibody 
levels to Bartonella in cats and humans. The IFA is probably the most common 
serologic assay used by laboratories and the sensitivity is reported to be 88% and the 
specificity is 94% (Regnery et al. 1996). IgG titer of >1:64 in a cat is considered a 
positive titer for B. henselae. Studies using the IFA for diagnosis o f cat scratch disease 
however, point out possible weakness o f the IFA (Zhinden et al. 1997; Bergmans et al.
1997). In studies by Zhinden et al. (1997); Bergmans et al. (1997) the sensitivity and 
specificity of the IFA was shown to be affected by the preparation of the Bartonella 
antigen (with or without cocultivation with Vero cells) and the cutoff titer of the test. 
Bergmans et al. (1997) demonstrated that one-point IgG serology is not diagnostic for 
B. henselae infection in humans and that two-point serology is necessary to detect 
ongoing B. henselae infections. Bergmans et al. (1997) also concluded that IgM 
serology was superior to IgG serology in diagnosing B. henselae in CSD patients.
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The serological picture with cats infected with B. henselae varies. Cats with 
B. henselae bacteremia were shown to be serologically positive with high titers. Other 
stu . ; found bacteremic cats with no detectable antibody levels. Results from a study 
by Bergmans et al. (1997) using the ELA to measure antibody to Bartonella, concluded 
that 20% of the 113 cats enrolled in the study were bacteremic and had anti-5, henselae 
antibodies whereas 30% o f  the 113 cats had antibodies to B. henselae but were not 
bacteremic, whereas 2% o f the 113 were bacteremic but were seronegative. This study 
concluded that the positive predictive value of the serologic assay for bacteremia is 
39%, and the negative predictive value of the serologic assay is 96%.
Histopathology and W arthin  Starry silver stain. Before culture, serological 
assay or nucleic acid detection became available, histologic findings with silver stains 
were used to characterize the causative agent of CSD and bacillary angiomatosis. Early 
reports in the literature described Warthin —Starry positive bacteria associated with 
cases o f cat scratch disease (Margileth et al. 1984; Kudo et al. 1988). Small 
pleomorphic bacilli were seen using the Warthin-Starry silver impregnation stain in 
both the skin at primary inoculation sites and in lymph nodes from patients with CSD 
(Margileth et al. 1984). Attempts to culture this organism were unsuccessful.
Histologic evaluation o f lesions in patients with CSD and bacillary angiomatosis 
revealed similar pleomorphic bacilli on silver stain. The histopathologic findings 
associated with infections caused by B. henselae in humans are described in the 
literature and are significant. Histopathological findings in lymph nodes depend on the 
stage o f the infection. There may be lymphoid hyperplasia, arteriolar proliferation, and 
reticulum cell hyperplasia early in the course of the infection (Sander et al. 1999). In
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the later stages of the infection, granulomas with central areas of necrosis, 
multinucleated giant cells, and multiple stellate microabscesses are seen (Bass et 
al.1997; Kaschula 1996). The histopathologic changes found in CSD are consistent 
with granulomatous inflammation with or without central suppuration (Min et al.1993). 
The lymph nodes from patients with CSD typically include stellate caseating 
granulomas, microabscesses, and follicular hyperplasia (Carithers 1985). The follicular 
hyperplasia may be seen with a distinct germinal center and plasmacytosis in the 
residual parts o f the lymph node (Kudo et al. 1988). Multinucleated giant cells with the 
zone of histiocytes can be seen (Kudo et al. 1988). Min et al, (1993) identified bacilli of 
cat scratch disease using a labeled polyclonal rabbit antibody to the outer surface 
protein o f B. henselae. The histopathological findings are typical but not specific for 
CSD (Sander et al. 1999). Infections caused by other agents, such as lymphogranuloma 
inguinale caused by Chlamydia trachomatis, atypical mycobacteriosis, yersiniosis, 
tularemia, brucellosis, certain mycotic and chronic granulomatous diseases o f childhood 
must be considered in the differential diagnosis (Anderson et al. 1994).
Bacillary angiomatosis is a neovascular disorder with the presence o f bacilli in the 
tissue. Cutaneous or subcutaneous lesions are seen in bacillary angiomatosis patients. 
Characteristic lobular proliferation o f blood vessels are seen in the lesions with 
hematoxylin and eosin stain. Granuloma formation are not seen in patients with 
bacillary angiomatosis.
Studies of cats seropositive to B. henselae report different findings in regards to 
histological abnormalities or clinical manifestations. Several studies have shown 
histological abnormalities in cats experimentally infected with B. henselae (Guptill et
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al. 1997; Korkick et al. 1999). Guptill et al. (1997) found histopathologic lesions in 
multiple organs of experimentally infected cats 8 weeks after infection. In this study, 
cats were described to have generalized peripheral lymphadenopathy with a marked 
lymphoid hyperplasia characterized by an expanded paracortex and secondary follicles 
with germinal centers. Mild to marked lymphoid hyperplasia of the spleen with 
development of prominent germinal centers was seen in cats infected with a strain o f 
B. henselae originally isolated from a cat. Circumscribed aggregates o f neutrophils or 
microabscesses were present throughout the red pulp of the spleen. Two weeks after 
infection, the liver from this group of cats contained small foci o f necrosis in the 
parenchyma and an increased number of neutrophils in the sinusoids o f the liver. Eight 
weeks after infection small foci of granulomatous inflammation in the liver could be 
seen. Focal pyogranulomatous nephritis and interstitial myocarditis could be seen in 
one cat 4 weeks after infection. Few bacteria were seen on Warthin-Starry stains of the 
spleen of cats examined 2 weeks after infection in this study. In a study done by 
Kordick et al. (1999), cats were experimental infected with B. henselae genotype II and 
histopathology evaluated after 454 days. In this study peripheral lymph node 
hyperplasia was seen in all 13 cats, splenic follicular hyperplasia in 9 cats, lymphocytic 
cholangitis in 9 cats, lymphocytic hepatitis in 6 cats, lymphoplasmacytic myocarditis in 
8 cats, and interstitial lymphocytic nephritis in 4 cats. Warthin-Starry silver stains were 
only suggestive of bacilli in tissue examined in this study.
Polymerase chain reaction (PCR). Polymerase chain reaction (PCR) is an in vitro 
method of nucleic acid synthesis by which a particular segment o f DNA can be 
specifically replicated. A single nucleic acid target molecule can be amplified until
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sufficient material is present to enable detection and identification. Amplification and 
detection can be detected in minutes to hours. PCR replaces the conventional process 
of biologic amplification i.e. growth in culture, with enzymatic amplification o f specific 
nucleic acid sequences. The ability to isolate and cultivate microbial pathogens on 
artificial medium represents one o f the great diagnostic triumphs o f the last century. 
Cultivation o f microbial pathogens from clinical specimens is the mainstay o f the 
clinical laboratory today. Despite its established value, however, in vitro cultivation has 
many drawbacks. The time required for growth of an organism in culture usually 
ranges from days to weeks, and definitive tests introduce additional delays. The number 
of bacterial species that are isolated on bacterial culture media is limited. It is 
estimated that less than 1% of the bacteria present on the earth have been described 
using cultivation (Reiman et al. 1998).
PCR technology amplifies a selected region of DNA. It involves two 
oligonucleotide primers that flank the DNA fragment to be amplified. These primers 
hybridize to opposite strands o f the target sequence and are oriented so that the DNA 
synthesis occurs across the region between the primers. PCR is based on the functions 
of DNA polymerase to copy and amplify a strand of DNA. DNA polymerase initiates 
elongation of the primer to a longer strand o f DNA. The starting material for PCR is 
called the target and is a DNA gene segment. The target sample reacts with a master 
mix that contains everything needed to synthesize DNA sequences. The PCR assay 
consists o f three steps per cycle which is repeated 20-40 times. Each cycle doubles the 
number o f DNA molecules in the previous cycle. Because the copies increase 
exponentially, more than 100 million copies can be made in only a few hours. The
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
three PCR cycles begin with denaturation, in which double stranded material is 
denatured into single-stranded material. The second step involves the annealing of a 
primer pair. The primer is a small piece o f synthetic DNA, an oligonucleotide, known 
to complement the DNA sequence of a particular genetic sequence. The primers flank 
the target sequence of interest. The primer searches out the separated DNA strands and 
anneals to its complementary sequence. The third step o f the PCR cycle is extension, in 
which the DNA polymerase extends the target sequences between the primers by 
addition of bases to the 3’ end of the strand.
PCR is a sensitive assay that can detect a single DNA molecule. However, a single 
protocol is not appropriate for all target sequences. Each PCR design requires 
optimization for best performance o f the assay. Factors to consider in the design of the 
PCR assay are the reaction components, the denaturation and annealing temperatures, 
and the number of cycles performed. Concentrations of reagents in the reaction mixture 
such as dNTPs, magnesium chloride, DNA, enzyme, and primers need to be optimized 
to maximize efficiency and fidelity of assay. Denaturation o f the target template is the 
first step in the PCR cycle. Strand separation occurs in this step and the correct 
denaturation temperature is critical. Primer annealing temperatures are important and 
should be approximately 5°C below the true melting temperature (Tm) o f the 
amplification primers. The primers used in the assay must be specific only for the DNA 
of the target organism. The specificity o f the primer increases as the temperature 
approaches the correct annealing temperature. Increasing the annealing temperature 
enhances discrimination against incorrectly annealed primers and reduces miss 
extension of incorrect nucleotides at the 3 ’ end of the primers.
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Since the development in 1984, PCR assays have been used in research and clinical 
applications. Advantages o f nucleic acid techniques include rapid detection of 
fastidious pathogens, detection of nonculturable agents, and discovery of new organism 
types and genotypic analysis. A PCR assay was used to discover and understand 
infections caused by B. henselae and to diagnosis cases o f bartoneilosis. Nucleic acid 
techniques, including PCR and nucleotide sequencing, were important early in the 
characterization o f B. henselae and its association with a variety of disease syndromes. 
Reiman et al. (1990), was the first to use broad-range PCR to detect the 16S rRNA gene 
sequence of B. henselae from tissue of patients with bacillary angitomatosis. B. 
henselae bacilli could be seen on silver stains within the lesions of patients but could 
not be isolated by culture techniques. Since that time, PCR has been used as a detection 
and identification method for B. henselae. Because o f the fastidious nature o f many 
organisms, including Bartonella species, and the limitations of cultivation technology, 
nucleic acid amplification techniques such as PCR are very useful methods to reveal 
novel microbes associated with disease. The PCR assay has been used to detect B. 
henselae in specimens in multiple human cases involving lymphadenitis, osteomyelitis, 
retinitis, postpartum coma, encephalopathy, endocarditis, and Parinaud’s oculoglandular 
syndrome in which the cultures were negative (Gottlieb et al. 1999; Robson et al.1999; 
Warren et al.1998; McCormack et al. 1998; Wheeler et al.1997; Drancourt et al.1996; 
Grando et al. 1999). The discriminatory power in identifying microbes is increased 
with genotypic methods as compared to cultivation and use of phenotypic methods. 
Once a microbe is amplified with a PCR assay, the product of that amplification can be 
confirmed by sequencing to determine the exact nucleic acid sequence o f the DNA
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fragment. PCR techniques have been used to determine genotypes o f strains involved 
in cases of CSD and bacillary angiomatosis (Bergmans et al. 1997; Heller et al. 1997; 
Sander etal. 1999).
Some of the B. henselae genes amplified by PCR are the 16S rRNA gene, the citrate 
synthase gene (gltA), and the htrA gene encoding a 60 kDa heat shock-like protein. 
Oligonucleotide primers are designed specifically to be complementary to regions of 
these genes.
The 16S rRNA gene is often used in nucleic acid detection methods. Multiple 
copies of a gene encoding a 16S rRNA are found in all eubacterium. The 16S rRNA 
gene found in these cells is highly conserved with interspersed regions o f hypervariable 
sequences. Broad range eubacterial 16S rRNA primers complementary to the 
conserved region and flanking the segment o f interest can be used in a PCR design to 
amplify the unknown variable region. The primers anneal to conserved region of 
microbial DNA, and the polymerase generates new DNA strands, including the variable 
region that can be sequenced for identity. Analysis of the variable portions permits 
determination o f phylogenetic and evolutionary relationships among organisms, and 
now forms the basis of a revised system o f natural classification (Woese 1987).
Because most bacterial genera and species have a unique 16S rRNA gene sequence, this 
sequence serves as the molecular fingerprints, and can be used to identify organisms. 
Pure cultured organisms can be the source o f  the 16S rRNA targets in PCR, or infected 
tissue can also be used.
The PCR assay is an extremely sensitive assay and can detect DNA fragments of a 
particular microorganism that are below the detection limits of culture. The levels of
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microbial DNA present in clinical specimens are frequently too low for measurement. 
PCR can produce sufficient amounts o f DNA in order for a microbe to be detected and 
identified. In theory, the PCR assay can detect as few as one microorganism. The 
limitations of culture vary with the range o f 10 to 100 organisms per ml o f fluid. 
Because each microorganism has a unique complement of DNA, this DNA can help 
produce an identity o f the microbe and allow for differentiation among microorganisms. 
The PCR is a specific reaction when a unique set of oligonucleotide primers 
complementary to regions of the DNA templates are used, and a PCR product o f a 
particular size is generated and seen on gel electrophoresis. In addition, confirmatory 
methods can be done including sequencing o f  the amplified product, annealing o f a 
specific oligonucleotide probe to a region o f  the amplification product, and restriction 
enzyme cleavage o f the amplified product with gel electrophoresis o f the digest and 
restriction fragment length polymorphism analysis. Sensitivity and specificity o f the 
PCR can be increased further by designing a nested PCR. In the nested PCR two 
reaction are performed using products from the first reactions in the second reaction and 
increasing the final product. In the nested PCR, products from a primary PCR reaction 
are used in a second reaction with primers that anneal to regions of the same gene, but 
at sites internal to the previous priming sites. In a hemi-nested PCR, one primer from 
the first PCR reaction is used in the second round reaction along with a different primer.
PCR assays have a high analytical sensitivity. However, high analytical sensitivity 
does not necessarily translate into high clinical sensitivity. Clinical performance of an 
assay such as PCR depends on various factors, including the method o f sample 
collection, preparation to ensure adequate number o f target molecules, the presence of
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inhibitors of the enzymatic processes of amplification, and the time at which the sample 
is collected. The volume o f sample tested has a direct bearing on clinical performance 
if  the target copy number is low. An analytical sensitivity o f a sample with only one 
target copy will be positive in less than 70% of all reactions performed (Persing 1993). 
In this hypothetical system, a sample would have to contain an average o f 10 targets to 
ensure that 99% o f all specimens contain a single copy for detection. Sensitivity also 
depends on the number o f target molecules in the organism o f interest. If multiple 
copies of the target are present in a single organism, the volume of sample may not be 
as critical.
A variety of components within clinical specimens may inhibit the PCR by 
interacting with components o f the enzymatic reaction. Inhibitors can interact with the 
nucleic acid or with the polymerase and inhibit the assay. Heme at 0.8 uM and its 
metabolic products are known inhibitors o f DNA polymerase. Cerebrospinal fluid, 
urine, and sputum also contain uncharacterized inhibitors o f the Taq DNA polymerase. 
Reagents traditionally used in the purification of nucleic acids such as EDTA, 
detergents, sodium dodecyl sulfate, chaotropes, and guanidinium HC1 are inhibitory to 
the amplification enzymes.
The fundamental goals o f sample preparation include release of nucleic acid, 
stabilization of nucleic acid against degradation, removal o f inhibitors, and 
concentration of target molecules. Various protocols for extraction and purification of 
sample DNA are available. A variety of methods to release the nucleic acid from 
microorganisms include boiling in distilled water or PCR buffer, detergents, sodium 
hydroxide, freeze-thaw, SDS-proteinase K, perchloric acid, enzymes, sonication and
45
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
heat. Additional extraction steps with phenol-chloroform remove amplification 
inhibitors. Methods of concentration usually include use o f alcohol precipitation. 
Target capture includes matrices such as magnetic particles, glass, Sephadex, and 
diatomaceous earth, which bind nucleic acids in chaotropic solutions. Following 
binding o f the nucleic acids to the solid-phase matrix, the impurities and amplification 
inhibitors are removed by centrifugation, washing, and elution of nucleic acids into a 
compatible buffer. Commercial kits such as InstaGene matrix Genomic DNA Isolation 
Kits (Bio-Rad Laboratories, Inc., Hercules, CA) and Qiagen Blood and Tissue Kit 
(Qiagen Inc., Chatsworth, CA) are available for extraction of DNA and are relatively 
simple and automated.
The advantages o f PCR for laboratory diagnosis o f B. henselae can be summarized 
in terms o f sensitivity, specificity (identification), and turnaround time. A PCR assay 
for B. henselae will detect the microorganism in cases where culture may be negative 
because o f  detection limits and because of the fastidious nature o f B. henselae. 
Identification of B. henselae and the various genotypes can be achieved with a high 
discriminatory level using confirmatory methods of sequencing or Southern blot using a 
probe. Identification can be accomplished either from a DNA fragment amplified from 
blood or tissue or from an isolate from culture.
Reverse transcription-polymerase chain reaction (RT-PCR). This procedure 
involves the reverse transcription o f RNA and PCR amplification. The enzyme reverse 
transcriptase converts RNA to complementary DNA (cDNA) and then the cDNA is 
amplified in the PCR reaction. The RT-PCR has been widely used in research 
laboratories as a rapid and sensitive technique for the detection, quantitation, and
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cloning o f specific mRNA and gene expression. The analysis of RNA expression can 
determine if cells are in an active growing state, or in a non-growing state, i.e. dormant 
resting state or nonviable state. RT-PCR is the most sensitive technique to determine 
the presence or absence of RNA templates or to determine gene expression. RT-PCR is 
used in clinical diagnostic laboratories for detection and quantitation o f infectious 
microorganisms, cancer cells, and genetic disorders. Two different techniques are 
commonly used for RT-PCR: the two step RT-PCR or the one step RT-PCR. In the two 
step RT-PCR, cDNA synthesis is performed with reverse transcriptase derived from 
avian myeloblastosis virus (AMV) or Moloney murine leukemia virus (MuLV) and Tth 
DNA polymerase from the first step. In the second step, a PCR with DNA polymerase 
is used. The two step reaction requires that the reaction tube is opened after the cDNA 
synthesis and reagents are added for the PCR part of the procedure. In the one step RT- 
PCR the cDNA and PCR reaction are performed without addition of reagents between 
synthesis of cDNA and PCR.
Understanding the Pathogenesis o f Bartonella henselae 
in the Domestic Cat
Research problem: Bartonella henselae is a serious zoonotic agent and is the 
etiologic agent for a wide spectrum of disease in humans. The domestic cat is the 
reservoir for B. henselae and a risk factor for contracting infections in which B. 
henselae is the etiologic agent. The pathogenesis o f B. henselae in cats is incompletely 
understood. To reduce the risk of contracting B. henselae from a domestic cat, a better 
understanding o f the infection in cats is needed. Many aspects of feline bartonellosis 
are unclear in particular the persistent nature o f the infection. B. henselae is a fastidious 
microorganism that has proven to be difficult to detect by standard bacterial culture.
47
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Laboratory methods with high sensitivity and specificity are needed to study the acute 
and chronic phase of these infections in cats. Understanding the acute and chronic 
phase o f the infection in cats will help reduce the risk o f humans contracting Bartonella 
from infected cats.
Purpose: Study the pathogenesis of B. henselae in the domestic cat using a 
molecular approach. This study will investigate the bacteremic and chronic phase o f B. 
henselae genotype I and genotype II infections in cats using a nested polymerase chain 
reaction (PCR).
Hypothesis: A molecular assay such as polymerase chain reaction (PCR) is a useful 
assay for detecting fastidious microorganisms involved in infectious diseases. In cats 
with B. henselae infections, Bartonella DNA persists longer than can be detected by 
standard bacterial culture and may explain the chronicity o f these infections.
Research objectives: •  Design a molecular assay that is sensitive and specific for
the species of Bartonella that are known to infect cats, i.e. Bartonella henselae
genotype I and genotype II and Bartonella clarridgeiae.
•  Determine if PCR assay can be used in biological samples, i.e. blood and tissue 
from experimentally infected cats.
•  Use PCR assay to follow experimentally infected cats in acute phase (bacteremic
phase), during recurrent episode of bacteremia and in postmortem tissue.
Compare PCR assay to bacterial culture.
•  Determine if B. henselae DNA persists in tissue of experimentally infected cats
that are abacteremic
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•  Determine if  there is any histopathology associated with B. henselae infection in
cats.
•  Determine the RNA expression of B. henselae found in tissue in cats chronically
infected using RT-PCR.
•  Investigate B. henselae genotype differences in experimentally infected cats
during bacteremia, relapsing bacteremia and in tissue.
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CHAPTER TWO
EVALUATION AND USE OF A NESTED PCR IN CATS EXPERIMENTALLY 
INFECTED WITH BARTONELLA H ENSELAE  GENOTYPE I AND 
BARTONELLA HENSELAE  GENOTYPE n
Introduction
The importance of Bartonella henselae as an emerging pathogen is recognized more 
each day by veterinarians, cat owners, and physicians. Bartonella henselae causes a 
wide spectrum of diseases and diverse pathology in humans and the domestic cat acts as 
a reservoir of this zoonotic disease. Diseases in humans primarily depend on the 
immune status of the patient. Disease ranges from granulomatous features as in cat 
scratch disease to vascular proliferative lesions as in bacillary angiomatosis. Cat 
scratch disease, the most common disease caused by B. henselae in immunocompontent 
patients, is usually a localized self-limiting disease that resolves in time. Sequela to cat 
scratch disease occurs in 14% of cases and manifests in serious clinical conditions 
(Regnery and Tappero 1995). Unusual manifestations that have been reported include 
cases of encephalitis, retinitis, conjunctivitis, hepatic granulomas, osteomyelitis, 
pulmonary disease, and endocarditis (Regnery and Tappero 1995). Bacillary 
angiomatosis and bacillary peliosis, caused by B. henselae in patients whose immune 
system is compromised, involve multiple organs and are serious life threatening 
diseases. B. henselae has been shown to establish persistent infection with an 
intravascular focus displayed as a bacteremia or endocarditis (Reiman 1998).
The domestic cat population in the United States numbers approximately 60 million, 
and 15 to 25 million cats may potentially be infected with B. henselae (Kordick et al. 
1995). The domestic cat is a common pet in many households and has the potential to
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act as a reservoir for human infections. B. henselae genotype I, B. henselae genotype II, 
and B. clarridgeiae have been isolated from cats and are also associated with human 
disease (Sanders et al. 1999). Epidemiological studies indicate that a high percentage 
o f cats worldwide have been naturally exposed to or are infected with B. henselae 
(Childs et al.1994; Jamerson et al. 1995). B. henselae has a worldwide distribution. In 
the United States seroprevalence varies and is as high as 65.4% in some regions (Childs 
et al. 1994; Jamerson et al. 1995). B. clarridgeiae infections in cats are less common 
with isolation rates reported to be approximately 10% in certain regions (Lawson and 
Collins 1996; Kordick et al. 1997a).
Clinical disease in cats experimentally infected with Bartonella species varies and is 
thought to be strain related (Reiman 1998). In several studies, isolation o f  B. henselae 
genotype II from cats was more common than isolation o f B. henselae genotype I 
(Gurfield et al. 1997; Sander et al. 1998b). Identifying and characterizing the strains or 
genotypes of B. henselae would be useful in studies o f the pathogenesis o f feline 
bartonellosis. Cats are reported to be coinfected with B. henselae and B. clarridgeiae or 
B. henselae genotype I and II (Gurfield et al. 1997). It is not known if there is a 
difference in virulence or pathogenicity associated with the various species or 
genotypes of Bartonella in cats.
Given the endemicity o f Bartonella infection in cats, understanding feline 
bartonellosis is important to those involved in veterinary medicine and human medicine. 
Because cats can be persistently and asymptomatically infected with B. henselae with 
intermittent bacteremia, recognizing and understanding feline bartonellosis is important 
(Regnery et al. 1992c). The bacteremia seen in B. henselae mfection in cats can be of
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significant magnitude in acute or chronic infection, or in chronic infection (Kordick and 
Breitschwerdt 1997). The likelihood of transmission o f B. henselae from cats to 
humans is thought to be highest during times when cats are bacteremic (O’Reilly et al. 
1999a).
The pathogenesis of B. henselae in the cat is not understood. Assays currently 
available to identify cats infected with Bartonella species include bacterial culture, 
serological assay, nucleic acid amplification methods, and Warthin-Starry silver stain. 
Bacterial culture for Bartonella species is not ideal and can be limited because o f  the 
fastidious nature of organism, the time required for isolation, and the detection limits of 
culture. Kordick et al. (1999) demonstrated the limitations o f culture by amplification 
of Bartonella DNA from the blood of culture negative cats.
The limitations of serological assays include differentiation of exposure from active 
infection, inconsistent results because o f the lack o f understanding of the antigenic 
variability within the Bartonella species, and incomplete knowledge of the feline 
immunological response to this pathogen. Immunological responses in cats to B. 
henselae vary. Chomel et al. (1995) demonstrated that two percent o f bacteremic cats 
in northern California were seronegative. Korkick et al. (1995) observed cats with 
relapsing bacteremia in conjunction with variable high antibody titers. Other studies 
have demonstrated a relapsing bacteremia without a peak in IgM level or a rise in IgG 
level (O ’Reilly et al. 1999a).
Argyrophilic stains such as the Warthin-Starry silver stain have been used to detect 
Bartonella in tissue, however, the sensitivity of the test is low (46%) and often fails to
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identify organisms in tissues from which the organism had been cultured and from 
bacteremic cats (Brouqui et al. 1997; Slater et al. 1994).
Polymerase chain reaction assays are important diagnostic and research tools 
because these assays are highly sensitive and specific. PCR assays are used for the 
detection and characterization of pathogenic microorganisms associated with infectious 
diseases. PCR assays are useful to amplify DNA from organisms that are difficult to 
culture and to detect small amounts of DNA. There are numerous reports in the 
literature of diagnosis of Bartonella infections in humans in which blood and organ 
cultures were negative, but B. henselae DNA was amplified from tissue (Holmberg et 
al. 1997; Warren et al.1998; Sander et al. 1998b). The discovery o f Bartonella as the 
etiological agent associated with CSD, bacillary angiomatosis was first made with PCR 
assays, and these assays continue to be a useful laboratory tool for diagnosing these 
infections (Reiman 1993).
A PCR assay for the identification of species and genotypes would assist in 
characterization of the various strains involved in feline bartonellosis. Our objective 
was to develop a tool that could be used to detect Bartonella in numbers below the 
limits of culture and to differentiate the various Bartonella species and genotypes. In 
this study, a nested PCR was developed using the 16S rRNA gene o f Bartonella species 
that is sensitive and is genus, species, and genotype specific. Experimentally infected 
cats were cultured and assayed by PCR during the acute and chronic phases of the 
infection. The application of PCR will assist our understanding of the pathogenesis of 
Bartonella species in the cat populations
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Materials and Methods
Experimental animals. Specific-pathogen-free (SPF) cats (n=16) were bred at 
Louisiana State University (n=4) or were purchased from Liberty Laboratories (Liberty 
Comers, NJ) (n=9) or Harlan Sprague-Dawley (Madison, Wis.) (n=3). Cats were 
culture negative for B. henselae and antibody negative for B. henselae by western blot 
analyses. Cats were housed individually or grouped in an environmentally controlled 
setting.
Bacterial strains. Bartonella strains were grown on chocolate agar or blood agar 
(TS A w/5% rabbit blood agar plates) (Remel, Lenexa, Kansas) and the other 
microorganisms were grown on blood agar (TSA w/5% sheep blood agar plates) 
(Remel, Lenexa, Kansas). Bacteria used to evaluate this PCR assay included Bartonella 
henselae 87-66 (ATCC 49793), Bartonella henselae Houston-1 (ATCC 49882), 
Bartonella quintana (ATCC VR-358), Bartonella clarridgeiae (ATCC 700095), and 
Bartonella elizabethae (ATCC 49927) obtained from the American Type Culture 
Collection (Rockville, MD). Bartonella henselae LSU 16 (O’Reilly et al. 1999a) and 
Bartonella henselae Baby (Parr et al, 1999) were isolated at Louisiana State University 
from naturally infected cats. Escherichia coli, Pseudomonas aeruginosa, Bordetella 
bronchiseptica, Brucella abortus, Pasturella multocida, Staphylococcus aureus and 
Streptococcus pneumoniae were obtained from the Louisiana Veterinary Medical 
Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University.
Experimental infections. Cats inoculated with B. henselae LSU 16, Baby, and 
Houston-1 strains were given approximately lxlO?CFU/ml. Cats inoculated with strain 
B. henselae 86-77 were given approximately lxlO9 CFU/ml. All cats were injected
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intradermally with 0.6 ml o f the respective inoculum divided among six sites on the 
skin o f the lateral trunk. Animal inoculations were conducted with a second-passage 
preparation o f organism. In one group of twelve cats, the cats were divided into 4 
groups o f three. Six cats were infected with 5. henselae LSU 16 genotype II, three cats 
were infected with B. henselae Baby genotype II, three cats were infected with B. 
henselae 87-66 genotype I, and three cats were infected with B. henselae Houston-1 
genotype I (Parr et al. 1999). The second group o f 8 cats was in a Bartonella henselae 
passive antibody study and were eventually infected with Bartonella henselae LSU 16. 
O f this group, four cats were given anti-5, henselae LSU 16 thirty minutes prior to 
inoculation with B. henselae LSU 16, one cat was given anti-5, henselae Houston-1 30 
minutes prior to inoculation with 5. henselae LSU 16 and three cats were inoculated 
with 5. henselae LSU 16 (Brown et al.1998). This group o f 8 cats was challenged a 
second time approximately 12 weeks after the first inoculation. Four cats in this group 
previously challenged with 5. henselae LSU 16 were given three injections o f 10 mg/kg 
o f methylprednisolone (Upjohn, Kalamazoo, MI) intramuscularly at two week intervals. 
Experimental infections, passive antibody, and drug administrations were conducted in 
the laboratory of Dr. K. L. O’Reilly.
Collection of blood specimens. Peripheral blood was collected weekly by the staff 
from Dr. K. L. O’Reilly laboratory beginning one week after inoculation and until the 
time o f necropsy. A total o f 362 blood specimens were collected in the study. Before 
each collection, cats were anesthetized with Telazol (Fort Dodge, Ames, Iowa) at the 
recommended dosage. Blood was collected aseptically by jugular puncture and placed 
in Vacutainer tubes (Becton-Dickinson, Franklin Lakes, NJ) containing EDTA for PCR
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assay and in pediatric lysis-centrifugation isolator tubes (Wampole Laboratories, 
Cranbury, NJ) for culture. Blood collected in EDTA tubes was frozen at -20°C 
overnight, and DNA extractions were performed the next day followed by PCR assay.
Blood cultures. Blood cultures were performed by staff in laboratory of K.L. 
O’Reilly on blood collected in pediatric Isolator® tubes. A 10-pl aliquot of blood was 
removed from the Isolator® tube and serially diluted. Dilutions (30 pi) were inoculated 
onto chocolate agar and incubated at 37°C in 5% CO2 for 7 days. Colony counts were 
recorded as the number of CFU per milliliter of blood. Isolates were confirmed to have 
phenotypic characteristics consistent with Bartonella henselae.
Defining bacteremia. Bacteremia in experimentally infected cats was determined 
by isolation o f Bartonella from a blood specimen (culture-positive) or amplification of 
Bartonella DNA from a blood specimen (PCR-positive).
Extraction of DNA from whole blood specimens. DNA was extracted from 200- 
pl of whole blood collected in a EDTA vacutainer tube using the QIAamp DNA Mini 
Kit and QIAamp DNA Blood Mini Kit (Qiagen Inc. Valencia, CA). The Blood and 
Body Fluid Spin Protocol was followed according to manufacturer directions.
Extraction of DNA from bacterial strains. Approximately 10 CFU of each 
bacterial isolate were taken from the agar with an inoculating loop, placed into 2 ml of 
PBS, vortexed and centrifuged. The bacterial pellet was suspended in 180 pi of Buffer 
ATL supplied in the QIAamp DNA Mini Kit and stirred vigorously. Twenty pi of 
proteinase K (supplied in kit) was added and the mixture was incubated at 56°C for 
approximately 1 hour. The QIAamp tissue protocol was then followed beginning with 
the addition o f the AL lysis buffer.
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Extraction controls. A control included all reagents without a DNA sample and 
were processed exactly as described above to ensure that extraction buffers and reagents 
were not contaminated with target DNA. Blood from negative cats were periodically 
extracted and checked for contamination. Blood from positive cats were periodically 
extracted as positive controls.
Bartonella genus, species, and type-specific oligonucleotide primers for PCR. 
The target gene chosen for amplification was the 16S rRNA gene o f Bartonella. By 
identifying conserved and hypervariable regions within the I6S rRNA gene, primers 
that are genus specific, that are species specific, and that are type specific were 
designed. The oligonucleotide primers were designed by Ron Tapp using an alignment 
of the 16S rRNA gene sequence for Bartonella species and other closely related 
bacteria (Tapp 2000) (Figure 1).
The primer sequence and nucleotide position are shown in Table 1. For 
amplification of genus specific Bartonella DNA, forward primer pair Bhenl6FF and 
reverse primer UB16SDR9 were used, generating an 823 bp fragment. A second 
reverse primer that is Bartonella genus specific Bhenl6SBBR 5’-CACATGCAA 
GTCGAGCACACTCTTTTAGAG-3 ’ was also designed to be used with the forward 
Bhenl6FF primer to amplify a 567 bp fragment.
The primer sets for each Bartonella species and genotype and the sizes of the 
amplification products are indicated in Table 2. For amplification o f species and 
genotype I-specific Bartonella DNA, the forward primer Bhenl6SGG and reverse 
primer Bhenl6SBBR were used. For amplification of species and genotype II-specific 
Bartonella DNA, the forward primer Bhenl6SHH and reverse primer Bhenl6SBBR
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Bartonella I6S rRNA Primer Diagram
I-------477bp—]
Bhenl6SGG  
Bhenl6SFF Bhenl6SHH
BhenI6SCC
I6S rRNA gene
Bhenl6SBBR UB16SDR9
567 b p ----------------
 823 bp
Figure i. A map o f  the relative positions of the PCR primers and product 
sizes for genus, species, B. henselae and B. clarridgeiae, and 
B. henselae genotype I, B. henselae genotype II (Tapp 2000) 
(Used by permission from Ron Tapp)
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Table 1. PCR Primer Sequences Bartonella
Primer Nucleotide Sequence (5’-3’)
Position*
UB16SDR9 854-877 GCCCCCGTCAATTCCTTTGAGTTT
Bhenl6SFF 52-98 CACATGCAAGTCGAGCACACTCTTTAG
AG
Bhenl6SBBR 648-673 CACTCACCTCTTCCACACTCAAGATA
Bhenl6SGG 159-196 C AAATTT GT GCT AAT ACCG AAT ACGTCC
TTAG
Bhenl6SHH 159-197 GAAATTTGTGCTAAT ACCGAAT ACGTCC
TATTTG
Bhenl6SCC 159-196 G AAATTT GT GCT AAT ACCGT AT ACGTCC
TACT
* Nucleotide positions are based on the reported 16S rRNA-gene sequence for
E.coli
Table 2. Primer Set and Product Size
Primer Set PCR Product Specificity
Bhen 16SFF-UB16SDR9 823 bp Bartonella genus
Bhen 16SFF-Bhen 16SBBR 567 bp Bartonella genus
Bhen 16SGG-Bhen 16SBBR 477 bp Bartonella henselae Genotype I
Bhen 16SHH-Bhen 16SBBR 477 bp Bartonella henselae Genotype II
Bhen 16SCC-Bhen 16SBBR 477 bp Bartonella clarridgeiae
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were used. For amplification of Bartonella clarridgeiae DNA, the forward primer 
Bhenl6SCC and reverse primer Bhenl6SBBR were used. The synthetic 
oligonucleotides were purchased from GeneLab (Louisiana State University, Baton 
Rouge, LA).
For the nested reaction, PCR primers were used in a primary reaction and a 
subsequent second reaction to amplify a region internal to the previous priming site. 
The Bartonella genus specific forward primer Bhenl6SFF was used in combination 
with reverse primer UB16SDR9 to amplify an 823 bp fragment. In a second reaction 
forward primer BhenI6SFF was used in combination with the inner reverse primer 
Bhenl6SBBR to generate a 567 bp Bartonella genus-specific fragment. The species 
and type-specific Bartonella nested PCR was done with combinations o f the outer 
primers Bhenl6SFF-UB16SDR9 and in the second reaction inner primers Bhenl6SGG, 
Bhenl6SHH or Bhenl6SCC and Bhenl6SBBR.
PC R  amplification of DNA. Reaction mixtures were prepared under a hood in a 
room separate from the extraction process. A separate set o f pipettes and aerosol- 
barrier pipette tips were used for reagent preparation. PCR amplification was 
performed in a final volume of 50 pi by using a reaction mixture containing 
deoxynucleoside triphosphates (200pM each), 1.75 mM MgCk, 0.2pM of each primer, 
2.5 U of Taq DNA polymerase, AmpliTaq™Gold, (Perkin Elmer), 4 pi of DNA 
template and 32.6 pi o f Perkin Elmer buffer. The PCR amplifications were carried out 
on a Model 9600 Thermal-Cycler Perkin-Elmer/Applied Biosystems (Foster City, CA). 
Amplification reaction consisted of 10 min. at 95°C; 30 cycles of 94°C for 1 min., 66°C 
for 1 min., 72°C for 1 min., and a final elongation step at 72°C for 10 min. A second
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amplification reaction of 20 cycles with the sample conditions as previously stated was 
performed using inner primers and 1 pi of DNA from the first PCR reaction. Amplicon 
carryover was prevented by using aerosol barrier pipette tips and by separation of 
extraction area, reagent mixture preparation, and amplification and electrophoresis area. 
As a negative control, PCR reagents without DNA template were included in each 
amplification assay. Positive controls of extracted Bartonella species were also used in 
each amplification assay.
Detection o f PCR products. The PCR-amplified products were detected by 
electrophoresis on a 2% agarose gel in Tris-borate-EDTA buffer and visualized with 
ethidium bromide and UV light transillumination. Sixteen microliters o f the final 
product was analyzed in each lane of the gel. A Low DNA Mass™ ladder (Life 
Technologies, Gaithersburg, MD) with six blunt-ended DNA fragments o f 2000, 1200, 
800, 400, 200, and lOObp was used as the molecular marker.
Sensitivity of PCR. To determine the minimum amount of Bartonella DNA that 
could be detected by this PCR assay specific for the 16S rRNA gene of B. henselae, 
genomic Bartonella DNA was extracted from a B. henselae culture using the QIAamp 
DNA Mini Kit (Qiagen, Valencia, CA) protocol for bacteria. The total DNA extracted 
from culture was measured by absorbance at 260 nm on a Beckman DU 640 
Spectrophotometer (Beckman Instrument, Inc. Hercules, CA) using the Warburg- 
Christian concentration method. Serial ten fold dilutions of the extracted DNA were 
made in the elution buffer from the Qiagen kit. PCR amplification was performed on 
each dilution to determine the limits of detection. To determine the minimum number 
of organisms that could be detected by PCR assay of the 16S rRNA gene o f B. henselae,
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serial dilutions of B. henselae organisms diluted in PBS and B. henselae diluted in 
sterile cat blood were prepared. Each dilution was extracted using the QIAamp DNA 
Mini Kit, and PCR amplification performed. A quantitative culture was performed on 
each dilution. The results o f  PCR and culture were compared to determine limits of 
detection of PCR.
Specificity of PCR. DNA extracted from Bartonella henselae 87-66 (ATCC 
49793), Bartonella henselae Houston-1 (ATCC 49882), Bartonella quintana (ATCC 
VR-358), Bartonella clarridgeiae (ATCC 700095), Bartonella elizabethae (ATCC 
49927), Bartonella henselae-LSU 16, and Bartonella henselae-Baby, Escherichia 
coli, Pseudomonas, Bordetella bronchiseptica, Pasturella multocida, Staphylococcus 
aureus and Streptococcus pneumoniae were used as templates in individual PCRs with 
primers Bhenl6SDR9, Bhenl6SBBR, Bhenl6SFF, Bhenl6SGG, Bhenl6SHH, 
Bhenl6SCC. The specificity o f this PCR was also performed with Brucella abortus 
(RB51 strain) DNA because o f the close phylogenetic relationship to Bartonella species
Sequence analysis. Amplicons derived from isolates o f  B henselae LSU 16, B. 
henselae Baby, B. henselae 87-66, B. henselae Houston-1, B. clarridgeiae and from 
blood of one infected cat (cat 86) were sequenced by the Louisiana State University 
GeneLab using an ABI Prism™ 377 DNA Sequencer (Perkin-Elmer) to confirm the 
amplification o f Bartonella DNA.
Results
Specificity of the nested PCR. The primers Bhenl6SFF-Bhenl6SDR9 amplified 
the predicted products of the 823 bp DNA in the first amplification from each o f the 
Bartonella species (Figure 2). The primers Bhenl6SFF-Bhenl6SBBR amplified the
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823 bp-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Figure 2. Specificity of Bartonella primers Bhenl6SFF-Bhenl6SDR9: PCR products 
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: B. henselae LSU 16 
Lane 3: B. henselae Baby 
Lane 4: B. henselae 87-66 
Lane 5: B. henselae Houston-1 
Lane 6: B. quintana 
Lane 7: B. elizabethae 
Lane 8: B. clarridgeiae 
Lane 9: E. coli
Lane 10: Pseudomonas aeruginosa 
Lane 11: Bordetella bronchiseptica 
Lane 12: Pasteurella multocida 
Lane 13: Staphylococcus aureus 
Lane 14: Streptococcus pneumoniae 
Lane 15: Brucella abortus 
Lane 16: Reagent control 
Lane 17: B. henselae positive control
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567 bp DNA in the second amplification o f PCR with DNA templates from each of the 
Bartonella species except B. elizabethae (Figure 3). Products were not amplified with 
the other microorganisms and negative controls as shown in Figures 2 and 3. Primers 
Bhenl6SGG and Bhenl6SBBR amplified the predicted product o f the 477-bp DNA of 
B. henselae genotype I, and primers Bhenl6SHH and Bhenl6SBBR amplified the 
predicted product of the 477-bp DNA o f B. henselae genotype II, and primers 
Bhenl6SCC and Bhenl6SBBR amplified the predicted product o f the 477-bp DNA of 
B. clarridgeiae (Figure 4).
Sensitivity of B. henselae nested PCR. The sensitivity limit of the assay were 
determined as the minimum amount of genomic DNA from an isolate of B. henselae 
and minimum number of B. henselae organisms in spiked cat blood that could be 
detected. The sensitivity limits of B. henselae genomic DNA of the first reaction with 
primers Bhenl6SFF-Bhenl6SDR9 was approximately 6.4 pg or 3.2 x 103 organism 
(Figure 5). By using the nested PCR the sensitivity limits o f the assay were increased to 
approximately 6.4 fg, which corresponds to 3.2 organisms (Figure 6). To estimate the 
quantity of genomic DNA in one cell o f Bartonella, the molecular mass o f Bartonella 
bacilliformis (1.76xl0 '15g or 1.7 fg or 1.6xl06bp and equal to 1.7 fg) was used. 
Applying this method of estimation, one Bartonella cell (2xl06 bp) is equal to 
approximately 2 fg. This assay was repeated three times.
Using 200 pi o f each dilution of B. henselae in sterile cat blood, the sensitivity 
limits of B. henselae in cat blood was determined to be one ten-fold dilution beyond the 
minimal detection limit of culture of 25 CFU/ml. This assay was repeated three times.
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567 bp-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Figure 3. Specificity o f Bartonella primers Bhenl6SFF-Bhenl6SBBR: PCR products 
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: B. henselae LSU 16 
Lane 3: B. henselae Baby 
Lane 4: B. henselae 87-66 
Lane 5: B. henselae Houston-1 
Lane 6: B. quintana 
Lane 7: B. elizabethae 
Lane 8: B. clarridgeiae 
Lane 9: E. coli
Lane 10: Pseudomonas aeruginosa 
Lane 11: Bordetella bronchiseptica 
Lane 12: Pasteurella multocida 
Lane 13: Staphylococcus aureus 
Lane 14: Streptococcus pneumoniae 
Lane 15: Brucella abortus 
Lane 16: Reagent control 
Lane 17: B. henselae positive control
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477 bp-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Figure 4. Specificity of Bartonella species and genotype primers. PCR products (2%
agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2-6: Primer Bhenl6SGG-Bhenl6SBBR genotype I specificity
Lane 2: B. henselae 87-66 genotype I
Lane 3: B. henselae LSU 16 genotype II
Lane 4: B. clarridgeiae
Lane 5: Reagent Control
Lane 6: B. henselae 87-66 genotype I positive control
Lane 7-11: Primer Bhenl6SHH-Bhenl6SBBR genotype II specificity
Lane 7: B. henselae 87-66 genotype I
Lane 8: B. henselae LSU 16 genotype II
Lane 9: B. clarridgeiae
Lane 10: Reagent Control
Lane 11:5. henselae-LSU 16 genotype II positive control
Lane 12-16: Primer Bhenl6SCC-Bhenl6SBBR B. clarridgeiae specificity
Lane 12: B. henselae 87-66 genotype I
Lane 13:5. henselae LSU 16 genotype II
Lane 14: 5. clarridgeiae
Lane 15: Reagent Control
Lane 16: 5. clarridgeiae positive control
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823 bp-
1 2 3 4 5 6 7 8 9 10  11 12 13 14
Figure 5. Sensitivity of Bartonella primers Bhenl6SFF-Bhenl6SDR9: PCR products 
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco), Lane 2: 640 ng/ml, Lane 3: 64 ng/ml, Lane 
4: 6.4 ng/ml, Lane 5: 640 pg/ml, Lane 6: 64 pg/ml, Lane 7: 6.4 pg/ml, Lane 8-13: blank, 
Lane 14: B. henselae positive control
Figure 6. Sensitivity of Bartonella primers Bhenl6SFF-Bhenl6SBBR: PCR products 
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco), Lane 2: 640 ng/ml, Lane 3: 64 ng/ml, Lane 
4: 6.4 ng/ml, Lane 5: 640 pg/ml, Lane 6: 64 pg/ml, Lane 7: 6.4 pg/ml, Lane 8: 640 
fg/ml, Lane 9: 64 fg/ml, Lane 10: 6.4 fg/ml, Lane 11-12: blank, Lane 13: B. henselae 
positive control
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The nested PCR enhanced detection of organisms from the blood o f cats experimentally 
infected with B. henselae. The limit o f detection in cat 87, when using primer set 
Bhenl6FF-UB162DR9 in the first reaction, was 19,000 CFU/ml. In the first reaction 
using primers Bhen 16FF-UB162DR9, the assay did not detect amplicons in the blood 
of cat when the culture results were 1,400 CFU/ml, 1,200 CFU/ml, or 300 CFU/ml. In 
the second reaction using the inner primers Bhenl6SFF-Bhenl6SBBR, the nested PCR 
assay detected amplicons of B. henselae in cat 87 below the limits o f culture (Figure 7). 
In the second reaction, the nPCR amplified Bartonella DNA when the culture results 
were 1,400 CFU/ml, 1,200 CFU/ml, 300 CFU/ml, and when the culture was negative 
for two consecutive weeks.
Bacteremia in Experimentally Infected Cats. In this study, cats experimentally 
infected with B. henselae were followed by PCR and culture beginning one week after 
inoculation and until time of necropsy. Over the course of this study, 362 blood 
specimens were used to investigate the bacteremic phase o f the infection using PCR 
assay and bacterial culture. Fourteen o f the sixteen cats experimentally inoculated with 
B. henselae Houston-1 did not become bacteremic. Bacteremia in the cats ranged from 
l.OxlO2 to 8.0x105 CFU/ml. The duration o f the bacteremia ranged from 5 weeks to 22 
weeks (Table 3). Bacteremia was determined by isolation of Bartonella from blood or 
amplification of Bartonella DNA from blood. In most samples, the PCR was useful in 
detecting Bartonella DNA after the culture became negative. The PCR assays were 
positive in 11 of the 14 cats after culture became negative. The PCR assay was positive 
for periods of 1 to 9 weeks after the culture became negative (Table 3 and Table 5). In
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823 bp- 
567 bp-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Figure 7. Bartonella DNA. Comparison o f nPCR assay and bacterial culture from 
blood samples from Bartonella henselae experimentally infected cat (87). PCR 
products from nPCR (2% agarose stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2-7 PCR products with primers Bhenl6SFF-Bhenl6SDR9 and CFU/ml
Lane 2: week-1 Blood sample 19,000 CFU/ml
Lane 3: week-2 Blood sample 1,400 CFU/ml
Lane 4: week-3 Blood sample 1,200 CFU/ml
Lane 5: week-4 Blood sample 300 CFU/ml
Lane 6: week-5 Blood sample 0 CFU/ml
Lane 7: week-6 Blood sample 0 CFU/ml
Lane 8-13 PCR products with primers Bhenl6SFF-Bhenl6SBBR and CFU/ml
Lane 8: week-1 blood sample 19,000 CFU/ml
Lane 9: week-2 blood sample 1,400 CFU/ml
Lane 10: week-3 blood sample 1,200 CFU/ml
Lane 11: week-4 blood sample 300 CFU/ml
Lane 12: week-5 blood sample 0 CFU/ml
Lane 13: week-6 blood sample 0 CFU/ml
Lane 14: Reagent Control
Lane 15: B. henselae positive control
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Table 3. Results of PCR assay and blood culture from bacteremic cats
Cat 10b Cat 83b Cat87b CatG3b
Week* PCR CFU/ml PCR CFU/ml PCR CFU/ml PCR CFU/ml
1 + 2.5x104 + 2.0x104 + 6.2x104 + 1.2xl03
2 + 8.3xl02 + 7.0x103 + 1.9xl04 + 1.8xl05
3 + 0 + 2.3x105 + 1.4xl03 + 8.0x105
4 + 0 + 7.0xl02 + 1.2xl03 + 1.3xl05
5 + l.OxlO2 + 2.0x103 + 3.0xl02 + 2.4x104
6 - 0 + 0 + 0 + 2.5x104
7 - 0 - 0 + 0 + 9.0x103
8 - 0 - 0 4- 0 + 2.3x104
9 - 0 - 0 + 0 + 3.0x102
10 - 0 - 0 - 0 + 0
11 - 0 - 0 - 0 + 0
12 - 0 - 0 - 0 + 0
13 - 0 - 0 - 0 + 0
14 - 0 - 0 - 0 + 0
15 - 0 - 0 - 0 + 0
16 - 0 - 0 - 0 + 0
17 - 0 - 0 - 0 + 0
18-29 NDf NDf NDf - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c inoculated with Bartonella henselae Baby Genotype II 
d inoculated with Bartonella henselae 87-66 Genotype I 
c inoculated with Bartonella henselae Houston-1 Genotype I 
f ND, not determined
(Table 3 continued)
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Cat L lc Cat 36IC Cat K3C CatL2d
Week* PCR CFU/ml PCR CFL /ml PCR CFU/ml PCR CFU/ml
1 + l.OxlO6 + 3.4x10s + 4.0x104 + 6.8x104
2 + 2.4x105 + 3.5xl04 + 3.2x104 + 4.4x104
3 + 3.0xl02 + 3.6xl05 + 1.5x10s + 4.0x105
4 + 3.5xl02 + 7.0x102 + 2.0x105 + l.lx l  05
5 + 0 + l.OxlO2 + 6.8x104 + 3.5x10s
6 + l.OxlO2 + l.OxlO2 + 4.5xl04 + 1.9x19s
7 + 0 + 1.5xl02 + 2.5xl04 + 1.3xl04
8 + 0 + 0 + 2.4x104 + 3.9xl03
9 + 0 + 0 + 1.3xl04 + 2.5x103
10 + 0 + 0 + 6.7x103 + 5.0x102
11 + 0 + 0 + 4.2x103 + 5.0x102
12 + 0 + 0 + 2.6x103 + l.OxlO2
13 + 0 + 0 + 6.6x102 + 8.3xl03
14 NDf NDf ND f NDf
15 + 0 - 0 + 2.6x102 + 8.6xl03
16 - 0 + 0 + 6.3x102 + 8.3xl03
17 + 0 - 0 + 1.3xl02 + 1.5xl04
18 - 0 - 0 + l.OxlO2 + 8.0x103
19 - 0 - 0 + 2.0x102 + 7.3xl03
20 - 0 - 0 - 0 + 5.3x103
21 - 0 - 0 - 0 + l.OxlO3
22 - 0 - 0 - 0 + l.OxlO3
23-29 - 0 - 0 - 0 - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c inoculated with Bartonella henselae Baby Genotype II 
d inoculated with Bartonella henselae 87-66 Genotype I 
c inoculated with Bartonella henselae Houston-1 Genotype I 
fND, not determined
(Table 3 continued)
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Week"
C at K4d
PC R  CFU/ml
Cat L3e 
PCR CFU/ml
C at F5e 
PCR CFU/ml
Cat 347* 
PCR CFU/ml
1 + 9.0x102 0 . 0 . 0
2 + 4.1xl04 - 0 - 0 - 0
3 + 3.0x104 - 0 - 0 - 0
4 + 5.1xl04 + 5.0x102 ■ 0 - 0
5 + 4.8x104 + 2.0x103 * 0 - 0
6 + 5.7x104 + 3.0x102 - 0 - 0
7 + 2.3xl04 + 2.0x102 - 0 - 0
8 + 6.0x103 - l.OxlO2 - 0 - 0
9 + 4.0x103 - l.OxlO2 - 0 - 0
10 + 4.0x102 - 0 - 0 - 0
11 + l.OxlO2 - 0 - 0 - 0
12 + 0 - 0 - 0 - 0
13 - 0 - 0 - 0 - 0
14 NDr NDf ND f NDf
15 - 0 - 0 - 0 - 0
16 - 0 - 0 - 0 - 0
17 - 0 - 0 - 0 - 0
18 - 0 - 0 - 0 - 0
19 - 0 - 0 - 0 - 0
20 - 0 - 0 - 0 - 0
21 - 0 - 0 - 0 - 0
22 - 0 - 0 - 0 - 0
23 - 0 - 0 - 0 - 0
24-29 - 0 - 0 - 0 - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c inoculated with Bartonella henselae Baby Genotype II 
d inoculated with Bartonella henselae 87-66 Genotype I 
c inoculated with Bartonella henselae Houston-1 Genotype I 
fND, not determined
(Table 3 continued)
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Cat N2d Cat N3b
Week* PCR CFU/ml PCR CFU/ml
1 + 4.0x103 + 1.2xl03
2 + 2.0x103 + 3.1xl04
3 + 2.7x104 + 2.2x105
4 + 2.4x104 + 2.0x104
5 + 2.8xI04 + 3.6x104
6 + 2.1xl04 + 2.9x104
7 + 2.2x104 + 6.0x103
8 + 1.6xI04 + 2.1xl03
9 + 7.6xl03 + 5.0xl02
10 + 5.0x103 + 0
11 + 2.8xl03 + 0
12 + l.OxlO3 - 0
13 + l.3x!02 - 0
14 NDf - 0
15 + 0 - 0
16 - 0 - 0
17 + 0 - 0
18 - 0 - 0
19 - 0 - 0
20 - 0 - 0
21 - 0 - 0
22 - 0 - 0
23-29 - 0 - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c inoculated with Bartonella henselae Baby Genotype II 
d inoculated with Bartonella henselae 87-66 Genotype I 
c inoculated with Bartonella henselae Houston-1 Genotype I 
fND, not determined
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each of the cats (n=14) that were followed during the bacteremic phase of the infection, 
the duration of bacteremia, as defined by culture and PCR, lasted for a longer time 
period when the PCR assay was used to detect circulating Bartonella as compared to 
culture (Table 3). In three cats, the PCR and culture were negative the same week. The 
culture was positive for 1-2 weeks when the PCR was negative in cat L3 and 321. In 
two of the experimentally infected cats there was a 1-week interval when the bacteremia 
was below the detection limits o f culture but detected by the PCR assay. In cat 10, the 
culture negative interval was 2 weeks during the acute bacteremia when the PCR assay 
was positive. In cat LI and 361, Bartonella species were bacteremic 1-3 weeks post­
inoculation. Two of the cats during the time when the culture was negative, the PCR 
assay were negative one week followed by a positive PCR the next week (Table 3).
Results o f the PCR assay were comparable to culture results in most of the 
specimens. The PCR assay was positive in 135 of the 138 (98%) blood specimens that 
were culture-positive. The PCR assay was negative from three blood specimens that 
were culture-positive with 100 colony-forming units per milliliter (Table 3 and Table 
5). O f the 223 blood specimens that were culture-negative, PCR assay was positive in 
40 (18%) o f these specimens (Table 4).
Table 4. Summary of PCR assay and blood culture results (n=362f
PCR positive (%) PCR negative (%)
Culture positive 135/138 (98) 3/138 (2)
Culture negative 40/223 (18) 183/223 (82)
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Relapsing bacteremia. Two cats, cat 86 and cat 321, infected with B. henselae 
LSU 16, a pathogenic strain o f Bartonella in cats, had an episode o f relapsing 
bacteremia (Table 5). Cat 86 experienced a culture-negative interval o f 7 weeks 
between the two episodes of bacteremia. The second bacteremia in cat 86 lasted for 8 
weeks before the blood culture became negative. The PCR assay in cat 86 was positive 
for 2 weeks longer than the culture in the first episode o f bacteremia. During the 
second bacteremia, both culture and PCR were positive from weeks 13 through 20. Cat 
321 was PCR and culture positive from weeks 1 through 6. At week 7, the PCR was 
positive and the culture was negative. At week 8, both assays were positive again for 3 
weeks. After an 11 -week culture-negative interval, cat 321 became culture and PCR 
positive again. The second bacteremia in cat 321 lasted for 4 weeks with positive 
culture results for 4 weeks and positive PCR results for only three o f those weeks.
Sequence analysis. The sequence data derived from B. henselae LSU 16 and B. 
henselae Baby were that of a B. henselae genotype II strain with the base pairs ATT 
located at positions 172 to 175 of the 16S r RNA gene identical to B. henselae genotype 
II as described by Bergmans et al. (1995) (Figure 8). The sequence data from B. 
henselae Houston-1 and B. henselae 87-66 located at positions 172 to 175 of the 16S r 
RNA gene were that of a B. henselae genotype I with the base pairs TAG as described 
by Bergmans et al. (Figure 8). The sequence data derived from the blood o f cat 86 was 
a B. henselae genotype II with the base pairs ATT (Figure 8). The sequence data from 
the isolate o f B. clarridgeiae was as reported with the base pairs ACT located at 
positions 172 to 175 of the 16S rRNA gene (Gene bank X97822) (Figure 8).
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Table 5. Results of PCR and blood culture from cats with relapsing bacteremia
Cat 86b Cat 321b
Weeka PCR CFU/ml PCR CFU/ml
1 4- 6.3x104 2.6x103
2 + 1.7xl04 + 3.9xl04
3 + 4.3x104 + 2.0x105
4 + 2.2x103 + 1.7xl04
5 + 3.0xl02 + l.OxlO2
6 + 0 + l.OxlO2
7 + 0 + 0
8 - 0 + 6.0x102
9 - 0 + 4.0x102
10 - 0 + 1.5xl02
11 - 0 - 0
12 - 0 - 0
13 + l.lx lO 4 NDC
14 + l.OxlO4 - 0
15 + 6.0x103 - 0
16 + 1.2xl03 - 0
17 + 3.3xl02 - 0
18 + 7.0x102 - 0
19 + 2.3xl02 - 0
20 + l.OxlO2 - 0
21 - 0 - 0
22 - 0 - 0
23 - 0 + 6.0x102
24 - 0 + 6.7x102
25 - 0 + 2.0x102
26 - 0 - 1.3xl02
27 - 0 - 0
28 - 0 - 0
29 - 0 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c ND, not determined
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Prim er Bhen 1 6 S F F -^
CA CA TG CCA G TCG A G CA CA CTCTTTTA G A G  
B. henselae LSU 16 genotype II 
B. henselae Baby genotype II 
B. henselae 87-66 genotype I 
B. henselae H ouston-1 genotype I 
3. clarridgeiae 
PC R  product blood cat 86
TA A C G C G TG G G A A TC TA C C C A TC T
B. henselae LSU 16 genotype II 
B. henselae Baby genotype II 
B. henselae 87-66 genotype I 
B. henselae Houston 
B. clarridgeiae 
PCR product blood cat 86
172-175 bp region
C T ACGG A A T AAC AC AG A G  A A A T TTG TG C T A A TTT A C C G T  A T
................................................................. A T T ......................................................
............................................................ T A G .....................................................
1 genotype I ............................................................  T A G ............................................
................................................................. A C T ....................................................
.................................................................A T T ....................................................
B. henselae LSU 16 genotype II 
B. henselae Baby genotype II 
B. henselae 87-66 genotype I 
B. henselae H ouston-1 genotype I 
B. clarridgeiae 
PC R  product blood cat 86
B. henselae LSU 16 genotype II 
B. henselae Baby genotype II 
B. henselae 87-66 genotype I 
B. henselae H ouston-1 genotype I 
B. clarridgeiae 
PC R  product blood cat 86
B. henselae LSU 16 genotype 13 
B. henselae Baby genotype II 
B. henselae 87-66 genotype I 
B. henselae H ouston-1 genotype I 
B. clarridgeiae 
PCR product blood cat 86
A CG TCCTA TTTG G A G A A A G A TTTA TG G A G A TG G A TG A G C C C
G CG TTG G A TTTA G C TA G TTG G TG A G G TA A C G G C TC A C C G A G
G C G A A A C G A TC C A TA G C TG G TC TG A G A G G A TG A TC A G C C A C
^  Prim er B h en l6 S B B R  
A TA G A A CTC A C A C C TTC TC C A C TC A C
B. henselae LSU 16 genotype II ACTG G G A CTG A G A CA
B. henselae Baby genotype II ..............................................
B. henselae 87-66 genotype I ..............................................
B. henselae H ouston-1 genotype I ..............................................
B. clarridgeiae..................................... ..............................................
PCR product blood cat 86 ..............................................
Figure 8. Partial sequence alignment o f 519-bp fragment amplified from 16S rRNA 
gene o f Bartonella henselae LSU 16 genotype II, B. henselae Baby, B. henselae 87-66, 
B. henselae Houston-1, B. clarridgeiae, and PCR product from blood o f experimentally 
infected cat 86. Region of 172-175 (ATT, TAG) identifies B. henselae genotype II and 
genotype I. Region of 172-176 (ACT) identifies B. clarridgeiae
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Discussion
A PCR assay that is both sensitive and specific is a good tool for studying persistent 
infections. The nPCR assay was specific for B. henselae LSU 16, B. henselae Baby, B. 
henselae Houston-1, B. henselae 87-66, B. clarridgeiae, and B. quintana, B. elizabethae 
was not amplified in the second reaction of the nPCR assay because the reverse primer 
Bhenl6SBBR is not specific for B. elizabethae. The sensitivity limits o f the PCR assay 
were improved with the nested design and proved useful in detecting low numbers of 
organisms. The nested PCR assay was able to detect Bartonella DNA in circulating 
blood of cats that were culture negative. The ability o f the PCR to detect Bartonella 
DNA in cats that were culture negative is a function o f the sensitivity limits o f the PCR 
as compared to culture. In theory, this nested PCR can detect approximately 3.2 
Bartonella organisms. The detection limits of culture in this study were approximately 
25 CFU/ml, and the limits of the PCR assay were one ten-fold dilution below 25 
CFU/ml. Although the amplification of Bartonella DNA from the blood o f Bartonella 
infected cats may represent dead bacteria, the detection of Bartonella DNA in some cats 
as long as 9 weeks after blood cultures were negative makes the detection o f dead 
bacteria unlikely. Rather, one could postulate that amplification o f Bartonella DNA in 
the blood of infected cats long after the blood culture is negative represents a small 
number of viable organisms circulating in the peripheral blood. One also could 
speculate that Bartonella DNA in the blood of these cats is due to the shedding of 
microorganisms into the peripheral blood from a sequestered location in the cat such as 
the endothelial cells of the vascular system.
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The PCR assay was able to detect Bartonella DNA in 40 samples that were culture 
negative. Again this could be explained by existence o f circulating nonviable 
organisms or because the sensitivity of the PCR assay is greater than that o f culture.
The question then becomes the infectious nature o f bartonellosis in cats in this stage of 
the infection. Kordick et al. (1997b) was able to transmit B. henselae from blood 
culture negative cat by inoculation of blood into a SPF cat. This observation indicates 
that a negative blood culture cannot be used to definitively rule out Bartonella infection 
in cats. If  cats are infectious after the culture is negative and PCR is positive, the PCR 
assay would be a more accurate laboratory assay for detecting cats with Bartonella.
Three blood specimens were culture positive and PCR negative. For unknown 
reason, the PCR assay missed three blood specimens that were culture-positive with 100 
colony-forming units per milliliter. This may be explained by the cohesion and 
aggregation factors that have been reported with Bartonella species. Clarridge (1996) 
reported a degree o f cohesiveness in B. henselae and B. clarridgeiae, and this was 
correlated with cells existing in a tightly packed array. Despite the fact that the blood 
was vortexed before sampling, the PCR could have been negative because o f the 
coherent nature of the organism. The PCR assay results were negative for one week 
followed by a positive result the next week in cats, LI, and 361. The results occurred 
when the bacteremia was waning and was below the minimum detection limits by PCR 
or because the result are representative of a false positive test.
The PCR assay did not detect Bartonella DNA earlier than the blood culture in the 
cats with a recurrent episode o f bacteremia or in the primary infection in cat L3. 
Possibly, if blood were taken within the week before the recurrent episode, a positive
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PCR for Bartonella DNA would have been detected. It is not known how the 
organisms seed the blood in these infections. If the organism slowly leaks into the 
circulating blood from a source like the endothelial lining, the PCR may be positive 
before the culture. If the organism seeds the blood suddenly with a number of 
organisms large enough for the culture to be positive, the PCR assay would not be 
positive any sooner than culture. However, because of the turnaround time of the PCR 
assay compared to culture, the detection of a positive Bartonella cat would be noted at 
an earlier time.
Specificity was addressed in this PCR assay with the use of specific primers in the 
first and second reaction of the nested PCR. Specific oligonucleotide primers for 
Bartonella genus were used in the first reaction by amplifying an 823 bp fragment or a 
567 bp fragment from the 16S rRNA gene of Bartonella. In the second reaction, 
specificity is increased further by the use o f another group of specific primers that 
amplifies a subset from the first reaction because they are complementary to a specific 
fragment o f Bartonella. B. clarridgeiae and Bartonella henselae genotype I and 
genotype II can be differentiated by the specific primer sets in the second reaction. An 
assay that can determine genetic differences in strains of Bartonella will be useful in 
studying the pathogenesis of this organism in cats.
Molecular assays such as PCR give a higher discriminatory power in identification 
of microorganisms than does identification by phenotypic characteristics (Reiman 
1993). The products amplified in this PCR reaction were confirmed by sequence 
analysis that is a very specific method o f identification and is based on genetic 
information, not phenotypic tests as in culture methods. In addition, molecular assays
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such as PCR that will amplify and allow for detection of microorganisms missed 
because of the insensitivity of a particular method is a powerful tool in research and 
clinical microbiology. This PCR assay has proven to be a useful assay that is both 
sensitive and specific and will be used in our laboratory for further studies for the 
understanding of the pathogenesis o f B. henselae in cats.
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CHAPTER THREE
PERSISTENT BARTONELLA DNA IN CATS EXPERIMENTALLY INFECTED 
WITH BARTONELLA HENSELAE GENOTYPE I AND BARTONELLA
HENSELAE GENOTYPE II
Introduction
During the past decade, Bartonella species has emerged as an important human 
pathogen. Five species, Bartonella henselae, B. quintana, B. clarridgeiae,
B. bacilliformis, and B. elizabethae have been associated with human disease. The 
spectrum of diseases produced by Bartonella species is wide and includes 
lymphadenopathy, relapsing bacteremia, endocarditis, retinitis, osteolysis, 
encephalopathy, hemolytic anemia, bacillary angiomatosis, and bacillary peliosis 
(Anderson and Neuman 1997).
Epidemiological studies have shown that ownership o f a cat and being scratched or 
bitten by a cat are risk factors for acquiring cat scratch disease (Zangwill et al. 1973). 
Following that study, two species, B. henselae and B. clarridgeiae, were isolated from 
cats (Gurfield et al. 1997). Prevalence studies have shown that a significant number of 
cats are subclinically infected with Bartonella, and that cats are a reservoir for human 
infections involving Bartonella species (Childs et al. 1994; Heller et al. 1997; Jamerson 
et al. 1995). B. henselae causes the widest spectrum of pathology, depending on the 
immune system o f the host, and includes disease with granulomatous features, vascular 
proliferative features, and a predominantly intravascular focus (Reiman et al. 1990).
The only known human disease associated with B. clarridgeiae is cat scratch disease.
Our knowledge o f the pathogenesis o f B. henselae in the cat is incomplete. It is 
known that the prevalence o f  B. henselae infections in cats is high, and that feline 
bartonellosis can be a persistent infection in cats (Kordick et al. 1999). What is not
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understood is the persistent phase o f feline bartonellosis. Many aspects o f the persistent 
phase such as the mechanisms of survival, host cell association, or tissue sequestration 
are unclear.
Clinically infected cats can be bacteremic and asymptomatic for long periods. The 
bacteremia in cats can be of significant magnitude and duration and can often recur 
(Kordick and Breitschwerdt 1997). In a study by Kordick et al. (1997b), cats in 
environmentally controlled settings were culture negative for periods up to 4 months 
between recurrent episodes of bacteremia. Kordick et al. (1999) observed recurrent 
episodes of bacteremia for up to 454 days in cats infected with B. henselae or B. 
clarridgeiae. In humans, relapsing bacteremia is also a characteristic of Bartonella 
infections and many o f these infections evolve into long-term asymptomatic persistent 
infections (Welch and Slater 1999). The persistence o f these infections in both cats and 
humans is suggestive o f  a carrier state with sequestration of the microorganism within 
the host.
During the acute bacteremic phase in cats, B. henselae has been cultured from 
lymph nodes, heart, lung, spleen, liver, kidney, pancreas, thymus, and bone marrow 
(Guptill et al. 1997). Clinical signs have been described in experimentally infected cats 
and include fever, lethargy, and mild neurologic signs consistent with CNS involvement 
in one cat (O’Reilly et al. 1999a; Guptill et al. 1997; Kordick et al. 1999). Within 2 to 6 
weeks after infection, enlarged mandibular or popliteal lymph nodes with lymphoid 
hyperplasia, a splenic microabscess, and a liver abscess in experimentally infected cats 
have been described (Guptill et al. 1997). Bartonella can be cultured from many tissues 
of cats that are bacteremic probably because o f the presence of organisms circulating
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through tissue. Whether Bartonella colonizes or sequesters in tissue after the acute 
bacteremic phase is unknown. Tissues from blood culture negative cats are often 
culture negative.
In addition to recurrent bacteremia, there is other evidence to support the belief that 
Bartonella is a persistent infection in cats. This evidence includes failure to eliminate 
infections readily with the use of antibiotics (Kordick et al. 1997b), pathological 
changes seen in the tissue o f cats infected for long periods with B. henselae (Korkick et 
al. \999), immunological evidence to suggest continued antigenic stimulation (O’Reilly 
et al. 1999a) and granulomatous response as seen in some Bartonella infections (Guptill 
et al. 1997). Granulomatous inflammation in the liver o f  cats infected with B. henselae 
was reported in this study but has not been confirmed as a typical cellular response 
(Guptill et al. 1997). Granulomatous inflammation has been reported in Bartonella 
infections in humans with CSD, in dogs with granulomatous lymphadenitis and 
granulomatous rhinitis, and in the liver o f mice (Pappalardo et al. 2000, Regnath et al. 
1998).
The immunological response of the cat also suggests that feline bartonellosis can be 
a persistent infection. Some cats respond with typical IgM and IgG antibody patterns of 
response, while other cats infected with B. henselae have been shown to have IgM 
levels which remain elevated above baseline suggesting continued antigenic stimulation 
(Freeland et al. 1999). Homologous protection without cross protection by various 
species and types has been shown (Yamamoto et al. 1998b). Human and murine 
immune responses to B. henselae have been shown to include T-cell activity, IFN-y 
production, and macrophage killing activity, suggesting an intracellular location with a
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Thl, CD4 type cytokine response (Karem et al. 1999). Freeland et al. (1999) identified 
a number of Bartonella-specific antigens to which strong antibody responses are 
generated in both experimentally and naturally infected cats. B. henselae may evade the 
cat’s immune system by methods of promoting uptake by nonimmune cells such as 
erythrocytes (Mehock et al. 1998). The strain B. henselae LSU16 was found to be 
resistant to killing by neutrophils when compared to the Houston-1 strain of B. henselae 
(O’ Reilly etal. 1999b).
In human cases, B. henselae DNA has been detected by PCR in atypical B. 
henselae infections involving organs such as heart (endocarditis), brain (encephalitis), 
lymph nodes, eye (peripapillary angioma), liver, and spleen (Koehler et al. 1997; Gray 
et al. 1998; McGrath, 1998; Wheeler et al. 1997; Baorto et al. 1998; Stuart and Norwick 
1998). B. henselae DNA was detected by PCR in the liver of a dog with peliosis 
hepatis (Kitchell et al. 2000). Regnath et al. (1998) showed that B. henselae infected 
mice cleared the cultivatable organism within the first 6 days of infection from liver and 
spleen but Bartonella DNA could be detected in the liver for at least 3 months.
Whether Bartonella has an intracellular niche other than the feline erythrocytes is 
unknown. An intracellular location of Bartonella in cats would be consistent with the 
persistent nature of feline bartonellosis. In the study by Kordick et al. (1997b), cats 
chronically bacteremic with Bartonella were treated for an extended duration o f 25 
weeks with enrofloxacin, which is partially converted to ciprofloxacin in the cat, with 
elimination of infection in 9 of 14 infected cats.
Bartonella infections in cats have been reported to cause pathologic changes in 
major organs in cats (Kordick et al. 1999). Kordick et al (1999) described cats
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experimentally infected with Bartonella, that had microscopic inflammatory foci in 
tissue which represent nonspecific histological changes consistent with systemic 
dissemination o f blood-bome infection. Follicular hyperplasia o f lymph nodes and 
spleen were seen in experimentally infected cats and thought to represent a tissue 
response to chronic antigenic stimulation, which is consistent with chronic Bartonella 
infection (Kordick et al. 1999). In another study done by Guptill et al. (1997), 
Bartonella-specific antibody-secreting cells were detected in spleen, bone marrow and 
peripheral lymph nodes in abacteremic experimentally infected cats thirty-two weeks 
post inoculation. The greatest number of antibody-secreting cells was detected in the 
spleen in that study.
Often Bartonella DNA can be amplified from various types o f clinical material in 
the absence o f a positive culture. Whether the Bartonella DNA represents 
microorganisms that are viable or ncnviable is not fully understood. The amplification 
of Bartonella DNA may represent viable organisms lying in a dormant state, viable 
organisms in numbers below the detection limits of culture or nonviable (dead) 
organism in tissue. One way to determine if a bacterial cell is viable is to measure the 
synthesis o f RNA. The RT-PCR, which first produces cDNA from RNA and then 
amplifies the cDNA, is one method for analysis of RNA expression.
The purpose of this study was to determine if persistent Bartonella DNA exists in 
the tissue o f abacteremic cats chronically infected with Bartonella. A nPCR assay that 
amplifies a 567-bp fragment of the 16S rRNA gene of B. henselae was used to detect 
Bartonella DNA in tissue. RNA expression in the tissue o f cats was examined using 
two different RT-PCR assays. One assay was designed to amplify a 354-bp fragment of
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the citrate synthase gene o f B. henselae, and the other RT-PCR was designed to amplify 
a 567-bp fragment o f the 16S rRNA gene o f B. henselae. Cats defined as abacteremic 
by culture and PCR assay were necropsied and tissues taken for isolation and 
amplification o f Bartonella. Results were complied from SPF cats experimentally 
infected with B. henselae. The findings of Bartonella DNA detected in tissue after the 
bacteremic phase o f the infection are discussed in this study.
Materials and Methods 
Experimental animals. Tissue used in this study were taken from twenty-three cat 
followed in the study. Sixteen of the cats were the same as referred to in Chapter 2. 
Four additional cats used in this study were bred at Louisiana State University as 
specific-pathogen-free cats (SPF) and three additional cat used in this study were 
purchased from Harlan Sprague-Dawley (Madison, Wis.) as specific-pathogen-free 
(SPF) cats.
Bacterial strains. As described in Chapter 2 
Infection in cats. Methods the same as in Chapter 2
Collection of tissue specimens. Cats were euthanized by cardiac puncture with 
overdose o f Beuthanisa (Schering Plough, Canada). Standard necropsies were 
performed on all cats. Tissue was collected using a separate set o f sterile instruments 
for each tissue. Representative fresh tissue samples were taken for bacterial culture, 
PCR analysis, and RNA extraction and formalin fixed tissues were taken for 
histopathology. For culture and PCR analysis tissue was placed in a sterile whirpak bag 
and placed on ice immediately. Tissue for RNA extraction was immediately frozen in
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liquid nitrogen. Tissue for histopathology was fixed in 10% neutral buffered formalin 
for paraffin embedding.
Cultures of tissues. Postmortem tissue specimens were collected aseptically on 
each cat at necropsy using a separate set o f sterile instruments for each tissue collected. 
Eight tissues including liver, spleen, bone marrow, heart valve, lung, brain, lymph node, 
and kidney and blood were taken from each cat. Each tissue was ground in a tissue 
grinder and a representative sample was cultured on enriched chocolate agar (Remel, 
Lenexa, Kansas) and brucella broth with 6 to 8% Fildes solution and 250 pg of hemin 
per ml (Schwartzman et al 1993). Broth cultures were observed weekly for growth. 
Broths were gram stained and subcultured on chocolate agar before discarding. All 
cultures were incubated at 37°C in 5% CO2 for 3 weeks.
Extraction of DNA from tissue. Extraction of DNA from tissue was performed 
using the Tissue Protocol within the QLAamp DNA Mini Kit (Qiagen Inc. Valencia, 
CA). A representative section of each tissue was taken from each cat at necropsy. Each 
tissue section was ground in a tissue grinder and 25 mg (Mettler PM 460) of tissue was 
used in the Tissue Protocol according to manufacturer directions. The extracted DNA 
was used as a template in the PCR assays. Extraction controls included tissue from 
Bartonella culture positive and negative cats and a reagent control without a DNA 
sample.
PCR amplification of DNA from tissue. Amplification of DNA was identical to the 
method described in Chapter 2. The PCR assay used in this study was not a quantitative 
PCR, therefore, the Bartonella DNA detected in the tissue of the cats could not be 
quantitated. The liver of cat 1 and spleen of cat 87 were chosen at random and the
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Bartonella DNA extracted. Extracted DNA was diluted 10-fold in elution buffer and 
amplified as described in the PCR assay.
Detection of PCR products. Methods the same as in Chapter 2
RNA extraction. Tissue that was positive for DNA fragments o f the 16S rRNA 
gene of Bartonella was used for RNA extraction. RNA extractions were done using the 
RNAeasy Kit, (Qiagen Inc. Valencia, CA). The procedure recommended by the 
manufacturer was followed with the exception of treatment with RNase-Free DNAase 
(Qiagen, Inc. Valencia, CA) for 1 hr at 37°C and a follow-up RNA extraction with the 
RNAeasy Kit.
RT-PCR of the 16S rRNA gene of B. henselae. The RT-PCR reaction mix was 
made using the Titan™ One Tube RT-PCR System (Roche Molecular Biochemicals, 
Indianapolis, IN) according to the manufacturer direction. This method uses the reverse 
transcriptase avian myeloblastosis virus (AVM) for the first strand synthesis and the 
Expand™ High Fidelity enzyme blend, which consists of Taq DNA polymerase and 
Pwo DNA polymerase for the PCR. Primers used in this assay were designed to 
amplify a 567-bp fragment of the 16S rRNA gene of Bartonella. A nested reaction was 
done using 4 pi o f RNA template in the first reaction with forward primers Bhenl6SFF 
5’ C AC ATGC AAGTCG AGC AC ACTCTTTT AG AG 3’ and reverse primer 
UB16SDR9 5’ GCCCCCGTCAATTCCTTTGAGTTT 3’. The RT-PCR reaction 
mixture consisted o f two reaction mixtures each of 25 pi. One reaction mixture 
consisted of 12.5 pi of sterile RNase and DNase free water, 4 pi of deoxynucleoside 
triphosphates (200 uM each), 2.5 pi dithiothreitol solution (DTT) (100 mM), and 4 pi of 
template. The second reaction mixture consisted of 10 pi of RT-PCR buffer (Titan), 14
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pi o f sterile RNase and DNase free water, and 1 pi o f Titan Enzyme mix (AMV and 
Expand ™ High Fidelity). Twenty-five pi of reaction mix one and 25 pi of reaction 
mix two were added together for thermocycling. The amplification reaction consisted a 
o f reverse transcription step o f 50°C for 30min., 30 cycles at 94°C for 30 s, 66°C for 
30s, 68°C for 1 min and a hold cycle for 68°C for 2 min. The second reaction (nested 
PCR) mixture consisted o f deoxynucleoside triphosphates (200 pM each), 1.75 mM 
MgCH, 0.2 pM of each primer, 2.5 U of Taq DNA polymerase, AmpliTaq™ Gold 
(Perkin Elmer), 1 pi o f DNA from the first reaction in PE buffer in a total volume o f 50 
pi. In the second reaction the primers were the forward primers Bhenl6SFF and 
reverse inner primer Bhenl6SBBR 5’ CACTCACCTCTTCCACACTCAAGATA 3’. 
Amplification reaction consisted of 10 min. at 95°C; 20 cycles o f 94°C for lmin., 66°C 
for 1 min., and 72°C for 1 min., and a final elongation step at 72°C for 10 min. The 
PCR amplification was carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied 
Biosystems (Foster City, CA).
RT-PCR of the citrate synthase gene of B. henselae. A second RT-PCR assay 
was designed to amplify a 354 bp fragment o f B. henselae gltA citrate synthase gene 
(Regnath et al. 1998). In this assay the outer primer sequences CSN-F1 5’ 
GGTCCCAACTCTT TGCCGCTATG 3’ and CSN-R1 5’ CAGCCGA 
CACTGGGTGCTAATG 3’ were used in the first reaction. The RT-PCR reaction 
mixture consisted of two reaction mixtures each o f 25 pi. One reaction mixture 
consisted of 12.5 pi of sterile RNase and DNase free water, 4 pi o f deoxynucleoside 
triphosphates (200 uM each), 2.5 pi dithiothreitol solution (DTT) (lOOmM), and 4 pi of
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template. The second reaction mixture consisted o f 10 pi o f RT-PCR buffer (Titan), 14 
pi of sterile RNase and DNase free water, 1 pi of Titan Enzyme mix (AMV and 
Expand Tm High Fidelity). Twenty-five pi of reaction mix one and 25 pi o f reaction mix 
two were added together for thermocycling. The amplification reaction consisted of a 
reverse transcription step of 50°C for 30min., 30 cycles at 94°C for 30 s, 66°C for 30s, 
68°C for 1 min., and a hold cycle for 68°C for 2 min. A nPCR was performed with the 
inner primers CSN-F2, 5’ ATGCCTAAAAATGTTACAAGA 3’and CSN-R2 5’ 
CGTGCTAA TGCAAAAAGAAC 3’. The reaction mixture consisted of 
deoxynucleoside triphosphates (200pM each), 1.75 mM M gCk, 0.2pM of each primer, 
2.5 U of Taq DNA polymerase, AmpliTaq™ Gold (Perkin Elmer), 1 pi of DNA from 
the first reaction in PE buffer in a total volume of 50 pi. The amplification o f the 
second reaction consisted of denaturation o f 4 min. at 95°C, and 20 cycles o f 1 min at 
94°C, 10 sec at 30°C, and lmin. at 72°C and a final extension step of 10 min at 72°C. 
PCR amplifications were carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied 
Biosystems (Foster City, CA).
Detection of PCR products. Methods the same as in Chapter 2.
Histopathology. Tissues taken at necropsy included brain, liver, spleen, kidney 
heart valve, lung, bone marrow, and peripheral lymph node. Representative sections of 
tissues were fixed in 10% neutral buffered formalin for paraffin-embedding, routinely 
processed, and 5 um thick sections were stained with hematoxylin and eosin and 
Warthin-Starry silver stains for histological examination. Dr. R. Bauer performed all of 
the necropsies and examined the histopathology in this study.
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Statistical analysis. The chi-square test was used to evaluate the relationship 
between types of tissue and presence of Bartonella DNA in various tissues. The 
analysis was considered significant at a probability of P < 0.05.
Results
Results of culture of tissue. Cats were euthanized from 4 weeks to 17 weeks after 
the bacteremic phase of the infection. At the time of euthanasia, all cats were both 
blood culture negative and PCR-negative. A total of 184 tissue specimens were 
analyzed in this study from the 23 cats. Agar and broth cultures from 184 tissues were 
negative after incubation for 3 weeks.
PCR results from tissue analysis. At the time of necropsy, Bartonella DNA was 
not detected from the peripheral blood of any cat. Although Bartonella was not 
cultured from any tissue, Bartonella DNA was amplified in 10 o f the 23 cats in at least 
one tissue specimen (Table 6). The distribution of Bartonella DNA in cats was from 1 
tissue to all 8 tissues in one cat. In two cats, Bartonella DNA was detected in the spleen 
only. Bartonella DNA was amplified from the brain of 3 (30%), from the liver of 5 
(50%), from the spleen o f 9 (90%), from bone marrow of 7 (70%), from the lung of 4 
(40%), the lymph node of 6 (60%), from the kidney of 4 (40%) and from the heart value 
of 5 (50%) (Table 7). There were no significant differences among tissue with regard to 
finding Bartonella DNA in tissue (x2 = 4.49, P>0.05). Two of the four cats receiving 
passive antibody to Bartonella LSU 16 were found to have Bartonella DNA in at least 
five tissue sites. The one cat that received passive antibody to Bartonella henselae 
Houston-1 had Bartonella DNA in 7 tissue sites. Three of the four cats injected with 
methylprednisolone were found to have Bartonella DNA in 5 to 8 tissue sites. The cat
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Table 6. Results of findings of persistent Bartonella DNA found in various tissues 
of cats experimentally infected with Bartonella henselae
Cat # Strain AB1* MPd Necropsy' Bartonella DNA in Tissue
1 LSU 16* na + 19 + (1 ,2 , 3, 4, 5, 7, 8)
10 LSU 16* +b na 12 -
81 LSU 16* +c na 19 + (1 ,2 , 3, 4, 5, 6, 7)
83 LSU 16* +b na 11 -
84 LSU 16* na + 19 -
85 LSU 16* na na 19 + (1 ,2 , 3, 4, 6, 7, 8)
86 LSU 16* +b + 4 + (1 ,3 ,4 , 5, 7,)
87 LSU 16* +b + 8 + (1 ,2 , 3, 4, 5, 6, 7, 8)
182 LSU 16* na na >19 -
184 LSU 16* na na >19 -
223 LSU 16* na na >19 -
G3 LSU 16* na na 12 + (2, 7)
321 LSU 16* na na 4 + (2, 3)
N3 LSU 16* na na 18 + (2)
LI Baby* na na 11 + (2)
361 Baby* na na 13 + (2, 3, 8)
FC3 Baby* na na 10 -
L2 87-66** na na 6 -
N2 87-66** na na 12 -
K4 87-66** na na 16 -
L3 Houston-1* na na 16 -
F5 Houston-la na na 29 -
347 Houston-la na na 29 -
* lx l0 7
** lx l09 
a not infected
AB130 anti-LSU 16 or anti-Houston-1, passively administered 
MPd given three methylprednisolone injections 2 weeks apart 
b anti-LSU 16 
c anti-Houston-1
d given three methylprednisolone injections 2 weeks apart 
c weeks post-bacteremia, time of necropsy 
na-negative
1-liver
2-spleen
3-bone marrow
4-heart valve
5-lung
6-brain
7-lymph node
8-kidney
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Table 7. Results o f culture and PCR assay from 10 of 23 cats with persistent 
Bartonella DNA in tissue
Tissue Culture positive PCR positive %positive
Brain
Liver
Spleen
Bone marrow 
Lung
Lymph node 
Kidney 
Heart valve 
Peripheral Blood
0/10
0/10
0/10
0/10
0/10
0/10
0/10
0/10
0/10
3/10
5/10
9/10
7/10
4/10
6/10
4/10
5/10
0/10
30%
50%
90%
70%
40%
60%
40%
50%
0%
with all 8 tissues positive had received both passive antibody and methylprednisolone. 
Cats 86 and 321, which had a recurrent episode o f bacteremia had Bartonella DNA in 5 
and 2 tissues respectively. Six of 14 cats that were infected but did not receive either 
passive antibody or methylprednisolone were found to have Bartonella DNA in at least 
one tissue. The amplified PCR products of Bartonella DNA from the tissue o f cat 1 
liver and cat 87 spleen are shown (Figure 9). Bartonella DNA was amplified in the 
undiluted extracted sample from the liver o f cat 1 but was not detected in one 10-fold 
dilution of the extracted DNA. Bartonella DNA was detected in the undiluted and in 
one 10-fold dilution o f extracted DNA from the spleen of cat 87.
RT-PCR results from tissue. Using primer specific for a 567-bp fragment of the 
16S rDNA gene o f  Bartonella and primer specific for a 354-bp fragment o f the citrate 
synthase gene of Bartonella, we were unable to detect any cDNA from cats with 
persistent Bartonella DNA in tissue. RT-PCR assay using the 16S rRNA primers did 
not amplify any cDNA products from the tissue o f the cats but the positive control 
Bartonella henselae) was amplified to verify the procedure (Figure 10). The PCR
94
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Figure 9. Bartonella DNA from tissue of experimentally infected cats. PCR products 
amplified from the 16S rRNA gene fragment of Bartonella species.
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Liver cat 1
Lane 3-5: Liver cat 1 (10-fold dilutions)
Lane 6: Spleen cat 87
Lane 7: Spleen cat 87 (IO-fold dilution)
Lane 8-13: Spleen cat 87 (10-fold dilutions)
Lane 14: Reagent Control
Lane 15:5. henselae positive control
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1 2 3 4 5 6 7
Figure 10. RT-PCR for detection o f  cDNA o f Bartonella henselae. PCR products 
amplified from 16S rRNA gene fragment o f Bartonella. Tissue samples from cats 
experimentally infected with B. henselae 
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Spleen tissue from cat 87
Lane 3: Liver tissue cat 1
Lane 4: Spleen tissue cat N3
Lane 5: Positive control B. henselae from PCR
Lane 6: Reagent Blank
Lane 7: Positive control B. henselae from RT-PCR
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primers for the citrate synthase (gitA) gene amplified the Bartonella henselae, used as 
positive control, but did not amplify cDNA in tissues from infected cats (Figure 11).
We were unable to detect Bartonella specific RNA from the tissue o f cats with 
persistent Bartonella DNA. The sensitivity of either assay was not determined.
Sequence analysis. The PCR product from cat 1 heart valve was sequenced for 
confirmation of Bartonella. The sequence data from the PCR product was identical to 
the 16S rRNA fragment o f Bartonella henselae genotype II with the identifying region 
ATT. Cat 1 was infected with B. henselae LSU 16 genotype II. (Appendix I).
Postmortem evaluation and histopathology. Gross necropsy results from the 
experimentally infected cats were unremarkable except for one cat had multifocal lung 
lesions and one cat had hydrocephalus. O f the 23 infected cats tested by PCR and 
culture, tissues from 19 cats were processed for histopathologic examination. 
Microscopic lesions were seen in the lymph nodes, liver, spleen, kidney, and bone 
marrow. Histopathological diagnoses in the infected cats were as follows: lymphoid 
hyperplasia o f the lymph nodes in 16 of the 19 cats; lymphocytic pericholangitis in 14 
o f the 19; lymphocytic hepatitis in 2 of the 19 cats; splenic lymphoid hyperplasia in 15 
o f the 19 cats; focal interstitial nephritis in 3 o f the 19 cats; focal lymphocytic 
interstitial pneumonia in 2 of the 19 cats; focal eosinophilic pneumonia was seen in one 
cat and focal bronchopneumonia was seen in one other cat; bone marrow hyperplasia 
was seen in 7 of the 19 cats and pulmonary edema in 2 of the 19 cats. The lesions 
ranged from scant to severe. Bacteria were not visualized in any o f  the tissue on routine 
staining or with Warthin-Starry stain on a few selected tissues o f some cats.
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354 bp-
1 2 3 4 5 6
Figure 11. RT-PCR for detection o f cDNA of Bartonella henselae with primers CSN- 
F1 and CSN-R1 and CSN-F2 and CSN-R2. Tissue samples from cats experimentally 
infected with B. henselae 
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Positive control B. henselae 
Lane 3: Positive control B. henselae 
Lane 4: Spleen tissue from cat 87 
Lane 5: Liver tissue from cat 1 
Lane 6: Spleen tissue from cat N3
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Discussion
Bartonella DNA was detected in the tissues o f experimentally infected cats although 
Bartonella DNA could not be detected in the peripheral blood at the time of necropsy. 
Bartonella DNA was not detected in the blood of these cats at the time o f necropsy 
tissue analysis. Therefore it is doubtful that Bartonella DNA detected in tissues was 
from circulating blood. In three cats, there was a 22-week interval between bacteremia 
and positive finding of Bartonella DNA in tissue. In cats with relapsing bacteremia, 
Bartonella DNA was found in tissues from both cats.
The quantity of Bartonella DNA in the tissues of these cats is unknown. Bartonella 
DNA could be detected in one 10-fold dilution of the extracted DNA from the spleen of 
cat 87 but could not be detected from one 10-fold dilution o f extracted DNA from the 
liver of cat 1. The sensitivity limits of the nested PCR assay were determined to be 6.4 
fg or approximately three organisms. Therefore, the number of Bartonella organisms in 
the tissue in cat 87 and 1 would be approximately 30 and 3 microorganisms respectively 
in the tissue of these cats. All cultures from the tissues of the cats were negative. The 
culture results may reflect the minimal detection limits o f culture or possibility o f a 
dormant nonculturable state o f the organism in tissue. The absence of detectable 
Bartonella DNA in some tissues may indicate that there was no Bartonella DNA in the 
tissue of these cats or the detection limits may have been exceeded. Many aspects of 
the pathogenesis of feline bartonellosis are unclear, including entry o f the 
microorganism into the cat, interaction with the phagocytic cells, the immunological 
Many aspects of the pathogenesis of feline bartonellosis are unclear, including entry of 
the microorganism into the cat, interaction with the phagocytic cells, the immunological
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response of the cat, predilection for certain tissue, or sequestration in tissue. The cat 
flea is known to play a role in the transmission of B. henselae from cat to cat. The 
spread of the microbe through the body or the events that might occur with the 
interaction with phagocytic cells of the host is open to speculation. Little is known 
about the virulence factors associated with Bartonella or mechanisms responsible for 
bacterial adherence, colonization, or invasion or the mechanisms o f persistence.
Bartonella infections in cats are characterized by an acute phase in which a 
bacteremia o f significant magnitude and duration can be detected by bacterial culture. 
Chronic infection with recurrent episodes of bacteremia is observed in some cats for 
long periods. This suggests that there is a subclinical phase of the infection in which 
some cats harbor the organism and remain persistently infected for years. The cyclic 
nature of the bacteremia seen in cats infected with B. henselae may represent 
sequestration o f Bartonella organisms in tissues with periodic release into peripheral 
blood. The nature o f  the persistence of this microorganism in cats is in question. 
Bartonella may use multiple mechanisms or evasive strategies to ensure prolonged 
survival in the cat. In this study, all cultures from the tissues were negative and no 
RNA expression was detected although Bartonella DNA could be detected. Does the 
Bartonella DNA represent dead organisms; is the organism viable in the tissue of cats 
below the detection limits of culture; is Bartonella in a viable but nonculturable state as 
reported with other organisms? A viable but nonculturable state occurs in many 
organisms such as Vibro cholerae and Escherichia coli, Salmonella enteritidis. Shigella 
sonnei, and Legionella pneumophila, which have lost the capacity to form colonies on 
culture media yet, remain viable (Dixon et al. 1998).
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Detection o f Bartonella DNA in tissue that is culture negative is not unusual and is 
seen in other hosts infected with Bartonella. In humans infected with B. henselae, 
diagnoses of Bartonella infections are often made by detection o f  Bartonella DNA in 
culture negative tissue. In cases involving dogs, endocarditis and peliosis hepatis have 
been diagnosed by amplification of Bartonella DNA from culture negative tissue. In a 
study by Regnath et al. (1998), B. henselae infected mice were shown to clear the 
cultivatable organism within the first 6 days of infection from liver and spleen but 
Bartonella DNA could be detected in liver for at least 3 months. Localization of 
Bartonella in tissue certainly seems logical. Mechanism o f localization o f Bartonella in 
tissue would depend on cell association. If  the microorganisms were free in the plasma, 
localization in tissue would depend on the ability o f the organism to adhere to or grow 
in vascular endothelial cells. There is evidence that Bartonella does adhere to and 
invade endothelial tissue in humans (Dehio et al. 1997). If  Bartonella is phagocytized 
by monocytes this would be a mechanism to carry the organism through tissue as the 
cells move in and out o f the vascular system. The erythrocyte association of Bartonella 
would allow travel through tissue on the erythrocyte. An intraerythrocytic location of a 
microorganism could be a protective site from phagocytosis by the reticuloendothelial 
system.
In human studies, B. henselae can invade or attach to endothelial cells, macrophages 
and neutrophils. In the cat, B. henselae has only been found within feline erythrocytes 
(Kordick and Breitschwerdt 1995). An intracellular location that facilitates persistent 
infections in cats has not been established. However, the persistent nature of Bartonella 
as well as the lack o f efficacy of antibiotics to clear infections is suggestive o f an
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intracellular location as observed with another intracellular organisms, Brucella, which 
is phylogenetically related to Bartonella (Review by Anderson and Neuman 1997). If 
Bartonella resides and grows in the macrophage, this mechanism may lead to infection 
of the organ harboring the macrophages with reseeding of bacteria into the blood by 
various tissues. In a study by Karem et al. (1999), using the BALB/c mouse as a model, 
Bartonella could be cultured from tissue of mice infected intraperitoneally 24 hr after 
infection but not after 6 hours or 7 days. Mice infected with B. henselae by the 
intraperitoneal route never became bacteremic although Bartonella DNA was detected 
within 6 hours in the liver and mesenteric lymph node and up to 7 days in spleen, 
kidney, and liver by PCR. This study suggests uptake o f the organism by phagocytes, 
which then are filtered by organs such as the liver in the mouse model. In cats infected 
with Bartonella, bacteremia is common and circulating organisms in the blood could 
localize in organs such as the liver and spleen.
The histopathologic findings in this study are not specific for Bartonella. However, 
Kordick et al. (1999) reported similar findings in lymph nodes, spleen, liver, and kidney 
in a group of B. henselae infected cats. In a study by Guptill et al. (1997), 
histopathologic lesions in multiple organs of infected cats 8 weeks postinfection were 
reported. Necrotizing granulomas were found in lymph nodes in 1 cat at 8 weeks 
postinoculation that were similar to what is seen in CSD patient. Guptill et al. (1997) 
found mild to marked lymphoid hyperplasia of the spleen, marked lymphoid 
hyperplasia in the lymph nodes, and foci of necrosis throughout the liver, focal 
pyogranulomatous nephritis, and interstitial myocarditis in a group of Bartonella 
infected cats. Bacteria were seen infrequently, were extracellular, and not associated
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with inflammatory lesions. Similar to the study by Kordick et al. (1999), abscesses or 
granulomata were not found in tissues from our cats.
Bartonella-induced histopathologic alterations of affected lymph nodes from human 
patients with CSD typically include stellate caseating granulomas, microabscesses, and 
follicular hyperplasia (Anderson and Neuman 1997). The histopathologic findings in 
the lymph nodes o f patients with CSD depend on the stage o f the infection (Sander et al. 
1999). Early in the course of CSD infections, lymphoid hyperplasia is seen, while 
granulomas with necrosis and stellate microabscesses are seen later in these infections 
(Bass et al. 1997; Kaschula 1996). In human patients with bacillary angiomatosis, a 
variety of internal organs including the liver, spleen, bone, brain, lungs, and bowel can 
be affected. The liver or the spleen or both are affected in patients with bacillary 
peliosis. The affected tissues contain numerous blood-filled partially endothelial cell- 
lined cystic structures and fibromyxoid stroma with a mixture o f inflammatory cells, 
dilated capillaries, and clumps of bacilli identified by Warthin-Starry staining (Welch 
and Slater, 1999). Inflammatory reactions to B. henselae infection without associated 
bacillary angiomatosis and or peliosis included granulomatous reactions characterized 
by nodular collections of histiocytes, lymphocytes and aggregates o f neutrophils and 
karyorrhexic debris suggestive of microscopic abscess formation that resemble lymph 
node lesions o f CSD (Liston et al. 1996). The hydrocephalus found in one cat and the 
multifocal lung lesions found in another cat are non-related findings and likely not 
related to the Bartonella infection in the experimentally infected cats. The multifocal 
lung lesions with eosinophils seen among the inflammatory cells is likely to be related 
to parasite migration or feline asthma.
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Regnath et al. (1998) used the mouse model to demonstrate the progression of 
Bartonella-induced histopathologic alterations. Three days postinfection liver lesions 
were characterized by a few small aggregates of lymphocytes and monocytes that 
expanded in number and size. In the second week postinfection granulomatous lesions 
consisting of lymphocytes, monocytes and epithelioid cells were observed. Necrosis in 
the mouse liver granulomas was not evident as observed in human patients with CSD.
Necrotizing granulomas or abscesses were not found in the cats in this study. The 
histologic changes are not specific for Bartonella. However, the follicular hyperplasia 
of lymph nodes and spleen as seen in these cats is suggestive o f nonspecific tissue 
response to a chronic antigenic stimulation. The cats in this study were not bacteremic 
at the time o f necropsy although 10 of the cats had persistent Bartonella DNA amplified 
from various tissues, suggesting chronic infection. Bartonella DNA was amplified 
from the spleen of the cats with splenic lymphoid hyperplasia, from the liver of cats 
with lymphocytic pericholangitis and lymphocytic hepatitis and from the lymph node o f 
the experimentally infected cats with lymphoid hyperplasia o f lymph nodes. Three cats 
had lesions in the kidney, and Bartonella DNA was amplified from the kidney o f four 
of the infected cats. Although neurological signs have been observed in cat 
experimentally infected with B. henselae LSU 16 (O’Reilly et al. 1999a), significant 
lesions were not seen in the brain of cats in this study which were infected with the 
same strain. Kordick et al. (1999) reported similar histopathological findings in a group 
of cats experimentally infected with B. henselae. Bartonella DNA was amplified from 
the brain o f three o f the cats. Bartonella henselae DNA has been amplified from both 
dogs and humans with endocarditis. Cats in this study did not have lesions from the
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heart valve despite the fact that Bartonella DNA was amplified from five cats. 
Organisms were not seen in any o f the tissues analyzed in this study. However, other 
investigators have reported the difficulty o f demonstrating Bartonella organisms in 
tissues. It is difficult to make any correlation between the pathologic changes seen in 
the tissues o f  these cats and the Bartonella infection. Without locating, Bartonella in 
the lesions o f infected cats there is no conclusive evidence that the lesions seen are 
related to Bartonella. However, with the high endemicity o f  Bartonella infections in 
cats, it is possible that the lesions are related to Bartonella. Bartonella may evade the 
immune system so that there are no inflammatory responses seen in the cat despite the 
fact that the organism is present.
In order to understand the metabolic state or viability o f the persistent Bartonella 
DNA found in the tissue of these cats, attempts to demonstrate RNA expression of the 
citrate synthase gene and the 16S rRNA gene was done. Because there are multiple 
copies of rRNA (104- 106) per cell, it should be possible to extract RNA and amplify the 
cDNA of the rRNA of Bartonella from the tissue o f cats in which persistent Bartonella 
DNA was found. Even if the amount of Bartonella DNA found in tissue was low, using 
rRNA as a target seemed to be a reasonable approach to this problem. Detecting RNA 
expression o f the rRNA of Bartonella found in the tissue could have given insight to 
the metabolic state of the organism. Using primers specific for the citrate synthase gene 
hoping to amplify cDNA from the reverse transcription o f mRNA of the citrate synthase 
gene was also reasonable. Because the half-life of mRNA is shorter than that o f rRNA, 
mRNA is a better marker for growth and viability. Complementary DNA (cDNA) was 
not amplified from any of the tissues with either RT-PCR assay. The failure to amplify
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cDNA from the rRNA or mRNA of the citrate synthase gene could be because of 
insufficient numbers of organisms in the tissue and thus insufficient amount of RNA, 
microorganisms in a dormant state, nonviable organisms, or problems with the activity 
of RNases. Whether the Bartonella DNA amplified from the tissue of the cats in this 
study represents viable but nonculturable organisms because o f a dormant state or 
because the detection limits of culture remains unknown. All o f the cats in this study 
were abacteremic at the time of necropsy, and some o f the cats that were positive for 
Bartonella DNA in tissue had been abacteremic for 19 weeks. In addition, Bartonella 
DNAwas amplified from both cats with recurrent episodes of bacteremia suggesting 
that the organisms do persist in the cat. Further work is needed to characterize the 
Bartonella DNA found in the tissue o f cats.
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CHAPTER FOUR
COMPARISON OF FINDINGS OF PERSISTENT BARTONELLA DNA IN CATS 
EXPERIMENTALLY INFECTED WITH BARTONELLA HENSELAE 
GENOTYPE I AND BARTONELLA HENSELAE GENOTYPE n
Introduction
The domestic cat is the reservoir for B. henselae and a risk factor for acquiring cat 
scratch disease (CSD) (Zangwill et al. 1993). Cats can be chronically infected with 
relapsing bacteremia for long periods o f time (Kordick et al. 1995). Persistent 
Bartonella DNA has been detected in the tissue o f cats long after the bacteremic stage 
of the infection, which suggests a harboring o f organism in the tissues o f chronically 
infected cats (Chapter 3).
Bartonella are fastidious, slow-growing microorganisms, and distinguishing between 
the species is difficult. Definitive identification o f the species requires molecular 
techniques. Various molecular methods have been used for identification o f  Bartonella 
species. Bartonella henselae and B. clarridgeiae presently are the most common 
species of Bartonella isolated from the blood o f cats and the most common species of 
Bartonella isolated from cats is B. henselae (Heller et al. 1997). By partial 16S rRNA 
gene sequence analysis, Bergmans et al. (1996), described genotype I and genotype II of 
B. henselae that differ from each other in three nucleotides located at positions 172 and 
175 o f the 16S rRNA gene. The sequences o f  genotype I and genotype II are analogous 
to the sequences o f B. henselae Houston-1 described by Regnery et al. (1992) and B. 
henselae “BA-TF” described by Reiman et al. (1992), respectively. Two types o f B. 
henselae, genotype I and genotype II have been shown to coinfect some cats (Gurfield 
et al. 1997). In a study by Heller et al. (1997), blood samples from 94 stray cats found 
that 34 % o f the isolates from cats were genotype I, 36% were genotype II and 30%
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were B. clarridgeiae. Bergmans et al. (1996) found that the majority of the lymph 
nodes from patients with CSD contained B. henselae genotype I, while Sander et al. 
(1999) found B. henselae genotype I in 59% of PCR-positive lymph nodes and 
genotype II in 23% of the PCR-positive lymph nodes o f CSD patients. Seven (18%) of 
the lymph nodes were negative in both genotype-specific PCRs. Sander et al. (1998b) 
found 16 of 17 isolates o f B. henselae from blood culture o f human patinets to be B. 
henselae genotype II. These authors have suggested that there may be a difference in 
the types of B. henselae and host specificity.
In this study, blood and tissues from cats experimentally infected with B. henselae 
genotype I and B. henselae genotype II were tested using a PCR assay designed to 
detect both genotypes of B. henselae using minor sequence differences between the 
genotypes in a region of the 16S rRNA gene of Bartonella.
Identifying strains and types of B. henselae will be useful in understanding the 
pathogenesis of these two genotypes
Materials and Methods 
Experimental animals. Tissue and blood used in this study was from twenty-three 
cats as reported in Chapter 3.
Bacterial strains. Methods the same as in Chapter 3 
Infection in cats. Methods the same as in Chapter 2 and 3 
Collection of blood and tissue specimens. Blood was collected with the same 
methods as in Chapter 2. Tissue was collected with the same methods as in Chapter 3 
Blood and tissue cultures. Blood was cultured with the same methods as in 
Chapter 2. Tissue was cultured with the same methods as in Chapter 3.
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Extraction of DNA from blood and tissue. Blood was extracted as in Chapter 2. 
Tissue was extracted with the same methods as in Chapter 3
PCR amplification of DNA from blood and tissue. A nested PCR was performed 
using primers previously described (R. Tapp 2000, Master Thesis, Louisiana State 
University, The Institute for Environmental Studies) to amplify a final product of a 477 
bp fragment o f the 16S rRNA gene o f Bartonella. For amplification of genus specific 
Bartonella DNA, forward primer pair Bhenl6FF 5’CACATGCAAGTCGAGCACA 
CTCTTTTAGAG 3’and reverse primer UB16SDR9 5’GCCCCCGTCAATTCCTTT 
GAGTTT 3’ were used, generating an 823 bp fragment. A second reverse primer that is 
Bartonella genus specific Bhenl6SBBR 5’-CACATGCAAGTCGAGCACA 
CTCTTTTAGAG-3’ was also designed to be used with the forward Bhenl6FF primer 
to amplify a 567 bp fragment.
For amplification of species and genotype I-specific Bartonella DNA, the internal 
forward primer Bhenl6SGG 5 ’ G AAATTT GTGCT A AT ACCG AAT ACGT CCTT AG 
3’and reverse primer Bhenl6SBBR were used to amplify a 477 bp fragment of the 16s 
rRNA gene o f B. henselae. For amplification of species and genotype II-specific 
Bartonella DNA, the forward primer Bhen 1616SHH 5’GAAATTTGTGCTAATAC 
CGAATACGTCCTATTTG 3’and reverse primer Bhenl6SBBR were used to amplify a 
477 bp fragment. Because genotype I and genotype II fragments were of the same base 
pair size both primer sets were performed simultaneously in separate reaction for each 
sample. The synthetic oligonucleotides were purchased from GeneLab (Louisiana State 
University, Baton Rouge, LA). DNA amplification was carried out in 50-pl reaction 
volumes. The PCR amplification was carried out on a Model 9600 Thermal-Cycler
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Perkin-EImer/Applied Biosystems (Foster City, CA). Each reaction mixture consisted 
o f deoxynucleoside triphosphates (200pM each), 1.75 mM MgC^, 0.2pM of each 
primer, 2.5 U of Taq DNA polymerase, AmpliTaq™Gold (Perkin Elmer), 4 pi of DNA 
in PE buffer in a total volume of 50 pi. Amplification reaction consisted o f 10 min. at 
95°C, 30 cycles of 94°C for 1 min., 66°C for 1 min., and 72°C for 1 min., and a final 
elongation step at 72°C for 10 min. In the first reaction, primers Bhenl6SFF and 
UB16SDR9 or Bhenl6SBBR were added. A second amplification reaction o f 20 cycles 
with the sample conditions as previously stated was performed using Bhenl6SGG and 
Bhenl6SBBR for genotype I and Bhenl6SHH and Bhenl6SBBR for genotype II and 1 
pg of DNA from the previous PCR reaction. As a negative control, PCR reagents 
without DNA template were included in each amplification assay. Positive controls of 
extracted B. henselae genotype I and genotype II were also used in each amplification 
assay.
Detection of PCR products. Methods the same as in Chapter 2 and Chapter 3
Sequence analysis. Methods the same as in Chapter 2
Results
Bartonella henselae genotype I and genotype II DNA detection during 
bacteremia and in tissue. The B. henselae primers specific for genotype I and 
genotype II were used to determine genotype specificity in the cats during the 
bacteremic phase o f the infection and in the tissue analysis (Figure 12). The bacteremic 
phase o f the infection was followed in 16 o f the 23 experimentally infected cats. In 
nine of the cats, the B. henselae genotype specific primers were used to determine if 
there was a genotype switch during periods o f  bacteremia. Cats remained infected with
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477 bp-
1 2 3 4 5 6 7 8 9 1 0  11
Figure 12. Bartonella henselae genotype I and genotype II DNA 
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Cat L2 infected with B. henselae 87-66 genotype I (primers Bhenl6SGG-BBR- 
genotype I specific)
Lane 3: Cat L2 infected with B. henselae 87-66 genotype I (primers Bhenl6SHH-BBR- 
genotype II specific)
Lane 4: Reagent Control
Lane 5: B. henselae 87-66 genotype I positive control (primers Bhenl6SGG-BBR- 
genotype I specific)
Lane 6: B. henselae 87-66 genotype I positive control (primers Bhenl6SHH-BBR-type 
II specific)
Lane 7: Cat 321 infected with B. henselae LSU 16 genotype II (primers Bhenl6SGG- 
BBR-genotype I specific)
Lane 8: Cat 321 infected with B. henselae LSU 16 genotype II (primers Bhenl6SHH- 
BBR-genotype II specific)
Lane 9: Reagent Control
Lane 10: B. henselae LSU 16 genotype II positive control (primers Bhenl6SGG-BBR- 
genotype I specific)
Lane 11: B. henselae LSU 16 genotype II positive control (primers Bhenl6SHH-BBR- 
genotype II specific)
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the same B. henselae genotype as was inoculated (Table 8). Seven cats were infected 
with B. henselae LSU-16 genotype II, and the type specific PCR primers confirmed the 
Bartonella DNA detected to be B. henselae genotype II throughout the bacteremia. 
Three cats infected with B. henselae Baby genotype II were also confirmed to be B. 
henselae genotype II DNA throughout the bacteremia. O f the three cats infected with 
B. henselae 87-66 genotype I, all remained infected with B. henselae genotype I and the 
one cat infected with B. henselae Houston-1 remained infected with B. henselae 
genotype I (Table 8). None o f the cats infected with B. henselae 87-66 genotype I or B. 
henselae Houston-1 experienced relapsing bacteremia.
Cat 86 and cat 321 experienced an episode of relapsing bacteremia. Both cats were 
infected with B. henselae genotype II, B. henselae genotype II was amplified from both 
cats during the relapsing bacteremia (Table 9).
Persistent Bartonella DNA was found in tissue samples from 10 o f 23 of the cats in 
this study. O f the 10 cats in which Bartonella DNA was found, all were B. henselae 
genotype II. Seventeen cats were infected with B. henselae genotype II. Of the four 
cats that became bacteremic with B. henselae genotype I, B. henselae DNA could not be 
found in tissues and thus genotype could not be determined (Table 10).
Sequence analysis. The sequence analysis of the PCR product from blood 
specimens o f cat 86 taken during the bacteremic phase of the infection confirmed the 
product was a B. henselae genotype II (Table 11). Cat 86 was experimentally infected 
with B. henselae LSU 16 genotype II. The sequence analysis o f the PCR product from 
blood specimen o f cat L2 taken during the bacteremic phase o f the infection was typical 
a B. henselae genotype I (Table 11). Cat L2 was experimentally infected with
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Table 8. Results of Bartonella henselae genotype from cats during period of bacteremia
Cat L lc Cat 361c Cat K3C CatG3b
Week* type CFU/ml type CFU/ml type CFU/ml type CFU/mi
1 II l.OxlO6 n 3.4x10s n 4.0x104 n 1.2xl03
2 + 2.4x10s + 3.5xl04 + 3.2xl04 ■f- 1.8x10s
3 II 3.0xl02 n 3.6x10s II 1.5x10s n 8.0x10s
4 + 3.5x102 + 7.0xl02 + 2.0x10s + 1.3x10s
5 II 0 ii l.OxlO2 n 6.8x104 n 2.4x104
6 + l.OxlO2 + l.OxlO2 + 4.5xI04 + 2.5x104
7 II 0 ii 1.5xl02 n 2.5x104 ii 9.0x103
8 + 0 + 0 + 2.4x104 + 2.3x104
9 n 0 ii 0 n 1.3xl04 ii 3.0x102
10 + 0 + 0 + 6.7x103 + 0
11 ii 0 ii 0 n 4.2x103 n 0
12 + 0 + 0 + 2.6xl03 + 0
13 ii 0 n 0 ii 6.6x102 ii 0
14 NDf NDf NDf NDf
15 II 0 - 0 II 2.6x102 n 0
16 - 0 n 0 + 6.3x102 + 0
17 II 0 - 0 II 1.3xl02 n 0
18 - 0 - 0 + l.OxlO2 + 0
19 - 0 - 0 n 2.0x102 ii 0
20 - 0 - 0 - 0 + 0
21 - 0 - 0 - 0 ii 0
22 - 0 - 0 - 0 + 0
23-29 - 0 - 0 - 0 - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c inoculated with Bartonella henselae Baby Genotype II 
d inoculated with Bartonella henselae 87-66 Genotype I 
c inoculated with Bartonella henselae Houston-1 Genotype I 
f ND, not determined
(Table 8 continued)
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Cat K4d Cat L3* Cat F5* Cat 347*
Week* type CFU/ml type CFU/ml type CFU/ml type CFU/ml
1 I 9.0x102 0 _ 0 . 0
2 + 4.1xl04 - 0 - 0 - 0
3 I 3.0xl04 - 0 - 0 - 0
4 + 5.1xl04 I 5.0x102 * 0 - 0
5 I 4.8x104 + 2.0xl03 ■ 0 - 0
6 + 5.7x104 I 3.0xl02 ■ 0 - 0
7 I 2.3xl04 + 2.0xl02 - 0 - 0
8 + 6.0x103 - l.OxlO2 - 0 - 0
9 I 4.0x103 - l.OxlO2 - 0 - 0
10 + 4.0x102 - 0 - 0 - 0
11 I l.OxlO2 - 0 - 0 - 0
12 + 0 - 0 - 0 - 0
13 - 0 - 0 - 0 - 0
14 ND‘ NDf NDf NDf
15 - 0 - 0 - 0 - 0
16 - 0 - 0 - 0 - 0
17 - 0 - 0 - 0 - 0
18 - 0 - 0 - 0 - 0
19 - 0 - 0 - 0 - 0
20 - 0 - 0 - 0 - 0
21 - 0 - 0 - 0 - 0
22 - 0 - 0 - 0 - 0
23 - 0 - 0 - 0 - 0
24-29 - 0 - 0 - 0 - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c inoculated with Bartonella henselae Baby Genotype II 
d inoculated with Bartonella henselae 87-66 Genotype I 
c inoculated with Bartonella henselae Houston-1 Genotype I 
fND, not determined
(Table 8 continued)
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Cat N2d Cat N3b Cat L2d
Week* type CFU/ml type CFU/ml type CFU/ml
1 I 4.0x103 n 1.2xl03 I 6.8x104
2 + 2.0x103 + 3.1xl04 + 4.4x104
3 I 2.7x104 ii 2.2x105 I 4.0x105
4 + 2.4x104 + 2.0x104 + l.lx lO 5
5 I 2.8x104 ii 3.6xl04 I 3.5x10s
6 + 2.1xl04 + 2.9x104 + 1.9xl05
7 I 2.2x104 ii 6.0x103 I 1.3xl04
8 + 1.6xl04 + 2.1xl03 + 3.9xl03
9 I 7.6x103 n 5.0x102 I 2.5x103
10 + 5.0xl03 + 0 + 5.0x102
11 I 2.8x103 n 0 I 5.0x102
12 + l.OxlO3 - 0 + l.OxlO2
13 I 1 .3xl02 - 0 I 8.3xl03
14 NDf - 0 NDf
15 I 0 - 0 + 8.6x103
16 - 0 - 0 I 8.3x103
17 + 0 - 0 + 1.5xl04
18 - 0 - 0 I 8.0xl03
19 - 0 - 0 + 7.3x103
20 - 0 - 0 I 5.3xl03
21 - 0 - 0 + l.OxlO3
22 - 0 - 0 I l.OxlO3
23-29 - 0 - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c inoculated with Bartonella henselae Baby Genotype II 
d inoculated with Bartonella henselae 87-66 Genotype I 
e inoculated with Bartonella henselae Houston-1 Genotype I 
f ND, not determined
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Table 9. Results o f Bartonella henselae genotype from cats with relapsing
bacteremia
Week*
Cat 86b 
type CFU/ml
Cat 321b 
type CFU/ml
1 II 6.3x104 n 2.6x103
2 + 1.7xl04 + 3.9xl04
3 n 4.3x104 n 2.0x105
4 + 2.2x103 4- 1.7xl04
5 ii 3.0xl02 ii l.OxlO2
6 + 0 + l.OxlO2
7 ii 0 u 0
8 - 0 + 6.0x102
9 - 0 ii 4.0x102
10 - 0 + 1.5xl02
11 - 0 - 0
12 - 0 - 0
13 ii l.lx lO 4 ND°
14 + l.OxlO4 - 0
15 ii 6.0x103 - 0
16 + 1.2xl03 - 0
17 ii 3.3xI02 - 0
18 + 7.0xl02 - 0
19 n 2.3xl02 - 0
20 + l.OxlO2 - 0
21 - 0 - 0
22 - 0 - 0
23 - 0 n 6.0x102
24 - 0 + 6.7x102
25 - 0 ii 2.0x102
26 - 0 + 1.3xl02
27 - 0 - 0
28 - 0 - 0
29 - 0 - 0
a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II 
c ND, not determined
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Table 10. Results o f findings of persistent Bartonella DNA in various strains of 
Bartonella henselae
Cat Strain Type Bartonella DNA in tissue
1 LSU 16* n + ( l ,2 ,  3 ,4 , 5, 7, 8)
10 LSU 16* II -
81 LSU 16* II + ( l ,2 ,  3 ,4 , 5, 6, 7)
83 LSU 16* n -
84 LSU 16* n -
85 LSU 16* n + (1 ,2 , 3 ,4 , 6, 7, 8)
86 LSU 16* ii + (1 ,3 ,4 , 5,7,)
87 LSU 16* ii + (1 ,2 , 3, 4, 5, 6, 7, 8)
182 LSU 16* n -
184 LSU 16* n -
223 LSU 16* n -
G3 LSU 16* ii + (2, 7)
321 LSU 16* n + (2, 3)
N3 LSU 16* ii + (2)
LI Baby* n + (2)
361 Baby* ii + (2 ,3 , 8)
K3 Baby* ii -
L2 87-66** i -
N2 87-66** i -
K4 87-66** i -
L3 Houston-1* i -
F5 Houston-13 i -
347 Houston-la i -
* lx l0 7 
**lx l09 
3 not infected
1-liver
2-spleen
3-bone marrow
4-heart valve
5-lung
6-brain
7-lymph node
8-kidney
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
B. henselae 87-66 genotype I. The Bartonella DNA amplified from the heart valve 
tissue o f cat 1 was typical o f a B. henselae genotype II (Table 11). Cat 1 was 
experimentally infected with B. henselae LSU 16 genotype II.
Table 11. Partial sequence data of Bartonella henselae strains amplified from 
experimentally infected cats
Cat Specimen Challenge Strain Sequence data
Cat 86 blood B. henselae LSU 16 genotype II CCTATTTGGA
Cat L2 blood B. henselae 87-66 genotype I CCTTAG- GCA
Cat 1 heart valve B. henselae LSU 16 genotype II CCTATT- GCA
Discussion
Use o f this PCR assay differentiated between the subtypes of B. henselae in cats 
experimentally infected with Bartonella henselae. It has been shown that cats can be 
coinfected with B. henselae genotype I and genotype II and or B. clarridgeiae. 
However, whether certain types are predominant over others during coinfection is 
unknown. Currently it is not known whether these genotypes are predictive o f 
pathogenicity or virulence.
Chronic infection with recurrent episodes of bacteremia is observed in some cats for 
long periods. This suggests that there is a subclinical phase of the infection in which 
some cats harbor the organism and remain persistently infected for years. The cyclic 
nature o f the bacteremia seen in cats infected with B. henselae may represent 
sequestration of Bartonella organisms in the cat with periodic release into peripheral 
blood. The nature o f the persistence of this microorganism in cats is in question. 
Bartonella may use multiple mechanisms or evasive strategies such as intracellular
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location, location in sites that are immunologically privileged, or antigenic variation to 
ensure prolonged survival in the cat.
There are discrepancies between the results o f Bartonella experimental infections in 
cats of various investigators. The differences are in the duration and reoccurrence of 
bacteremia experienced in experimentally infected cats. Different parameters o f the 
infection process such as dose, route of inoculation, response of the host, and strain of 
the organism could be reasons for some of these discrepancies. In the experimental 
infection with B. henselae Houston-1 by Regnery et al. (1996) and Greene et al. (1996), 
bacteremia o f short duration and without relapse was reported. Kordick et al. (1999) 
used B. henselae genotype II from donor cats to induce prolonged bacteremia with 
relapse for 454 days in experimentally infected cats. In the study by O’Reilly et al. 
(1999a), acute clinical disease was established in cats using B. henselae LSU 16 
genotype II isolated from a naturally infected cat.
Identifying and characterizing the strains or subtypes of B. henselae would be useful 
in the studies o f the pathogenesis of feline bartonellosis. B. henselae strain typing by 
genotypic methods will be useful in comparing the diversity o f strains within the cat 
reservoirs with the diversity o f strains that cause the various human clinical syndromes. 
It has been suggested that the majority of human clinical samples associated with cat 
scratch disease involve B. henselae genotype I, while the majority o f the isolates from 
cats are genotype I I B. henselae (Sander et al. 1998; Bergmans et al. 1996).
In this study, all 10 cats with persistent Bartonella DNA detected in tissues were 
cats infected with B. henselae genotype II. Bartonella DNA was not found in any o f the 
cats infected with B. henselae genotype I despite the fact that the three cats infected
119
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
with B. henselae 87-66 genotype I were inoculated with a higher dose (109 versus 107) 
of organism than the cats infected with B. henselae genotype II. These results suggest 
that B. henselae genotype II may be more pathogenic are more adapted in cats because 
of the prolong duration of Bartonella DNA found in tissues of these cats. Bacteremia 
was established in all the B. henselae genotype II cats. Bacteremia was established in 
cats infected with B. henselae 87-66 genotype I however a higher dose was used. Only 
one of the three cats inoculated with B. henselae Houston-1 became bacteremic. 
Episodes of recurring bacteremia were seen in the two cats infected with B. henselae 
genotype II. None of the cats infected with B. henselae genotype I had episodes of 
recurring bacteremia during the course of this study. Relative differences in virulence- 
associated genes and pathogenicity related to strain are still not clear. The finding of 
persistent Bartonella DNA in the tissue of cats infected with B. henselae genotype II 
and the relapsing bacteremia seen in those same cats is suggestive of a virulence- 
associated strain. The cats with persistent Bartonella DNA in tissue were infected with 
two different isolates of B. henselae genotype II and suggest that persistence and 
chronic infections in cats may be associated with genotype II. Use o f genetic tools, to 
identify disease-associated genes o f B. henselae will be nice.
Freeland et al. (1999) found differences in absorption antibody profiles with B. 
henselae Houston-1 and B. henselae LSU 16 genotype II which may represent 
differences in immunodominant antigens expressed by these two types of Bartonella.
The cats experimentally infected and used in this study were examined by other 
investigators (Parr et al. 1999) for comparison of clinical disease in the various strains. 
Parr et al. (1999) described differences in clinical disease, bacteremia, antibody
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response, and the number o f circulating antibodies to the various strains o f B. henselae. 
In general clinical disease was more severe in B. henselae genotype II than in B. 
henselae genotype I as defined by fever, lymphadenopathy, lethargy, diarrhea, and 
anorexia. In addition, cats infected with B. henselae LSU 16 displayed neurological 
signs not observed in the other cats. The IgM response peaked earlier (3 weeks) in the 
B. henselae genotype II strain than in the B. henselae genotype I strain (6 weeks). The 
IgG patterns were also different with the peak IgG level appearing at 9-12 weeks in the 
genotype II strains and at 7 weeks in the genotype I strains. These results are 
suggestive that there may be a difference in virulence and pathogenicity among the 
strains of B. henselae
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CHAPTER FIVE 
CONCLUSIONS 
Summary of Results
The nested PCR assay developed was successful in amplifying genus, species, and 
genotypes of Bartonella and was a valuable research tool in this study. The nested PCR 
design using outer and inner primer sets amplified an 823 bp fragment, a 567 bp 
fragment, and a 477 bp fragment o f the 16S rRNA gene of Bartonella. Sequence 
analysis of the PCR products were as predicted and were confirmed to be Bartonella 
henselae. Sensitivity limits o f the PCR assay were determined to be 3.2 organisms per 
milliliter o f blood and below the detection limits o f culture.
Experimentally infections were established in 23 cats and the PCR assay was able to 
detect Bartonella in all of the infected cats and in more samples and for longer periods 
than bacterial culture. The PCR assay was positive in 40 of the blood samples in which 
the blood culture was negative. The bacteremic phase of the infection was extended by 
1 to 9 weeks as defined by the PCR assay.
The chronicity of Bartonella infections in cats was demonstrated by detecting 
persistent Bartonella DNA in 10 o f the 23 cats. Bartonella DNA was detected in 10 
cats in multiple tissues. Bartonella DNA were found in the spleen o f  9 o f the 10 cats. 
Other tissues in which Bartonella DNA was detected was liver, kidney, brain, lymph 
nodes, bone marrow, heart valve, and lung. Chronicity of Bartonella infection was 
demonstrated in two cats with episodes o f relapsing bacteremia. Bartonella DNA was 
found in tissues from both of these cats.
Histopathologic analysis o f tissues o f infected cat showed reactions that were typical 
o f chronic antigenic stimulation but nonspecific for Bartonella. Lymph nodes from 16
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of the 19 infected cats displayed lymphoid hyperplasia and, in IS of the 19, splenic 
lymphoid hyperplasia was observed. Specific diagnostic lesions associated with 
Bartonella infections could not be made from these cats.
Determination of viability of organism detected in these cats with persistent 
Bartonella DNA was not accomplished by RNA express analysis with the RT-PCR 
assays. RNA expression of the citrate synthase gene or the 16S rRNA gene was not 
detected in tissue specimens.
The particular B. henselae genotype used to infect the cats did not change over the 
course of the acute or chronic bacteremic phase of the infection. The persistent 
Bartonella DNA detected in tissue in the chronic phase o f the infection was determined 
to be B. henselae genotype II. B. henselae genotype I was not detected in tissue from 
any of the cats infected with that genotype.
Future W ork
Many aspects of the pathogenesis of Bartonella henselae are still unclear. Research 
designed to investigate virulence factors, strain variability, cell association of the 
organism, and mechanisms of persistence are needed. Understanding the nature of the 
persistence by determining viability of Bartonella DNA detected in tissue is an 
interesting area. Is the organism viable but dormant in tissue and the source o f 
relapsing episodes o f infection? Moreover, what are the factors that allow the 
bacteremia to reoccur? Whether B. henselae DNA found in the tissue o f cats long after 
the acute phase of the infection represents sequestration o f a viable organism which has 
lost the capacity to form colonies on culture media or is nonviable and not the source of 
recurring infection is unknown. The concepts of culturability and viability are
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confusing. An organism that is culturable is able to reproduce and an organism that is 
viable is alive but not necessarily reproducing or culturable in the present state or 
environment. There are over 30 bacterial species in which a viable but nonculturable 
response occurs when exposed to adverse environmental factors (Oliver 1999). There is 
a great deal o f study necessary to understand the molecular and physiological basis of 
dormancy in microorganisms. Understanding the sensing mechanisms used by 
organisms in various environments inside and outside of the host and the responses 
generated to modify metabolism is a dominant theme in studying pathogenesis. 
Determining if the Bartonella DNA found in the cat is a source of clinical bacteremia 
when sequestered in the host and if there is a tissue predilection for sequestration will 
help in the understanding of the course of Bartonella infection in cats. Therapeutic 
decisions may evolve around the determination of persistence. Chronic infections may 
be eliminated by treatment of cats in the acute phase o f infection to avoid sequestration. 
Using RNA expression as an indicator for growth and metabolism of prokaryotic cells 
requires adequate amounts of RNA. The amount o f Bartonella DNA detected in the 
tissue of cats is probably low and a limiting factor in the recovery of detectable RNA. 
Another approach to characterizing the Bartonella DNA in terms of viability would be 
to inoculate tissue with detectable Bartonella DNA into other animals and observe for 
signs of infection.
From this research, Bartonella DNA was detected by PCR from culture-negative 
blood of infected cats. The infectious nature o f PCR positive and culture negative 
blood would be interesting to know and could be determined by infecting cats with this 
blood or using fleas for transmission.
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Knowledge of strain variability involved in Bartonella infections will allow for 
comparison of the diversity o f strains within cat reservoirs with the diversity o f strain 
that causes various human clinical syndromes. There may be strains that are more 
pathogenic similar to the strain B. henselae LSU-16. Using molecular strain typing 
methods such as pulsed-field gel electrophoresis o f endonuclease-restricted 
chromosomal DNA or restriction fragment length polymorphism (RFLP) of the 
intergenic transcribed spacer region may help identify the strains o f Bartonella.
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APPENDIX A
PILOT EXPERIMENT: CULTURE TECHNIQUES FOR ISOLATION OF 
BARTONELLA HENSELAE
Cat ID** Date infected* Date necropsied HIAb BBC VCd
1 1/97 6/97 - - -
10 1/97 6/97 - - -
33 1/97 6/97 - - -
43 1/97 6/97 - - -
46 1/97 6/97 - - -
48 1/97 6/97 - - -
55 1/97 6/97 - - -
57 1/97 6/97 - - -
61 1/97 6/97 - - -
62 1/97 6/97 - - -
63 1/97 6/97 - - -
B. henselae positive control + + +
** cats were blood culture negative
a Cats were infected with B. henselae Houston-1. Cats were necropsied and tissue taken 
for culture. Tissue sampled for culture included; lung, liver, spleen kidney, lymph node, 
bone marrow, tonsil, brain, uterus, ovary, blood, buffy coat, plasma. Blood was 
collected in Dupont Isolator tube, EDTA vacutainer tube.
b Heart Infusion Agar with 5%Rabbit blood. Cultures were incubated at 37% C in 5% 
CO2 for 3 weeks
c Brucella broth with Fildes 250 ug/ml and Hemin 6-8%. Cultures were incubated at 
37% in 5% CO2 for 3 weeks and subcultured on HI A agar
d Vero Cells-tissue was placed in tissue grinder for processing. Subcultures were made 
from vero cell culture on to HIA agar.
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APPENDIX B
SUMMARY OF RESULTS OF EXTRACTION TECHNIQUES
Sample_________________ Extraction technique_____ FFDR9*______ FFBBRb
Bartonella henselae 87-66 genotype I Qiagen* + +
Bartonella henselae Houston-1 type Qiagen* + +
Bartonella henselae LSU 16 Qiagen* + +
Bartonella henselae Baby Qiagen* + +
Bartonella clarridgeiae Qiagen* + +
ICM-3 (20 cfu/ml)c CTAB** - -
ICM-3 (20 cfu/ml)c Qiagen* + +
Cat 351-2 (90 cfu/ml)c CTAB** - +
Cat 351-2 (90cfu/ml)c Qiagen* + +
*Qiagen Kit for Tissue and Blood Extraction (Qiagen Inc., Chatsworth, CA)
** Preparation o f Genomic DNA from Bacteria Phenol chloroform CTAB extraction 
with ethanol precipitation (Current Protocols in Molecular Biology, 1994) 
a primers used in the first reaction o f the nPCR 
b primers used in the second reaction o f the nPCR 
c 200ul of blood used as sample
143
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX C
COMPARISON OF BLOOD SPECIMENS COLLECTED FROM CATS 
EXPERIMENTALLY INFECTED WITH BARTONELLA HENSELAE
Collection tube Culture" PCR1
Dupont Isolator™ +
Vacutainner Hepamin ND
Vacutainer EDTA + +
Vacutainer EDTA frozen ++
b
“blood was cultured on Heart Infusion Agar with 5% rabbit blood at 37°C in 5%
CO2 for 3 weeks
bpolymerase chain reaction done using Bartonella genus and species specific primers in 
50 pi volume using reaction mixture containing deoxynucleoside triphosphates (200 
pM each), 1.75 mM MgCh, 0.2 pM of each primer, 2.5 U of Taq DNA polymerase, 
AmpliTaq TM Gold, 4 pi of DNA template and 32.6 pi of Perkin Elmer buffer. The 
PCR amplifications were carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied 
Biosystems (Foster City, CA). Amplification reaction consisted o f 10 min. at 95°C; 30 
cycles of 94°C for 1 min.; 66° C for 1 min., 72°C for 1 min.; and a final elongation step 
at 72° C for 10 min.
+ low numbers 
++ high numbers 
ND not determined
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APPENDIX D
RESULTS OF VARIOUS SPECIMENS FOR PCR ASSAY FOR DETECTION
OF BARTONELLA HENSELAE
Specimen Number positive by PCR*
Serum3 
Mouth swabb 
Whole blood0
0/39
0/22
12/39
"polymerase chain reaction done using Bartonella genus and species specific primers in 
50 pi volume using reaction mixture containing deoxynucleoside triphosphates (200 
pM each), 1.75 mM MgCI2, 0.2 pM of each primer, 2.5 U o f Taq DNA polymerase, 
AmpliTaq TM Gold, 4 pi of DNA template and 32.6 pi of Perkin Elmer buffer. The 
PCR amplifications were carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied 
Biosystems (Foster City, CA). Amplification reaction consisted of 10 mins. at 95°C; 30 
cycles of 94°C for 1 min.; 66° C for 1 min., 72°C for I min.; and a final elongation step 
at 72° C for 10 min.
3 blood drawn in serum vacutainer tube and separated. 12 o f the 39 were positive using 
whole blood.
b sterile cotton swabs were used to swab the mouth of cats. Swabs were placed in sterile 
phosphate buffered saline for 1 hour and concentrated for PCR assay. All cats in this 
group were bacteremic as defined by PCR and culture.
0 blood was drawn in EDTA vacutainer tube and frozen before PCR assay performed.
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APPENDIX E 
BACTERIAL SPECIES AND REFERENCE STRAINS
Genus, Species and Strain Genotype Source G ene Bank 
Accession M
Bartonella henselae Houston-1 I ATCC #49882 AJ223780
Bartonella henselae 87-66 I ATCC #49793 AJ223780
Bartonella henselae LSU 16 II LAVMDL* NA**
Bartonella henselae Baby n LAVMDL* NA**
Bartonella clarridgeiae ATCC #700095 X97822
Bartonella quintana ATCC #VR-358 M73228
Bartonella elizabethae ATCC #49927 L01260
Pseudomonas aeruginosa ATCC #25330 X06684
Escherichia coli ATCC #11303 E05133
Bordetella bronchiseptica LAVMDL* NA**
Pasturella multocida LAVMDL* NA**
Staphylococcus aureus LAVMDL* NA**
Streptococcus pneumoniae LAVMDL* NA**
Brucella abortus LAVMDL* NA**
^Louisiana Veterinary Medical Diagnostic Laboratory 
**Not applicable
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APPENDIX F
INDIRECT FLUORESCENT ANTIBODY ASSAY (IFA) FOR BARTONELLA
HENSELAE
Antigen preparation:
1. Bartonella henselae LSU 16 grown in Vero Cells for 5 days or until > 80% 
infected. Antigen for IFA testing was prepared by pelleting and resuspending 
the microorganisms in 0.5% bovine serum albumin in phosphate-buffered 
saline (FBS).
Slide preparation
1. 12 well Teflon coated slides were washed with glass washing detergent and rinsed 
and soaked in 95% ethyl alcohol prior to use.
2. 5 pi o f antigens are spotted on slide with capillary tube
3. Antigen is allowed to completely air-dry and are fixed to slides by immersion in 
clean acetone for 15 minutes, then air-dried.
4. Slides are wrapped and stored in freezer.
IFA Procedure
1. Sul o f patient serum is added to 155 pi o f  Vero cells and allowed to incubate for 30 
minutes at 37°C.
2. Twofold dilutions of serum ranging from 1:32to 1:1024 were made in skim milk..
3. 25 pi of each dilution is added to antigen spot well with positive and negative 
controls.
4. Incubate slides for 30 minutes at 37°C in a covered dish.
5. Rinse slides in (PBS) for five minutes. Repeat once and rinse in distilled water. 
Allow slides to air dry.
6. Cover each antigen spot well with 25 pi o f FITC-conjugated goat anti-cat conjugate 
(Kirkegaard and Perry Laboratories, Gaithersburg, MD).
7. Incubate slides for 30 minutes at 37°c.
8. Rinse slides in PBS for five minutes. Repeat once and rinse in distilled water.
9. Slides are examined at 40x with a fluorescence microscope.
Interpretation o f Results: Slides are examined for fluorescing bacilli. A positive titer is
taken as 1:64 or greater.
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APPENDIX G
PERSISTENT BARTONELLA DNA FOUND IN VARIOUS TISSUES BY PCR
C a t# Strain AB ^  MPd Necropsy* Bartonella DNA in Th
1 LSU 16* na + 19 + (1 ,2 , 3 ,4 ,5 , 7, 8)
10 LSU 16* +b na 12 -
81 LSU 16* +c na 19 + (1,2, 3, 4, 5, 6, 7)
83 LSU 16* +b na 11 -
84 LSU 16* na + 19 -
85 LSU 16* na na 19 + (1 ,2 , 3,4, 6, 7, 8)
86 LSU 16* +b + 4 + (1 ,3 ,4 , 5, 7,)
87 LSU 16* +b + 8 + (1,2, 3,4, 5, 6, 7, 8)
182 LSU 16* na na >19 -
184 LSU 16* na na >19 -
223 LSU 16* na na >19 -
G3 LSU 16* na na 12 + (2, 7)
321 LSU 16* na na 4 + (2,3)
N3 LSU 16* na na 18 + (2)
LI Baby* na na 11 + (2)
361 Baby* na na 13 + (2,3, 8)
K3 Baby* na na 10 -
L2 87-66** na na 6 -
N2 87-66** na na 12 -
K4 87-66** na na 16 -
L3 Houston-1* na na 16 -
F5 Houston- l a na na 29 -
347 Houston-la na na 29 -
* lx l0 7 
* * lx l0 9 
a not infected
AB1* anti-LSU 16 or anti-Houston-1
MPd given three methylprednisolone injections 2 weeks
banti-5, henselae LSU 16
c anti-5, henslelae Houston-1
c weeks post-bacteremia, at time of necropsy
na-not applicable
1-liver
2-spleen
3-bone marrow
4-heart valve
5-lung
6-brain
7-lymph node
8-kidney
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APPENDIX H 
LETTER OF PERMISSION
Alma Roy
School of Veterinary Medicine 
Louisiana State University 
Baton Rouge, LA 70803
Dear Mrs. Roy,
You have my permission to use Figure 2.1: Primer Design, page 14, that is published 
my thesis titled: DNA DIAGNOSTICS FOR THE DETECTION AND 
IDENTIFICATION OF CAT SCRATCH DISEASE CAUSING AGENTS.
Sincen
Ronald Aaron Tapp Jr.
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APPENDIX I
SEQUENCE ANALYSIS OF PCR PRODUCT FROM  HEART VALVE O F CAT 
ONE. CAT ONE WAS EXPERIMENTALLY INFECTED WITH B. H ENSELAE  
LSU 16 GENOTYPE H.
1 TACCC ATCTCT ACGG AAT AAC AC AG AG AAA 45
46 TTTGTGCT A ATTT ACCGT AT ACGTCCT ATTTGGAGAAAGATTTATC 91
92 GGAGATGGATGAGCCCGCGTTGGATTAGCTAGTTGGTGAGGTAAC 136
137 GGCTCACCGAGGCGACGATCCATAGCTGGTCTGAGAGGATGATCA 181
182 GCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCA 225
316 GTG AAG AT AATG ACGGT AACCGG AG AAGAAGCCCCGGCT AACTT 359
405 G ATTT ACTGGGCGT AAAGCGC AT GT AGGCGG AT ATTT AAGTC AG A 449
450 GGTGAAATCCC AGGGCTCAACCCTTGAACTGCCTTTGATACTGGG 494
495 T ATCTTGAGTGTGG AAGAAGGG AG 519
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